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GENERAL INTRODUCTION
Surgery is still one of the main forms of treatment in the management of prima-
ry tumors and initial metastatic spread. Accurate surgical resection of cancer-re-
lated tissue requires a balance to be struck between radical excision, increasing 
the chance of a good oncological outcome, and minimal damage to healthy tis-
sues, decreasing the chance of surgery related side effects [1-3]. We and others 
have reasoned that resection of all diseased tissue while sparring healthy tissue, 
can be achieved when technologies become available that advance the surgical 
precision. It is of much importance, both during preoperative diagnosis and in-
traoperative guidance, that technologies become available that are able to spe-
cifically define and localize which tissues are tumor infected and which are not. 
When tracers are available that can specifically stain the disease-related tissue, 
a need is created for detection modalities able to carefully localize these tracers. 
Intraoperatively, such detection modalities can aid tracer localization via a com-
bination of acoustical, numerical or image-based feedback, providing a so-called 
‘image guided surgery’ setup.
 Radioactive tracers, also called nuclear tracers, are the clinical stan-
dard for molecular imaging due to their sensitivity and high tissue penetration 
[4]. Radiotracers are used for both preoperative diagnosis and intraoperative 
radioguidance. Fluorescent tracers offer complementary features such as high 
resolution, real-time and visual guidance within the surgical field [5]. Unfortu-
nately, tissue attenuation limits the value of fluorescence tracers to superficial 
indications [6]. Consequently, hybrid tracers, being both radioactive and fluores-
cent, have been investigated [7, 8]. These tracers provide a best-of-both-worlds 
scenario for lesion localization. To optimally benefit from these complementary 
tracer signatures, the development of dedicated hybrid surgical detection mo-
dalities has been proposed [9-11]. Surgical navigation takes the concept of im-
age guided surgery even a step further. Analogues to how we use the global po-
sitioning system (GPS) based navigation on our smartphones to guide ourselves 
through traffic in every-day-life, surgical navigation systems specifically guide 
the surgeon’s tool towards the targeted tissue in the patient [12, 13]. 
 In this thesis, the engineering of a number of novel tracing, imaging and 
navigation modalities is introduced and their potential within image guided sur-
gery has been evaluated. 
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OUTLINE OF THIS THESIS
Part one of this thesis is focused towards the concept of surgical navigation and 
investigates the application specifically in combination with fluorescence guided 
surgery. Chapter 2 starts off with an introduction in to the general concept of 
using navigation in the operating room. The first part of this chapter focusses 
on providing a technical background of the basic concepts needed for a surgical 
navigation workflow. The second part provides a short overview of the clinical 
applications, specifically looking at the fields of needle-based interventions, sur-
gical resections and orthopedic surgery. 
 My research efforts specifically focused on hybrid surgical guidance 
concepts that make use of both nuclear and fluorescence imaging. In particular, 
navigation was used to position the fluorescence camera, thereby facilitating 
the execution of fluorescence guided surgery for applications were lesions are 
located deep within the patient anatomy. Chapter 3 introduces the navigation of 
a fluorescence laparoscope in the robot-assisted surgery setting, a field rapidly 
emerging for a lot of different surgical indications (e.g. prostatectomy). In Chap-
ter 4, the same navigation concept was translated to a fluorescence laparoscope 
and exoscope, making the hybrid navigation concept applicable to both open 
surgery (evaluation in penile cancer patients) and laparoscopic surgery (evalu-
ation in prostate cancer patients). From the different proof-of-concept evalua-
tions reported in this thesis and the study by KleinJan et al. [14], it turned out 
that near-infrared optical tracking, used in the current navigation setup, in some 
cases obstructed fluorescence imaging. Chapter 5 investigates this limiting phe-
nomenon in detail, suggesting several engineering solutions that could be used 
to overcome this obstruction.
 Part two introduces the engineering of new (hybrid) detection modal-
ities. Chapter 6 describes the creation of a preclinical animal imaging modality 
able to optimally support preclinical hybrid tracer development. Chapter 7 in-
troduces the concept of freehand Fluorescence imaging, allowing for (pseudo-) 
3D imaging and navigation using fluorescent tracer signatures in the operating 
room. When combined with freehand SPECT this provides a singular hybrid mo-
dality, able to benefit from the advantages of nuclear and fluorescence imag-
ing to supply tracer imaging, navigation and augmented reality display. Chapter 
8 specifically focusses on optimizing detection of radioactive tracer signatures 
during robot-assisted laparoscopic surgery, introducing a tethered and highly 
flexible DROP-IN gamma probe. 
Chapter 9, the future outlook of this thesis, places all the introduced concepts, 
including surgical navigation, hybrid surgical guidance and DROP-IN modalities, 
in the perspective of computer-assisted surgery. This chapter provides a review 
of the recent clinical evaluations in this field, connecting the evaluated technol-
ogies and recommending future directions of research. A summary of the thesis 
is provided in Chapter 10.
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ABSTRACT
Anatomical and/or functional imaging modalities like computed tomography 
(CT), magnetic resonance imaging (MRI) and ultrasound, often combined with 
contrast agents, and molecular imaging modalities like single-photon emission 
computed tomography (SPECT) and positron emission tomography (PET) have 
become standard tools to aid in the diagnosis, monitoring and treatment of 
disease or injury. Yet, translating this wealth of detailed preoperative imaging 
information into better surgical treatment and clinical outcome is an ongoing 
challenge. Patient scans usually provide a 3D map of the disease, often placed 
in the context of the patient’s anatomy, that surgeons can use as a reference to 
guide them during an intervention. It would be very convenient for the surgeon 
to know exactly where surgical tools are on this map relative to the target loca-
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INTRODUCTION
An analogy can be made between surgical navigation and global positioning sys-
tem (GPS)-based navigation apps available on smartphones and similar devices, 
as illustrated in Figure 1. Smartphone navigation shows a map of our surround-
ings, analogous to a patient scan (Figure 1a). It shows our current location on 
this map (using GPS tracking), analogous to showing where surgical tools are 
in the image of the patient (Figure 1b). The user can mark the objective on the 
map, analogous to marking the location of the surgical target (e.g. tumor, lymph 
node; Figure 1c). Subsequently, the navigation app then suggests an optimal 
route between our current location and the objective, analogous to suggesting 
an optimal trajectory of the surgical tools to the target (Figure 1d).
 Navigation is a collective term that describes any workflow where pa-
tient scans, real-time tracking, and, occasionally, computer-aided planning are 
combined into real-time spatial information that provides orientation (Figure 1b, 
c) and sometimes even guidance to reach the target location (Figure 1d) during 
an intervention. The main benefit of this technology is the possibility to precisely 
indicate where structures of interest are located relative to the surgical tools in
Figure 1. Analogy between surgical navigation and smartphone navigation apps. (a) Raw 3D 
map of the region of interest (Depicted: Shibuya Station, Tokyo). (b) Current location of the surgical 
tools on the map, analogous to GPS localization. (c) The target location for navigation, i.e. the ob-
jective, can be marked on the map. (d) Guidance of surgical tools to the target along optimal path 
(in green), whilst avoiding damage to nearby critical structures. Images generated with Google 






3D. This is possible even when the structures of interest are covered by tissue 
and cannot be seen during surgery. Although surgical navigation technologies 
have not yet reached full maturity, clinical evidence already suggests it is of ben-
efit to many clinical applications. Navigation promises to bring machine preci-
sion to clinical interventions, and will likely contribute to the emergence of more 
precise, less invasive and, hopefully, more effective procedures.
 This chapter starts with the presentation of a typical navigation workflow 
and the methodologies behind this approach. Subsequently a broad overview of 
navigation in various clinical fields, including radioguided surgery, is provided. 
We close the chapter with a short discussion on the presented applications and 
the general developments we may expect in the upcoming years.
NAVIGATION WORKFLOW
The tracking systems (Figure 2.5) are an essential component in all navigation 
workflows as they define the intraoperative coordinate system during an in-
tervention. They are used to estimate the position and orientation of special-
ly marked objects (Figure 2.7,8). These estimates, combined with registrations, 
enable the placement of tracked tools, patient scans and, if available, (comput-
er-aided) planning in the same coordinate system. For object tracking, there 
are a number of different techniques available, e.g. near-infrared (NIR) optical 
tracking, electromagnetic (EM) tracking, mechanical tracking and acoustic track-
ing [1–4]. Of these techniques, NIR optical tracking and EM tracking are by far 
the most commonly used in clinical practice and will therefore be of main focus 
for this book chapter. With NIR optical tracking systems (Figure 2a.5), the emis-
sion and detection of NIR light is used to determine the position of trackers in 
space. To obtain stereo-vision, thus depth optical perception, this NIR light has 
to be captured by at least two cameras in a known spatial configuration. NIR 
optical tracking can only work when enough fiducial markers (small objects that 
each approximate a point and jointly representing three noncollinear points of 
a tracker; see next section) are in the line of sight of these NIR cameras. Marker 
occlusion, e.g. by surgical staff standing between the tracking system and the 
fiducials, is a limitation of this tracking technique and of optical tracking in gen-
eral.
 EM tracking systems (Figure 2b.5), on the other hand, rely on variations 
in the magnetic field generated by a dedicated field generator to determine the 
position of sensor coils present on the tracker relative to the generator. The 
varying magnetic field induces current and potential in the coils. Usually, mul-
tiple coils are combined into a single tracker, and the combined readings from 
these coils provide enough information to estimate the position and orienta-
tion of the tracker in space. Unlike NIR tracking, EM tracking systems do not 
require a direct line of sight to the trackers, but they have different limitations: 
19
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Figure 2. Overview of a typical navigation workflow. (a) Uses optical tracking and (b) Uses elec-
tromagnetic tracking. (c) Describes the sequence of steps in a typical workflow. 1 patient with 
tracker, 2 multiple patient scans, 3 computer-aided planning, 4 tracker visible in preoperative and 
intraoperative  coordinate  systems, 5 tracking system, 6 navigation platform, 7 tracked tools, 8 pa-
tient with tracker on OR table. CAD models of dummy human male (by LeonMaryasin) and hospital 
bed (by Felipe Ospina Ochoa) found in the community library of grabcad.com.
(1) Nearby metal objects can distort the magnetic field, leading to incorrect po-
sition and orientation estimations, and (2) the working volume of current EM 
tracking systems is usually smaller than that of NIR optical tracking systems.
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In most navigation workflows, the purpose of tracking surgical tools is to deter-
mine their position relative to the patient’s anatomy and the diseased tissue 
therein (as in Figure 1b) as such to better guide the surgeon during the proce-
dure. The typical navigation workflow will make use of preoperative imaging, 
meaning that the preoperative imaging data set (Figure 2.1-3) has to be coupled 
to the interventional intraoperative coordinate system (Figure 2.5-8). The trick 
used to achieve this preoperative and intraoperative co-registration is to place a 
special tracker (Figure 2.4) at the same position on the patient during preopera-
tive imaging and during the intervention. This tracker is, by design, both visible 
to the tracking system and easily segmented from the preoperative scan. Once 
segmented, the position of the tracker relative to the patient can be calculated, 
leading to a registration between the coordinates of the patient and the tracker.
 To use the patient scan as a 3D map that is accurately positioned in the 
intraoperative coordinate system, the patient-to-tracker registration has to be 
coupled to the tracked position of the tracker in the intervention room. Essential 
requirements for precise registration are the identical placement of the tracker 
during preoperative imaging and during the intervention, and as little tissue de-
formation as possible between imaging and the intervention.
 A tracker is an object that is visible to the tracking system and holds 
enough information for the tracking system to unambiguously establish all six 
degrees of freedom of the tracker in 3D space (three degrees of freedom for 
the position and three for the orientation). Trackers can be attached to surgi-
cal tools or to portions of the patient’s anatomy, enabling their tracking (Figure 
2.7,8). To accomplish tracking, the position of at least three noncollinear points 
must be monitored, as we illustrate in Figure 3. Most trackers are designed to 
be clearly visible to the tracking system and easy to segment from patient scans, 
as seen in Figure 2.4. Such trackers are visible both in the preoperative and in 
the intraoperative coordinate systems, providing the link between them and 
making registrations possible. The composition of a tracker is dependent on the 
tracking technology that will be used during the procedure. For example, NIR 
optical trackers (Figures 2a.4 and 3) consist of a rigid frame holding multiple 
(usually three noncollinear, sometimes more) fiducial markers. A fiducial marker 
is a small object that approximates a point. Most NIR fiducial markers are both 
clearly visible in preoperative scans and clearly visible to the tracking system. On 
the other hand, a modern EM tracker usually consists of a bundle of sensor coils 
inside a small case (around 0.5 cm3) attached to a cable (wireless variants exist 
[5], but are uncommon) (as an example, the small black box attached to the sur-
gical tools on Figure 2b.7 is an EM tracker). An EM tracker variant that is visible 
in patient scans (see Figure 2b.4) consists of a standard EM tracker attached to a 
frame that is large enough to be easily segmented in the patient scans.
21
2
Surgical Navigation: An Overview of the State-of-the-Art Clinical Applications
Figure 3. Fiducial markers on a rigid tracker. (a) One fiducial, no orientation information (b) Two 
fiducials, orientation around dotted line unknown (c) Three noncollinear fiducials, unambiguous 
position and orientation
 The (EM and NIR optical) trackers described above provide a simple way 
to perform tracking and registration to the patient scans; of course, more com-
plicated alternatives exist. For example, instead of a tracker, multiple loose fidu-
cial markers can also be used to track the position and orientation of an object, 
provided at least three fiducials are noncollinear. This is equivalent to using a 
tracker, since both approaches provide enough measurements to cover the six 
degrees of freedom. Some authors report the use of fiducials which are visible 
in the patient scans, but not to the tracking system. For example, Krücker et al. 
[6] reported placing such fiducials on the patient’s skin. During the intervention, 
the position of the fiducials then had to be marked by a tracked pointer, thus 
providing the connection between patient scans and tracking system.
Tracking of Surgical Tools
A similar, but simpler, approach is used to determine the position of the surgical 
tools in the intraoperative coordinate system. For this, a tracker is attached to 
the surgical tool that needs to be navigated. Here it is crucial that this tracker is 
placed at a predefined position on the surgical tool (see Figure 2.7), and that the 
tool is calibrated relative to the navigation platform. This calibration, in combi-
nation with the tracking information of the surgical tool tracker, allows tracking 
of the tip of the tool (or of any other part of the tool that is relevant during 
the intervention) thereby providing navigation from the perspective of the tip of 
the surgical tool. Tools like needles are routinely tracked using the methods de-
scribed above. Some authors even report tracking tools to aid in implant place-
ment [7–9]. Aside from surgical tools, it is also possible to track (handheld) im-
aging systems (e.g. ultrasound probes, gamma probes, portable gamma cameras 
and portable fluorescence imaging systems) as will be discussed later. A tracked 
scanning procedure performed with a handheld imaging system is referred to as 
“tracked freehand imaging”. 
A CB
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Limitations and Implicit Assumptions of Tracking
Most navigation workflows make an implicit assumption about the body that 
is being tracked, namely, that it is a rigid body, i.e. that it has exactly the same 
shape any time during preoperative imaging and during surgery. If a body does 
not deform, it is sufficient to track the position and orientation of a tiny portion 
of it to know where the rest is. This is the justification for only placing a sin-
gle tracker and/or a minimal amount of fiducial markers on a patient to track 
his or her position and orientation. Of course, the rigid body assumption may 
sometimes be unrealistic and can lead to mistakes. If the object being tracked is 
not a rigid body, the tracking approaches described in this text are, in general, 
inadequate. For example, a patient may change pose between preoperative im-
aging and the intervention without affecting the relative positions of the fiducial 
markers; in this case, the change in shape would not be detected by the tracking 
system. Surgeons must be aware of the implicit rigid body assumption of track-
ing systems and of the entailing limitations. In particular, it is always sensible to 
verify the precision of any registration between preoperative and intraoperative 
coordinates prior to and during an intervention, especially if a change in the 
shape of the patient is likely.
 Current tracking systems work by tracking a relatively small number of 
points in 3D; in general, this is not sufficient to deal with arbitrary deformations. 
Some authors, e.g. Krücker et al. [6] for thoracic and abdominal cavity inter-
ventions and Matziolis et al. [10] for navigated total knee arthroplasty, report 
the use of a redundant amount of fiducials/trackers, providing more information 
than necessary to obtain the six degrees of freedom of a rigid body. As a conse-
quence, more than one rigid body could be tracked in such a workflow. This can 
accommodate some kinds of movement, e.g. the movement of the tibia relative 
to the femur. Still, these multi-rigid, landmark-based, arrangements also make 
implicit rigidity assumptions on the patient’s shape, like the single rigid body 
case, and cannot accommodate arbitrary deformations particularly well. This 
said, redundant fiducials/trackers can be used to measure body deformation; if 
the spatial configuration changes during tracking, this information can be useful 
to correct, or at least explain, tracking errors during navigation. In addition, such 
findings may allow for elastic registrations which are a promising approach to 
handle body deformation (briefly discussed later in this chapter). Another rea-
son for a redundant amount of fiducials, specific to optical tracking techniques, 
is that some fiducials may not lie in the direct line of sight of the tracking system; 
a large amount of fiducials reduces the chance that less than three noncollinear 
fiducials are visible.
 On the other hand, images acquired with tracked freehand imaging are, 
due to tracking, automatically located in the intraoperative coordinate system; 
this means such images are already in the same coordinate system as the tracked 
surgical tools, rendering a registration between preoperative and intraoper-
ative coordinates unnecessary. As a consequence, navigating tools in tracked
23
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Figure 4. Image fusion. CT and SPECT are registered, which enables a fused visualization
freehand imaging scans is fairly straightforward. Such workflows are already re-
ported in literature [11–13]. In the absence of specialized (and expensive) op-
erating rooms with integrated MRI or CT scanners, tracked freehand imaging is 
often the only kind of 3D imaging that can be made available in the operation 
room. Intraoperative imaging can also be used to help verify the progress of a 
procedure, to cope with patient movement and sometimes even to quickly per-
form 3D intraoperative scans of the region of interest [11–14]. Tracked freehand 
ultrasound [15] is already available. An interesting novelty, especially for ra-
dioguided surgery, is tracked freehand SPECT, a SPECT generated from a tracked 
portable gamma camera [12, 13, 16–18].
Registration and Fusion
In the previous section, we explained how two coordinate systems (preoperative 
with patient scans and intraoperative with tracking information) can be connect-
ed via tracking of trackers, allowing objects from both coordinate systems to be 
shown in a single coordinate system. This connection between coordinate sys-
tems is called a registration. Since combining the complementary information of 
different patient scans allows for a more complete model of the patient, e.g. in 
the form of PET and MRI data, the registration concept described in the previous 
section should be expanded to more than two coordinate systems. This is readily 
possible using image registration. In fact, it is possible to register an arbitrary 
number of coordinate systems in a chain of registrations.
 In a typical navigation workflow, all preoperative scans (Figure 2.2) are 
registered to each other. In at least one of these preoperative scans, the patient 
has to be outfitted with a tracker (Figure 2.1); this scan is then used to register 
the preoperative and intraoperative coordinate systems. With this registration, 
all other preoperative scans are also (indirectly) registered to the intraopera-
tive coordinate system and can be navigated on. Registered patient scans are 
sometimes shown in composite views, where information from multiple scans is 
condensed into a single “fused” visualization, as illustrated in Figure 4. Note that 
registering multiple patient scans (i.e. performing image registrations) is often 
a complex and error-prone task, especially when there is deformation in the 
patient’s anatomy between scans. For this reason, image registrations should 




Figure 5. Types of registration. (a) Rigid registration, a composition of rotation and translation. (b) 
Elastic registration, a deformation field is applied to warp the square into a circle.
 Registration methods can be separated into two types: rigid and elastic. 
A registration that consists exclusively of a composition of rotation and transla-
tion is called a rigid registration (see Figure 5a). Rigid registrations can always 
be described by a transformation matrix. The vast majority of registrations cur-
rently performed in clinical practice, including most registrations using trackers 
or fiducials, are rigid. Rigid registrations are relatively easy to understand, fairly 
simple to verify, correct, and often precise enough for the intended application. 
But rigid registrations are, by definition, limited in the degrees of freedom that 
they can accommodate.
 A very common example of rigid registrations is a SPECT and CT regis-
tration (see Figure 4). Here a hybrid imaging device combines a measure of the 
distribution of a radiotracer (SPECT) with a scan of (CT) the patient’s anatomy 
in a single imaging session; no significant patient movement is assumed during 
imaging, so the transformation matrix for this rigid registration is the identity 
matrix. Since many clinical applications only require a good alignment inside 
a small region of interest, rigid registrations will often be sufficient, even if a 
correct rigid alignment of the whole scans is not possible. In the cases where 
rigid registrations are not adequate to align scans as a result of extensive tissue 
movement, e.g. breast MRI scans [19] or preoperative to intraoperative brain 
scan alignment [20, 21], other types of registration are required.
 Registrations that can handle arbitrary deformations, meaning random 
tissue movements, are called elastic or deformable registrations (see Figure 5b). 
Elastic registrations cannot be described by a transformation matrix, due to their 
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are the topic of image analysis papers for decades already, but their use in clini-
cal practice has been very limited thus far. The main reason for this is that there 
is a trade-off between flexibility, the ability to handle arbitrary deformations, 
and robustness, the ability to consistently yield reasonably precise registrations. 
There is not one sweet spot between flexibility and robustness that works for 
all clinical applications, meaning an elastic registration algorithm has to be fine-
tuned for each specific application. This, combined with the difficulty of finding 
an elastic registration method that works for the target application in the first 
place, greatly lowers the appeal of this technology, compared to the more gen-
erally applicable rigid registrations.
Computer-Aided Planning
Tracking and registration enable us to see the position of the tracked surgical 
tools overlaid on patient scans. The distance or the preferred route towards the 
target cannot be established with this information alone. Computer-aided plan-
ning software provides the navigation platform with the additional information 
needed to achieve both distance and route (Figure 1c) estimates. To enable such 
planning, it is necessary to segment (i.e. define the boundaries of) the target 
structure in the patient scans and provide this segmentation to the navigation 
platform. For some surgeries, damage to critical structures must be avoided at 
all costs; in such cases, navigation from point A to B in a straight line does not 
suffice (Figure 1c).
 Here navigation can be further improved to navigation along a path that 
avoids damage to nearby critical structures, as schematically shown in Figure 
1d. In order to provide such a “smart” route towards the target structure, it is 
also necessary to segment all critical structures that need to be avoided. To fur-
ther clarify this approach, we illustrate how computer-aided planning fits into a 
navigation workflow by considering the resection of a kidney lesion (see Figure 
6). The starting point is the patient scan shown in Figure 6a. If computer-aided 
planning is used, the kidney lesion and nearby critical structures are segmented 
(Figure 6b). This segmentation can then be used to compute an optimal trajec-
tory to the target (Figure 6c). This plan is transferred to the navigation platform 
and can be used to position the surgical tools along the computed optimal path.
 In computer-aided planning, manual and semi-automatic segmenta-
tions are currently the tools of choice in clinical practice. Manual segmentations, 
as their name implies, require manual drawings of the contours and interior of 
all structures that have to be segmented. The main advantage of manual seg-
mentations is that the user has complete control over what label each voxel 
in the 3D preoperative scan gets. However, manual segmentations can be ex-
tremely time consuming, especially for high-resolution 3D scans. Among all seg-
mentation methods, manual segmentations, unsurprisingly, also suffer from the 
highest interobserver variability. A semi-automatic segmentation is a manual 
segmentation with some automatic assistance. For example, a drawing tool that
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Figure 6. Computer-aided planning in the treatment of a kidney lesion. (a) Raw patient scans 
(b) Segmentation of kidney lesion (yellow), nearby critical structures (orange) and nearby bones 
(pink) (c) Optimal paths to lesion (green dotted lines); as short as possible whilst avoiding damage 
to critical structures.
automatically fills surrounding voxels of a similar color, or, for example, a tool for 
vessel segmentation, where only the start and endpoint of the segment have to 
be defined manually. Semi-automatic segmentations require far less user input 
and can be performed significantly faster and with higher reproducibility than 
manual segmentations. On the other hand, the user partially surrenders the seg-
mentation process over to the computer, thereby reducing his or her personal 
touch. Automatic segmentations, and in particular atlas-based segmentations 
[22], have improved a lot in recent years and are slowly gaining more accep-
tance.
 A fully automatic segmentation is a segmentation that requires no user 
interaction. The obvious advantage of automatic segmentations is that they nei-
ther need to be performed nor supervised by a trained medical specialist. Ex-
perienced human operators, whilst usually superior to automatic methods, are 
subject to time constraints and susceptible to boredom, unlike machines. These 
time and boredom constraints are not limiting when a single segmentation of 
a target structure has to be performed, but can become an issue when repet-
itive or more extensive segmentations are required. For example, segmenting 
all bones in thousands of full-body scans for an anatomy experiment would cer-
tainly yield interesting insights, but very few experts would volunteer for such a 
tedious task. Computers do not get bored; as a consequence, they can provide 
much more extensive segmentations than could reasonably be expected from a 
human expert. It goes without saying that automatic segmentations always have 
to be critically evaluated by an expert.
CLINICAL APPLICATIONS OF NAVIGATION
Attempts at surgical navigation have already been reported as early as the year 
1889 [23]; these involved stereotactic frames combined with generic atlases (i.e. 
maps) of the anatomy, used as reference during the procedure. Due to the an-
atomical variation found in humans, generic atlases cannot be correct for all 
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guidance. Patient-specific approaches to navigation, where patient scans are 
used instead of generic atlases, only became realistic with the development of 
3D imaging technologies like CT and MRI, that became commercially available in 
the 1970s [24] and 1980s, respectively. We focus on patient-specific navigation 
approaches in this chapter and do not delve further into publications from be-
fore the time of 3D imaging.
 Neurosurgery is one of the pioneering fields in surgical navigation; 3D 
navigation experiments are reported as early as 1986 [4]. Additional neuronav-
igation systems and studies are reported in the 1990s, e.g. by Germano et al. 
[25] and Gumprecht et al. [26], among many others. The navigation workflow 
described in these works corresponds to the “typical” navigation workflow seen 
in clinical practice today, namely, navigation of the surgical tools in preoperative 
patient scans. The most important limitation of this approach can be seen when 
the intraoperative reality significantly deviates from the anatomy depicted in 
the preoperative scans. In this case the estimated position of the tracked tools 
relative to the patient’s anatomy can be off by many centimeters, negating the 
precision benefits navigation is supposed to bring. Outside its application in neu-
rosurgery and in external beam radiation therapy (not discussed in this chapter; 
see Khan et al. [27] for a review on radiation therapy), navigation is not very 
widespread in clinical practice thus far, even though many other clinical applica-
tions could greatly benefit from a well-thought-out navigation workflow. Mount-
ing evidence of navigation’s benefits for particular types of treatment, ideally 
combined with a greater awareness of what is technically feasible, should slowly 
change this state of affairs. To grant the reader a short overview of how naviga-
tion can be applied in various clinical fields and what the current limitations are, 
the remainder of this section presents selected research on needle placement, 
navigated resections, and navigation in orthopedic surgeries.
Needle Placement
The objective of a needle placement procedure is to insert a needle into the 
patient so that the tip of the needle is as close as possible to the target location. 
Needles can be used to obtain biopsy samples, radio-frequency (RF) ablations, 
micro-wave ablations and electrode placement, among many other clinical ap-
plications. Some of these applications require a very precise needle placement, 
and it is expected that these will benefit most from navigation. The main chal-
lenge encountered during needle placement is that both the target location de-
fined on imaging and, once the insertion begins, the needle tip are not visible to 
the physician. To compound these difficulties, the tissue (or needle) may deform 
during or as a result of the needle placement.
 Needle navigation workflows combine patient scans with needle track-
ing. With tracking (and registration of the tracking system to the patient scans), 
the estimated (3D) position of the needle tip in the anatomy can be shown in 
real-time on all patient scans. In most needle navigation workflows, the target
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location is marked on one of the registered patient scans, as in Figure 1c; this way 
the navigation platform can indicate the current needle trajectory or estimate 
the shortest route from the needle tip to the target location. A more sophisti-
cated workflow could also incorporate the segmentation of critical structures 
along the possible paths of the needle, allowing for the selection of an optimal 
path towards the target location whilst avoiding damage to critical structures, as 
shown in Figure 6c.
 Stereotactic needle navigation is already used for decades to aid in the 
placement of electrodes for deep brain stimulation [28]. For more sophisticated 
navigation procedures, needles are usually tracked with the NIR optical or EM 
tracking systems. NIR optical tracking requires the tracker to be in direct line of 
sight of the cameras, meaning the tracker must be attached to a portion of the 
needle that is not inserted into the patient. Depending on the precision of the 
tracking system, and the distance from the tracker to the needle tip, aggravated 
by the possibility of needle bending, estimates of the needle tip position using 
NIR optical tracking may be somewhat imprecise. EM tracking does not possess 
the direct line of sight limitation, and trackers could be attached anywhere on 
or inside the needle. A particularly interesting recent development are minia-
turized EM trackers with less than 1 mm in diameter, i.e. narrow enough to be 
placed inside needles. As a consequence, EM tracking can now be used to direct-
ly track the tip of a needle [29]. Additionally, multiple EM trackers can be used to 
monitor the bending of needles [30].
 Müller et al. [31] investigated needle navigation for soft tissue biopsies, 
using NIR optical tracking. Navigated and conventional CT-guided liver needle 
biopsies were compared in five pigs, with a total of 20 tumors biopsied. The au-
thors report that the navigated biopsies, on average, involved significantly fewer 
CT scans (p = .01) and lower dose length products (p = .001) compared to the 
conventional biopsies. Krücker et al. [6] describe the navigation of needles for 
biopsies and RF ablations, mostly targeted at liver and kidney lesions. Their trial 
involved 51 navigated needle placements in 40 procedures with a workflow con-
sisting of segmenting the needle target location in preoperative CT scans, some-
times combined with PET scans. During the intervention, navigation of the (EM) 
tracked needle was combined with conventional ultrasound and 1–5 intraopera-
tive CT scans, to make a correct placement more likely. Both during registration 
and needle placement, the patient needed to hold his or her breath, to minimize 
registration errors. The authors compared the precision of conventional image 
guidance with that of navigation for 19 targets (liver, kidney, neck and paracar-
diac mediastinum). The authors report a significantly (p = .0006) better preci-
sion using navigation: range [0.4–12.1 mm] with median 2.5 mm, against range 
[3.3–81.9 mm] with median 14.8 mm. Additionally one interventional radiolo-
gist assessed the utility of all 51 placements: 22 of the placements (43 %) would 
be very difficult or impossible to perform without navigation and an addition-
al 24 placements (47 %) were facilitated by navigation. This study puts needle
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navigation in a very positive light, though the authors point out that the number 
of patients was relatively small and that a statistically meaningful comparison of 
outcomes with a control group was not performed.
 Ungi et al. [11] propose a radiation-free, ultrasound-only workflow for 
navigated facet joint injections. The assumption is that this workflow yields the 
same clinical outcome as alternatives using fluoroscopy or CT imaging, whilst 
minimizing radiation exposure of the patient and surgical crew. The suggested 
method would work as follows: (1) a tracked freehand ultrasound scan of the 
spine segment to be treated is performed prior to needle insertion; (2) after 
imaging, the target location is segmented in the reconstructed 3D ultrasound 
volume; and (3) the tracked needle is then navigated to the target. Recall that 
both tracked tools and images acquired with tracked freehand imaging are in the 
intraoperative coordinate system, so, in this case, no registration step is required 
prior to navigation. A particular problem in conventional ultrasound-guided nee-
dle placement is that the ideal needle path is often blocked by the transducer 
during insertion. Hence, separating the imaging and needle insertion steps is a 
sensible approach. The authors performed 100 facet joint injections in cadaveric 
lamb models, 50 using the conventional ultrasound-guided method and 50 with 
the suggested (navigated) method. This increased the insertion success rate 94 
% vs. 44 % and significantly shortened insertion times.
Navigated Resections
The surgical removal of all, or part, of an organ, tissue or structure is often per-
formed to treat diseases like cancer. To avoid recurrences, it is important to re-
move all tumorous tissue during surgery. Ideally the tumor should not be pierced 
during surgery, to avoid the spillage and possible spread of tumor cells. To ac-
complish both a thorough tumor removal and minimize spillage, surgeons usually 
define a safety margin surrounding the tumor and perform the resection around 
this margin; all tissue inside the safety margin is removed. The resected speci-
men is then sent to pathology to check for positive margins, i.e. the presence of 
tumor cells in the edges of the excised specimen. Ideally, pathology should con-
firm negative specimen margins in all tumor resections. Unfortunately, this is not 
always the case; for example, Jacobs [32] cites reports of positive margin findings 
ranging from 20 % to as high as 70 % for partial mastectomies. Identification of 
the boundary between the diseased and healthy tissues can be addressed by the 
use of tracers, especially radionuclides, as described in detail in other chapters 
of this book. Imprecise surgical resection, can probably be improved by naviga-
tion. For example, navigation is widely used to resect brain tumors; some of the 
first navigation systems were designed for neurosurgery applications [2, 25, 26]. 
On the one hand, the brain is quite susceptible to damage, so surgical interven-
tions should be as precise and minimally invasive as possible, yielding good dis-
ease treatment whilst minimizing the chance of permanent neurological dam-
age. Moreover, the brain is embedded in a rigid bone case (the neurocranium), 
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meaning it does not deform significantly between imaging and surgery. This 
strong need for precision combined with the favorable rigidity of the target anat-
omy led to the development of clinically and commercially successful neuronav-
igation systems (using NIR optical tracking), which make use of preoperative CT 
or MRI scans. Over the years, attempts to integrate many neurosurgery specific 
tools, like pointer tools or even entire surgical microscopes [3, 26], have been 
reported.
 Many resections, including brain tumor resections, involve significant 
tissue deformation during surgery, making traditional preoperative scan-based 
navigation progressively more imprecise. To counter this, intraoperative CT and 
MRI systems have been suggested [33, 34]. Due to their relatively high price, 
complicated logistics, large volume, and relatively long acquisition times, it is 
questionable if these imaging systems will find widespread adoption in clinical 
settings. Tracked freehand imaging may prove to be a more viable intraoperative 
imaging solution. Unsgaard et al. [14] describe a modern neuronavigation work-
flow for brain tumor resections with preoperative MRI for initial planning and 
multiple intraoperative tracked ultrasound scans to monitor the progress of the 
resection and to cope with brain shift [20]. The system used by the authors si-
multaneously shows the position of the tracked instruments side-by-side on the 
preoperative MRI and on the latest ultrasound volume. Whenever significant tis-
sue changes occurred, a new ultrasound scan was performed and the navigation 
procedure was adapted. In addition to more accurate navigation, the authors re-
port that intraoperative ultrasound was very useful in detecting residual tumor 
after the planned resection was performed. In their subjective experience, in 
over half of the 91 procedures investigated, residual tumor was discovered in re-
sections that were otherwise considered to be complete. The system described 
by the authors used NIR optical tracking.
 Radioguided interventions are interventions that make use of tracers, 
especially radioactive tracers that allow for SPECT and PET imaging; fluorescent 
and hybrid fluorescent-radioactive tracers are also used for some applications 
[35–37]. Tracers mainly aid in the detection of target structures (like tumors or 
lymph nodes) and in more precise refinement of their borders. Tracers can be 
of use both preoperatively, enabling SPECT/CT (Figure 5) and PET/CT scans, and 
intraoperatively, providing real-time acoustic or visual feedback from radiation 
or fluorescence readings [38–41].
 SPECT, and to a lesser extent PET, scans are generally used to preopera-
tively identify the lesions that should be taken out during surgery using special-
ized imaging devices, like gamma probes (1D) or gamma/fluorescence cameras 
(2D) [42, 43]. A logical evolution of this is to track the intraoperative devices, 
allowing navigation of them on the preoperative images, possibly reducing 
the time needed and increasing the accuracy of the intraoperative radioactive 
hotspot localization. Brouwer et al. [44] successfully navigated a tracked gamma 
probe in preoperative SPECT/CT images towards sentinel lymph nodes in ten
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patients with penile carcinoma. Here preoperative SPECT/CT-based naviga-
tion was combined with the intraoperative acoustic feedback produced by the 
tracked gamma probe. Tracked gamma probes can be used even more extensive-
ly in navigation workflows, for the generation of freehand SPECT [16] scans, that 
can be created during both the pre- and intraoperative process. Freehand SPECT 
scans have a smaller field of view and may have lower resolution than traditional 
SPECT scans, but they can be performed with cheaper and significantly less bulky 
devices. A particular advantage of freehand SPECT is that multiple scans can be 
performed during surgery if necessary, allowing the surgeon to double-check 
his or her work thereby decreasing the chance of incomplete resections. Rahbar 
et al. [45] performed navigated parathyroidectomy combining both preopera-
tive SPECT/CT and freehand SPECT. Other authors report performing navigated 
sentinel lymph node biopsies on freehand SPECT scans in, for example, breast 
[12] and head and neck cancer [13, 46]. Recently, Engelen et al. [47] reported on 
the use of the freehand SPECT technology in combination with a mobile gamma 
camera. Compared to the gamma probe-based procedure, the use of a mobile 
camera could speed up the generation of the freehand SPECT, and the sensitivity 
of the camera might help improve lesion resolvability. All freehand SPECT works 
cited here used NIR optical tracking to track the gamma probes.
 With the introduction of hybrid tracers, that contain both a radioactive 
and a fluorescent label (e.g. indocyanine green (ICG)-99mTc-nanocolloid [38, 39, 
48]), the field of radioguided surgery further expanded. These tracers can ex-
tend navigation workflows based on SPECT/CT and freehand SPECT with intra-
operative fluorescence image guidance. Brouwer et al. [49] presented a proof of 
concept via navigation of a tracked fluorescence laparoscope towards the hybrid 
tracer-containing sentinel lymph node seen on preoperative SPECT/CT. Here, as 
soon as the fluorescence laparoscope was near enough to the sentinel lymph 
node, fluorescence imaging could be performed to complement the navigation. 
A requirement for a successful hybrid workflow is that navigation leads the lap-
aroscope to less than 1 cm from the target location, since fluorescence signal 
depth penetration is only around 1 cm in human soft tissue [50]. The benefit 
provided by the fluorescence imaging is that a real-time visual feedback of the 
tracer with respect to the local anatomy is provided. This real-time feedback can 
be used to better cope with potential inaccuracies in the SPECT/CT-based navi-
gation, e.g. due to patient movement and tissue deformation.
Navigated Orthopedic Surgeries
Orthopedic surgeries are performed to treat fractures and congenital muscu-
loskeletal malformations and to replace worn out joints with implants, among 
many other applications. Many orthopedic surgeries, especially procedures 
involving implant placement, are focused on bones, making them particularly 
promising candidates for navigation. Bones, unlike soft tissue, usually do not 
deform. This rigidity should, therefore, lead to precise registrations and, as a 
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consequence, precise navigations. The assumption is that the machine precision 
provided by navigation leads to a faster and more precise implant placement. 
This increased implant placement accuracy may lead to a better clinical out- 
come, e.g. increased range of motion, better joint stability, increased implant 
longevity and later onset of arthritis.
 Rambani et al. [51] reviewed numerous applications of navigation in or-
thopedic surgery, with an emphasis on navigated total knee arthroplasty (TKA) 
and total hip arthroplasty (THA). The authors pointed out that both for TKA and 
THA, correct implant alignment is essential to increase implant longevity and 
to achieve a good functional outcome. It was assumed that navigation may im-
prove implant alignment compared to conventional TKA and THA. However, a 
recent meta-analysis involving 3423 patients (33 studies) concluded that navi-
gated TKA brings no clear benefits in clinical outcome compared to conventional 
TKA, whilst at the same time, the mean duration of surgery was increased by 23 
% [52]. On the other hand, a meta-analysis of three THA studies (n = 250) con-
cluded that navigation in THA improves the precision of acetabular cup place-
ment [53]. Taking both these studies into account, the authors conclude that the 
potential benefits of navigation both for TKA and THA are not yet clearly proven 
or disproven and suggest multicenter randomized controlled trials with long-
term follow-up for these procedures.
 Larson et al. [7] described the navigated placement of pedicle screws in 
pediatric patients with congenital spine deformity. Their workflow consisted of 
an initial planning of the screw placement performed on preoperative CT scans. 
Then, during surgery, one or more intraoperative CT scans of the spine, with 
an optical tracker screwed onto the patient, were used for surgical navigation 
(as in Figure 1b). This form of navigation allowed the authors to measure the 
width and depth of each screw tract, allowing screw dimensions to be custom 
fit to each pedicle. Results of 14 patients were presented (four cases of isolated 
hemivertebra and ten cases of complex spinal deformations), with a total of 142 
screws placed. In this study, a 99.3 % success rate was achieved, even though 
the majority of screws was placed in vertebrae with congenital deformities. The 
authors report that comparable precision for pedicle screw placement without 
navigation was obtained in other studies [54], albeit for patients without con-
genital spine deformity.
 Both Rana et al. [9] and Gander et al. [8] describe the reconstruction 
of unilateral orbital fractures combining the use of selective laser-melted pa-
tient-specific implants (PSIs) and navigated implant placement. Gander et al. 
point out that inadequate implant shape and imprecise implant placement may 
lead to visual disturbance and aesthetically poor results. It is assumed that PSIs 
have a shape that better fits to the fractured anatomy and that navigation im-
proves the precision of the implant placement. The workflow starts with a CT 
scan of the patient, depicting both the fractured and the uninjured orbits, fol-
lowed by a computer-aided planning step to determine the desired shape of the
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implant. PSIs are outfitted with ridges and landmarks, which enable navigated 
placement. The implants are not tracked directly; instead a tracked pointer is 
manually placed along the implant’s ridges and landmarks during navigated in-
sertion. Once the implant is in place, the tracked pointer can be used to verify 
that the implant placement is precise enough, potentially avoiding the need of 
additional scans to verify the implant placement after surgery. The navigation 
is performed on the preoperative CT scan. Both groups proceed to analyze if 
the proposed workflow is superior to the more traditional (manually) pre-bent 
titanium mesh (PBTM) implants. Based on their experiments, both groups sug-
gest PSIs are superior to PBTM implants. Unfortunately, none of the groups di-
rectly measured the impact navigation had on the procedure or on the clinical 
outcome; navigation was simply used in all procedures, presumably under the 
assumption that this would lead to more precise (or equally precise, but faster) 
implant placement.
DISCUSSION
In this chapter we described surgical navigation methods and their clinical appli-
cations over a broad range of medical fields. Navigation promises to bring ma-
chine precision to the operating room. Most authors reported a positive opinion 
of navigation, usually backed by experimental results from (small) clinical stud-
ies. Additionally, many authors expressed the subjective opinion that navigation 
was beneficial or helpful for their respective application; Krücker et al. [6] go 
as far as stating that “procedures were facilitated that would have otherwise 
been difficult or impossible to perform without this technology”. These results 
place navigation in a good light, but there are some issues that still need to be 
considered.
 We identified three navigation workflow variants in clinical practice. The 
first variant is navigation on preoperative scans alone, which is usually seen in 
interventions with no significant tissue deformation during surgery, for exam-
ple, the navigated reconstruction of unilateral orbital fractures [8, 9]. The same 
type of navigation can also be used to bring surgical instruments close to the 
target location in (laparoscopic) surgeries, as reported by Brouwer et al. [49]. 
Navigation on preoperative scans is the most straightforward and probably most 
widely used navigation variant. In some cases, however, the navigation based 
on preoperative scans alone can become quite imprecise, especially in the lat-
er stages of an intervention, where significant tissue deformation and patient 
movement may have taken place. To date tissue deformation and patient move-
ment between imaging and surgery present significant challenges to navigation 
on preoperative scans. Fortunately, many creative solutions to detect and deal 
with deformation are already reported in literature. Krücker et al. [6], who in-
vestigated navigation in the thoracic and abdominal cavities, mentioned breath 
holding and respiratory gating to minimize deformations. Using a redundant
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amount of fiducials, non-rigid movement could be detected. A second navigation 
variant combines navigation on preoperative scans with intraoperative scans. In 
this variant, the navigation on preoperative scans only provides rough guidance, 
and, whenever more precision is needed, intraoperative scans are taken. Such 
workflows are described in [6, 7, 14]. Navigation workflows using preoperative 
scans alone are unsuitable for many clinical applications. With the integration 
of intraoperative imaging into a workflow, such navigation can, however, be ap-
plied in a much broader range of settings. The final navigation variant is naviga-
tion on intraoperative scans alone. This variant has become practical with the 
recent emergence of tracked freehand imaging. Recall that both tracked tools 
and images from tracked freehand imaging are in the same coordinate system, 
meaning no registration between patient scans and surgical tools is required, 
thus leading to a simpler navigation workflow. This navigation variant is already 
reported by a few groups [11–13], and we expect this list to grow significantly 
with the more widespread adoption of tracked freehand imaging systems.
 Regarding tracking technologies, both EM and NIR optical tracking are 
widely used both for freehand imaging and navigation. Both technologies work 
well most of the time. Tracker occlusion is the main drawback of NIR optical 
tracking; distortion of the magnetic field due to metallic objects and small work-
ing volume are the drawbacks of EM tracking. It is not yet clear which technology 
will become dominant. However, with the advent of miniaturized EM trackers, 
that fit inside needles and can directly track the tip [29], it seems EM tracking 
has an advantage, at least, in needle placement interventions.
 Most navigation workflows presented in this chapter compared favor-
ably to their conventional, non-navigated alternatives. This, however, is not suf-
ficient evidence to make blanket statements about the usefulness of navigation 
in general. In fact, there also is evidence suggesting that navigation provides no 
tangible benefits during some types of surgery; for example, Bauwens et al. [52] 
pointed out that navigation seems to bring no benefits to TKA surgeries. Another 
important issue is the amount of evidence presented to back up the claims of 
the benefits of a navigation workflow. Randomized controlled trials (RCT) involv-
ing large numbers of patients, the current gold standard for clinical trials, have 
not been performed for any of the reported methods. An open question is how 
much and what kind of evidence is considered sufficient to prove the benefits 
(or lack thereof) of a navigation workflow. It is unclear how the alleged benefits 
of a particular navigation workflow compared to an equivalent non-navigated 
alternative should be measured. Perhaps precision should be measured directly, 
as reported by Krücker et al. in [6], where the needle angle insertion is measured 
both for the navigated and non-navigated workflows; based on these measure-
ments, estimates of the procedures’ precision can be calculated and compared. 
Or perhaps the clinical outcome after a number of years should be evaluated 
instead, as in the meta- analysis of TKA and THA clinical studies reported by 
Rambani et al. in [51]. Alternatively, the subjective opinion of an expert [6, 14] 
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may also provide a relevant measure. Should the experience of a surgeon also 
influence the measure? If so, how should one combine results from multiple sur-
geons with different skill sets? The lack of a consensus on how to measure the 
benefits of a navigation workflow surely stands in the way of large clinical trials. 
It is unclear when, or even if, a consensus on this measure will emerge. Even if 
a consensus measure emerges, one should consider if RCTs are the ideal type 
of trial for navigation workflows. Can clinical equipoise, i.e. the existence of a 
general uncertainty in the expert medical community over whether a technique 
is beneficial or not, be assumed for all navigation workflows? If a surgical team 
strongly believes a navigation workflow is superior to the alternative for a specif-
ic type of surgery, is it acceptable to perform non-navigated surgery just for the 
sake of a more statistically sound trial? Given all these questions, chances are 
RCTs will not be performed for many current and future navigation workflows. 
Alternative ways of gathering convincing evidence should probably be investi-
gated. It should be pointed out that convincing evidence of the clinical benefits 
of a technique is a precondition for reimbursement by health insurance compa-
nies in many countries, so providing such evidence for navigated workflows is 
essential for them to become mainstream.
 Whilst navigation is not (yet) the ultimate solution to improve surgical 
outcomes across the board, it does seem to be genuinely beneficial in various 
types of surgery. Evidence suggesting better clinical outcomes in these cases 
combined with ever lower barriers to its adoption leads us to believe that the 
use of navigation will be much more widespread in the near future, hopefully 
contributing to better clinical outcomes for ever more patients.
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ABSTRACT
Robot-assisted laparoscopic surgery is becoming an established technique for 
prostatectomy and is increasingly being explored for other types of cancer. 
Linking intraoperative imaging techniques, such as fluorescence guidance, with 
the three-dimensional insights provided by preoperative imaging remains a 
challenge. Navigation technologies may provide a solution, especially when di-
rectly linked to both the robotic setup and the fluorescence laparoscope. We 
evaluated the feasibility of such a setup. Preoperative single-photon emission 
computed tomography/X-ray computed tomography (SPECT/CT) or intraopera-
tive freehand SPECT (fhSPECT) scans were used to navigate an optically tracked 
robot-integrated fluorescence laparoscope via an augmented reality overlay in 
the laparoscopic video feed. The navigation accuracy was evaluated in soft tissue 
phantoms, followed by studies in a human-like torso phantom. Navigation accu-
racies found for SPECT/CT-based navigation were 2.25 mm (coronal) and 2.08 
mm (sagittal). For fhSPECT-based navigation, these were 1.92 mm (coronal) and 
2.83 mm (sagittal). All errors remained below the <1-cm detection limit for flu-
orescence imaging, allowing refinement of the navigation process using fluores-
cence findings. The phantom experiments performed suggest that SPECT-based 
navigation of the robot-integrated fluorescence laparoscope is feasible and may 
aid fluorescence-guided surgery procedures.
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INTRODUCTION
Despite the fact that robot-assisted laparoscopic surgery can provide value in 
many surgical applications (e.g., gynecologic [1], liver [2], and rectal [3] surgery), 
it is still most commonly used for the surgical management of prostate cancer 
[4]. In addition to the removal of the primary prostate cancer (prostatectomy), 
such procedures are often accompanied by a form of lymph node dissection fo-
cused on the removal of lymphatic metastases, e.g., a (extended) lymphadenec-
tomy, a sentinel node (SN) procedure [5], or, in the future, a prostate-specific 
membrane antigen targeted nodal dissection [6]. 
 It is widely accepted that image guidance toward the (possible) location 
of prostate cancer metastases may help improve surgical accuracy and therefore 
reduce the procedure-associated side effects [7]. It is for this reason that the da 
Vinci robotic platform (Intuitive Surgical Inc., Sunnyvale, California) is now rou-
tinely equipped with a near-infrared (NIR) fluorescence laparoscope (Firefly, In-
tuitive Surgical Inc.). The concept here is that fully integrated visual identification 
of the target, using fluorescence guidance, helps the urologist to interpret the 
surgical field and, as such, improves surgical guidance. Unfortunately, fluores-
cence guidance has a very limited in-depth signal penetration due to absorption 
and scatter of the fluorescence excitation and emission light by tissue (roughly 
<1 cm) [8,9]. This makes the technology lose value when lesions are located at 
unknown locations hidden deep within the patient’s anatomy. We underlined 
this shortcoming during robot-assisted SN biopsy procedures that made use 
of a tracer that is both radio- and fluorescence-labeled indocyanine green (IC-
G)-99mTc-nanocolloid [10,11]. These studies illustrated that, dependent on the 
camera system, up to 19.6% of the SNs were missed during the urologist’s fluo-
rescence-based inspection of the surgical field. Here, insight with regard to the 
tracer location, provided by the preoperative single-photon emission computed 
tomography/X-ray computed tomography (SPECT/CT) images, enabled the urol-
ogist to also resect the SNs not directly visible using fluorescence imaging. Ex 
vivo fluorescence imaging then confirmed the presence of the fluorescence sig-
nal in the resected SNs.
 Based on the preoperatively acquired imaging information, surgeons 
can cognitively plan their route toward target structures [e.g., tumorous tissue 
or (tumor positive) lymph nodes] and around delicate structures (e.g., blood 
vessels, nerves, and/or ureters). Unfortunately, applying this information in the 
operating room (OR) remains challenging. The link between using pre- and intra-
operative imaging methods may be strengthened using surgical navigation (via 
e.g., optical patient tracking), allowing a technological integration of pre- and 
intraoperative findings. Applying this technology to soft tissue environments is 
challenging due to tissue shift and deformation. Here, movement after acquisi-
tion of the patient scan(s) poses the biggest problem [12-15]. Such deformations 
can only be corrected using intraoperative imaging findings and/or reference
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marker points placed at the tissue of interest. For example, a radioactive readout 
can be used to confirm the navigation accuracy or even provide an intraoperative 
freehand SPECT (fhSPECT) scan that allows for navigation in a three-dimensional 
(3-D) “snapshot” map generated in the OR setting [16-19]. Alternative to (or in 
conjunction with) using a radioactive signature for intraoperative confirmation 
of the navigation accuracy, validation in the form of fluorescence imaging can 
be used [20,21]. In this study, we describe the integration of the above features
in a robotic setup using (human-like) phantoms. For this, we used both SPECT/
CT and fhSPECT findings as the basis for the navigation process. Additionally, 
we have integrated these data sets into the laparoscopic video feed using an 
augmented reality overlay. Such a “hybrid navigator” concept also means that in 
the future, different pre- and intraoperative imaging sources can be integrated 
in an interactive augmented reality view that can be fed into the console of the 
operating urologist.
METHODS
Navigated Fluorescence Laparoscope Setup
The complete navigation setup consisted of a combination of the Firefly lapa-
roscope, integrated with the da Vinci® Si surgical robot, and the declipseSPECT 
navigation system (SurgicEye GmbH, Munich, Germany; Figure 1a) with integrat-
ed NIR optical tracking system (OTS; Polaris Vicra, Northern Digital Inc., Water-
loo, Canada), which provides a tracking accuracy <0.5 mm (95% confidence in-
terval; 0.25 mm root mean square (RMS) [22]). Different reference targets were 
used to optically track the 3-D position and orientation (3-D pose) of objects, 
such as the laparoscope, gamma probes, and the different phantom setups. All 
reference targets contained a unique asymmetric geometry of at least three fi-
ducials visible to the OTS.
 To allow for the navigation device to describe all the different objects 
(e.g., surgical target and laparoscope) in the surgical workflow, all objects had to 
be connected by placing them in a common coordinate system provided by the 
OTS [23]. Transforming a 3-D object pose from one coordinate system to another 
was achieved using 4 × 4 transformation matrices. An overview of the differ-
ent transformations needed in this setup is illustrated in Figure 1. Estimation of 
these transformations is described in more detail throughout the text below.
Single-Photon Emission Computed Tomography/X-Ray 
Computed Tomography 
Before acquisition of the SPECT/CT scan, a three-fiducial phantom reference tar-
get (PRT) was fitted to the exterior of the phantom setups, allowing for optical 
tracking by the OTS. It remained at a fixed position with respect to the phantom 
throughout the experiments. Next to its visibility to the OTS, this PRT is also
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Figure 1. Overview navigation setup and underlying coordinate transformations. (a) Schematic 
overview of the navigation setup showing the navigation system with the overhead camera and 
OTS positioned above the patient. Both patient and fluorescence laparoscope are tracked with a 
unique reference target. Transformations from both the PRT and LRT coordinate systems to the 
OTS coordinate system are displayed with the red arrows. (b) Zoom-in of the PRT and LRT fixed to 
the patient and laparoscope, respectively. The green and blue arrows in the lower left corner are 
figurative and describe the transformation from the SPECT data coordinate system to that of the 
CT data and from the CT data to the PRT, respectively. The blue LRTTCAMERA transformation arrow is 
calculated in the calibration shown in (c) and the blue LRTTLTIP transformation arrow is calculated in 
the calibration shown in (d), with LTIP indicating the laparoscope’s tip. (c) Schematic overview of 
the coordinate transformations in the checkerboard calibration step. Both of the blue transforma-
tion matrices shown here are found in this calibration step. The green transformation is given to 
the navigation system (here, CB stands for checkerboard and CBRT stands for checkerboard refer-
ence target). (d) Schematic overview of the coordinate transformations in the tip calibration step. 
This calibration step determines the blue transformation matrix LRTTLTIP. Similar as stated above, the 
green transformation is given to the navigation (here, CRT stands for calibrator reference target). 
3-D models of dummy human male (by user Areshero) and hospital bed (by user Felipe Ospina 
Ochoa) come from the community library of grabcad.com.
clearly distinguishable in the CT imaging data, allowing the navigation system to 
segment it from the CT imaging data and calculate the transformation PRTTCT from 
the CT coordinate system to the PRT coordinate system (Figure 1b) [20]. Since 




















Healthcare GmbH, Erlangen, Germany) was a combined apparatus, the regis-
tration between the CT and SPECT imaging data itself is provided in the digital 
imaging and communications in medicine tags of the 3-D images. This allows for 
the connection between the SPECT imaging data and the CT coordinate system 
provided by the transformation matrix CTTSPECT.
Freehand Single-Photon Emission Computed Tomography
Multiple fhSPECT scans were acquired using either an SOE 311 gamma probe 
with a Europrobe 3 control unit (Eurorad S.A., Eckbolsheim, France) or a HiSens 
gamma probe with a, SG03 control unit (Crystal Photonics GmbH, Berlin, Ger-
many). A four-fiducial gamma probe reference target (GPRT) was fitted to allow 
tracking of these modalities by the navigation system. Scanning times varied be-
tween 2 and 3 min. Placement of the PRT was the same as for SPECT/CT-based 
navigation. Using both the PRT and the GPRT during the fhSPECT acquisition, the 
3-D fhSPECT scanning data can be placed in the navigation workflow by linking 
it to the PRT via the 4 × 4 transformation matrix PRTTfhSPECT, provided by the navi-
gation system itself. 
Fluorescence Laparoscope
During the navigation experiments, both the standard laparoscope white-light 
setting and the fluorescence light setting were used. To connect the laparo-
scope video feed to the navigation system, an Epiphan frame grabber (DVI2PCIe, 
Epiphan Systems Inc., Ottawa, Ontario, Canada) was integrated into the naviga-
tion cart. Either the laparoscope processed video feed was connected directly 
from the digital visual interface (DVI) output at the back of the surgical robot vi-
sion cart or the laparoscope raw video feed was connected from the component 
output on the back of the camera console. To track the 3-D pose of the laparo-
scope with the navigation system, a three-fiducial reference target was attached 
to the camera housing (laparoscope reference target (LRT); see Figure 1b). The 
optical wavelengths used for object tracking and fluorescence emission partly 
overlapped, being both in the 800- to 900-nm range. Nevertheless, interference 
issues were not expected during intra-abdominal use of the laparoscope.
 An adapted version of the declipseSPECT 6.0 (SurgicEye GmbH) software 
was used to incorporate the laparoscope video feed in both calibration and nav-
igation workflows. Two steps of calibrations were performed with the fluores-
cence laparoscope to allow proper use in the navigation workflow:
1. Calibration of intrinsic and extrinsic camera-system parameters using a 
“checkerboard” calibration and the Open Source Computer Vision (OpenCV) 
camera calibration library [24]. The intrinsic camera parameters were the 
focal length and principal point while the extrinsic camera parameters de-
scribed the translation and rotation with respect to the LRT coordinate sys-
tem represented by the transformation matrix LRTTCAMERA (see Figure 1b-c).
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The calibration of these camera parameters was performed to enable an 
augmented reality projection of the processed pre- or intraoperative imag-
ing data on top of the fluorescence laparoscope video feed; thus providing 
the augmented projection of navigation targets (with SPECT) and anatomi-
cal reference (with CT) in both the whitelight and fluorescence light camera 
options.
2. Calibration of the 3-D pose transformation from the coordinate system of 
the laparoscope tip to that of the LRT was defined as transformation matrix 
LRTTLTIP (see Figure 1d). The laparoscope tip calibration was performed with a 
cylindrical construction (a calibrator), tracked with a four-fiducial calibrator 
reference target (CRT). Because of the known geometry of the calibrator, it 
was possible to determine the relation between the CRT and the center of 
the tip of the laparoscope, represented by the transformation matrix CRTTLTIP. 
During the navigated procedure, this tip calibration allows the navigation 
system to display the relative distance from the laparoscope tip to one of the 
selected navigation targets.
Soft Tissue Phantom
The soft tissue phantom setup (Figure 2a) consisted of a tray with the PRT placed 
on a stand and a silicone half sphere with four Eppendorf tubes (Eppendorf AG, 
Hamburg, Germany) placed inside. The silicone half sphere structure, with a di-
ameter of ~15 cm at its base and a height of ~5 cm, was cast from Dragon Skin® 
FX-Pro silicone rubber (Smooth-On Inc., Macungie, Pennsylvania), with addition 
of Thi-Vex® Silicone Thickener (Smooth-On Inc.) for the skin part and Slack-
er® Tactile Mutator (Smooth-On Inc.) for the softer fat part. SilTone pigments 
(FormX, Amsterdam, The Netherlands) were used to color the rubber.
 Two 260-μL Eppendorf tubes served as the navigation targets, to be 
scanned with (fh)SPECT imaging, and were placed at roughly 5 cm apart. With 
a volume of 260 μL, the Eppendorf tubes should resemble a typical lymph node 
size found in lymph node dissection for prostate cancer; KleinJan et al. [25] re-
ported a range of 80 to 860 μL, with a median of 170 μL. These tubes were filled 
with a mixture of ICG and 99mTc: 253 μL of an ICG solution and 7 μL of a 99mTc solu-
tion (~5 MBq). The ICG solutions used, in this study, consisted of 31.25 μg/mL 
ICG (ICG-Pulsion, Pulsion Medical Systems, Munich, Germany) dissolved in hu-
man serum albumin (Albuman 200 g/l, Sanquin, Amsterdam, The Netherlands). 
With this as stock solution, the effective ICG solutions used in the phantom ex-
periments range from 9.62 to 31.03 μg/mL. This quantity was chosen based on 
both clinical relevance (0 to 18.10 μg/mL typically found in lymph nodes during 
prostatectomy [25]) and best visibility during fluorescence guidance (best visi-
bility found between 2.44 and 78.27 μg/mL [26]). The 99mTc solutions used, in 
this study, were obtained from a 99mTc-sodium pertechnetate solution (750 MBq/
mL saline, Technekow, Mallinckrodt Medical BV, Petten, The Netherlands). Two
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Figure 2. Navigation of the fluorescence laparoscope based on preoperative SPECT/CT imaging 
and intraoperative fluorescence guidance as performed on the tissue-mimicking phantom set-
up. (a) Volume rendering of the fused SPECT/CT scan of the tissue-mimicking phantom setup. The 
SPECT hotspots are shown in purple/blue. (b–f) Augmented reality video feed from the perspective 
of the fluorescence laparoscope as seen on the navigation device, when navigating to the naviga-
tion targets. These targets are indicated as gray and green circles and are defined by the SPECT 
signal (displayed purple/blue). The distance shown is the distance from the tip of the camera to the 
selected (green) target. The CT overlay is shown in white/gray. (b) The phantom shown by white-
light modus, without augmented SPECT/CT overlay. (An error states that the mobile camera is not 
tracked due to the LRT being just at the border of the tracking volume.) (c) White-light modus with 
augmented SPECT/CT overlay. (d, e) Fluorescence light modus with augmented SPECT/CT overlay. 
In this mode, the background video is shown in gray. (f) Fluorescence light modus without aug-
mented SPECT/CT overlay. Fluorescence is displayed in green.
additional 500-μL Eppendorf tubes were hidden on the sides of the tissue mim-
icking structure to serve as “anatomical reference” in the CT images. These tubes 
were filled with CT contrast agent [Ultravist 300 mg/mL (Bayer AG, Leverkusen, 
Germany) 50% diluted with demineralized water]. To constrain movement of all 
the objects in the phantom setup, and therefore constrain the navigation error, 
the silicone structure and the PRT stand were glued to a silicone bottom layer 
in the tray. The PRT itself was taped to the stand. Note however, to allow easy 
access to the target sources, the precut phantoms were opened with a wound 
spreader during navigation, a manipulation that could have possibly introduced 
a (minor) deformation error to the navigation setup. 
Laparoscopic Torso Phantom
The human-like laparoscopic torso phantom was made out of a standard life-
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purposes. A transparent plastic mannequin was split in two parts over the cor-
onal plane and the skeleton was cut to fit inside. The skeleton was fixed after 
which a silicone model of the prostate and three lymph nodes were incorporat-
ed, thereby simulating the SN biopsy procedure during robot-assisted laparo-
scopic prostatectomy [10,11,27]. Both the prostate model and the lymph node 
models were cast from Dragon Skin® FX-Pro silicone rubber and Slacker® Tactile
Mutator using the color pigments for different colors. Mixtures of ICG and 99mTc 
were then inserted into the prostate and SN models. For the prostate model, 
a 1.5-mL Eppendorf tube was incorporated in the cast and was used to store a 
260-μL tube filled with 80 μL of the ICG solution and 180 μL of the 99mTc solution 
(~200 MBq). The lymph node phantoms contained a 260-μL tube with a mixture 
of 258 μL of the ICG solution and 1.8 μL of the 99mTc solution (~2 MBq). This 
resulted in a 100:1 ratio in radioactivity for the prostate model with respect to 
each of the individual lymph nodes, which should be a reasonable ratio in SN 
mapping [28-31]. 
 Four 12-mm trocars were placed in the transparent shell of the torso 
phantom to allow docking of the da Vinci robot, including the fluorescence lap-
aroscope. A PRT was fixed at the sternum location of the phantom.
Evaluation Navigation Accuracy
The total navigational accuracy was evaluated in the soft tissue phantom setups 
and divided in both coronal and sagittal errors. The laparoscope was placed in 
a stand vertically with respect to the navigation target at a distance of roughly 
5 cm. The navigation accuracy determination was then performed manually by 
comparing the target distance as given by the navigation system to the distance 
found with a ruler (measurement precision of ~1 mm), in a manner similar to 
that described by Brouwer et al. [16]. For the sagittal plane, the distance from 
laparoscope tip to target was indicated by the navigation system in numbers 
(precision of 1 mm). The coronal distance was indicated with the augmented re-
ality overlay over the laparoscopic video feed, consisting of a green target point 
and a scalable purple/blue cloud of activity around it. The green target point 
provided a clear reference for the accuracy determination and was compared 
to the actual target as seen on the video. Since the navigation targets consisted 
of small Eppendorf tubes, the midpoint of the fluid was used for the measure-
ments. For each navigation setup (SPECT/CT and fhSPECT), three different soft 
tissue phantoms were used with each their own scans, each containing two dis-
tinct targets (n = 6 over three phantoms). Each individual measurement was 
performed by two different observers, resulting in 24 measurements in total. 
IBM SPSS statistics 22 software (International Business Machines Corp., New 
York, USA) was used to compare if the accuracy of SPECT/CT- and fhSPECT-based 
navigation was significantly different using an unpaired t-test (95% confidence 
interval).
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Figure 3. Navigation of the fluorescence laparoscope based on intraoperative fhSPECT imaging 
and intraoperative fluorescence guidance as performed on the tissue-mimicking phantom set-
up. (a) Acquisition of the fhSPECT scan with a tracked gamma probe from the perspective of the 
overhead navigation system camera. (b) Acquired fhSPECT scan (shown in purple/blue) displayed 
as an augmented reality projection over the phantom setup. The distance shown is the distance 
from the tip of the laparoscope to the selected (green) navigation target, defined by the fhSPECT 
signal hotspots. (A red sign in the upper left corner indicates that the gamma probe is no longer in 
the tracking volume, since it is no longer in use after the scan acquisition.) (c) Video feed from the 
perspective of the fluorescence laparoscope in fluorescence light modus, with augmented fhSPECT 
overlay. (d) Video feed from the perspective of the fluorescence laparoscope in fluorescence light 
modus, without augmented fhSPECT overlay.
Overview of Coordinate Frames and Calibration Steps
An overview of the different coordinate transformations applied for the naviga-
tion workflow is provided in Figure 1. All transformations are divided in three 
different colors (red, blue, and green) to distinguish how they are found. The 
transformations determined by the OTS in real time are shown in red, the ones
calculated during registration or calibration procedures are shown in blue, and 
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RESULTS
Figure 2 shows an example of the navigation process performed using preoper-
ative SPECT/CT; Figure 2b-f show snapshots of the Firefly video feed combining 
the laparoscopic view (in white-light and fluorescence modus) and an augment-
ed overlay of the SPECT/CT data. The navigation targets, displayed as dots, are 
defined by the signal hotspots found in the SPECT imaging data and the two 
white Eppendorf-shaped signals in the CT view (Figure 2a, c and d) function as 
anatomical markers. In a similar manner, we could also use “intraoperative” 
fhSPECT data sets for navigation (see Figure 3). 
 In the laparoscopic navigation view, the CT and/or (fh)SPECT overlay 
could be turned on and off independent of each other and the size of the SPECT 
hotspots (threshold on the SPECT signal) could be scaled according to prefer-
ence. Qualitatively, navigation to the different targets (depicted as green colored 
dots) in the soft tissue phantoms appeared accurate using both scan modalities; 
during the navigation process, the augmented hotspots in the video feed and 
the distance to the targets seemed well registered to the fluorescent findings. 
As mentioned in the ‘Methods and Materials‘ section, optical wavelengths of 
the OTS and fluorescence emission overlapped. However, other than in previous 
studies [21], the NIR light of the OTS did not interfere with the fluorescence de-
tection of the Firefly. 
 The navigation accuracy for the SPECT/CT- and fhSPECT-based naviga-
tion procedures was quantified (see Table 1). Average errors for the SPECT/CT-
based navigation were 2.25 mm (median 2 mm) and 2.08 mm (median 2 mm) in
the coronal and sagittal plane, respectively. For the fhSPECT-based navigation, 
these were quite similar: 1.92 mm (median 2 mm) and 2.83 mm (median 3 mm). 
These results underline that the navigation accuracy, in the setup studied, stays 
well below the 1-cm tissue limit needed for successful fluorescence detection 
[8,9]. Comparison of the errors found for both scan modalities did not result in 
a significant difference (p values of 0.764 and 0.282 for the coronal and sagittal 
plane, respectively). 
Table 1. Overview of the accuracy measurements in the tissue-mimicking phantom setups for 











SPECT/CT Coronal 2.25 1.86 0 to 5
Sagittal 2.08 1.02 0.5 to 3.5
fhSPECT Coronal 1.92 1.88 0 to 4.5
Sagittal 2.83 1.25 1 to 4
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 Evaluation of the navigation setup using a torso phantom (Figure 4) illus-
trates the clinical setup to which the navigation should be translated. In addition, 
it demonstrates the setup remained effective when the robot is fully docked.
DISCUSSION
We have integrated surgical navigation, made possible via optical tracking, 
with (robot-assisted) laparoscopic fluorescence-guided surgery. Hereby, a ro-
bot-docked fluorescence laparoscope could be successfully navigated to target 
structures located in two different phantom setups with an accuracy of ~2 mm. 
All different imaging modalities used (fluorescence, SPECT/CT, and fhSPECT) 
could be available during navigation, thereby allowing compensation for the 
weaknesses of the individual modalities (e.g., the limited tissue penetration of 
fluorescent signals or the inaccuracies of surgical navigation due to soft tissue 
deformations). The presented soft tissue navigation setup suggests a next step 
in providing surgeons with more precise orientation and localization during ro-
bot-assisted procedures.
 Theoretically, a preoperatively acquired SPECT/CT scan can be consid-
ered more precise than an intraoperatively acquired fhSPECT; with SPECT/CT, a 
lot more information is collected for the 3-D image reconstruction due to larger 
gamma cameras and longer scan times [18]. Therefore, for a rigid phantom set-
up, one would expect the navigation errors found when navigation was based 
on SPECT/CT to be smaller than when navigation was based on fhSPECT. In our 
measurements, performed on the semi-rigid soft tissue phantoms, navigational 
accuracy was similar for both the two scan methods. This suggests that naviga-
tion based on fhSPECT may serve as a valuable and cost-effective alternative for 
navigation based on SPECT/CT.
 Moreover, due to the intraoperative nature of fhSPECT imaging (e.g., 
using a DROP-IN gamma probe [31,32]), the technique should suffer much less 
from tissue deformations that result from patient movement. In fact, due to the 
short acquisition time (roughly between 2 and 3 min), one could easily acquire a 
new scan after any expected tissue deformation or displacement (e.g., removal 
of the primary tumor site). In addition, intraoperative real-time visualization of 
fluorescence can be used to compensate for navigational errors below ~1 cm.
 Translation of the proposed navigation setup to clinical use should be 
straightforward, as the robotic setup remains identical. We do see two questions 
that require attention, depending on the specific clinical application chosen: (1) 
Will NIR optical tracking be sufficient for a dynamic robotic intervention? (2)
What will be the range of tissue deformation found in patients and how does 
this relate to the fluorescence detection limit?
 Regarding the first point, in this study, optical tracking was used to define 
the 3-D pose of the phantom setup, laparoscope, and gamma probe using three 
different reference targets containing at least three fiducials each. As shown, 
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Figure 4. Evaluation of the combined fluorescence navigation system based on preoperative 
SPECT/CT. (a) Operation room setup with the navigation system, fluorescence laparoscope, the 
surgical robot, and the torso phantom. On both the torso phantom and the fluorescence laparo-
scope, a reference target is attached. (b) Volume rendering of the fused SPECT/CT scan of the torso 
phantom setup. The SPECT hotspots are shown in pink/blue. The arrows indicate the prostate (P) 
and 3 lymph nodes (LN). (c–e) Augmented reality video feed from the perspective of the fluores-
cence laparoscope as seen on the navigation device when navigating to the navigation targets. 
These targets are indicated as gray and green circles and are defined by the SPECT signal (dis-
played purple/blue). The distance shown is the distance from the tip of the laparoscope to the 
selected (green) target. (c) White-light modus; letters indicating the specific lymph nodes (LN 1 
and LN 2) and the prostate (P) in the anatomy of the phantom. (d) Fluorescence light modus with 
augmented SPECT overlay. (e) Fluorescence light modus without the augmented SPECT overlay. 
Lymph node LN 1 is located too close to the highly active prostate P (1:100 ratio in radioactivity) to 











this was feasible, but a general limiting factor was that the OTS has to maintain 
a direct line-of-sight to at least three of the reference target fiducials to allow 
for 3-D pose determination of the tracked object [23]. A feature that limits the 
OR layout and logistics. This may be overcome by increasing the number of fi-
ducials per reference target or by using multiple OTS cameras on different sides 
of the OR [33]. A possible drawback of using NIR optical tracking in combination 
with NIR fluorescence imaging is the overlap in spectra used for object tracking 
and fluorescence imaging. In previous work, we found that this could be a con-
siderable issue when using an open surgery fluorescence camera [21]. To our 
surprise, we did not detect such an extensive interference when the Firefly lap-
aroscope was applied outside of the phantom body. This finding could provide a 
basis for solving the issues previously reported. This said, in a laparoscopic set-
ting, the tracking light is not likely to interfere with the fluorescence detection, 
since fluorescence imaging is conducted inside the patient’s body.
 Alternative to NIR optical tracking, electromagnetic (EM) tracking or 
mechanical tracking could also provide outcome. With an intrinsic accuracy up 
to ~0.5 mm (RMS) for EM tracking versus ~0.25 mm (RMS) for optical tracking 
[22,34], EM tracking still seems quite promising. However, a major disadvantage
with this technique is the susceptibility to distortions of the EM tracking field 
by nearby metal objects or EM interferences, rendering it much less accurate 
[35]. Although inaccurate, mechanical tracking of the robotic arms is possible by 
using forward kinematics to calculate the 3-D pose of the end effector such as 
the laparoscope or the surgical instrument [36]. Fuerst et al. greatly improve this 
accuracy to an approximate error of 0.2 mm by combining the mechanical track-
ing with visual-based tracking via the stereoscopic laparoscope video feed [32].
 In the presented navigation workflow, the navigation targets are dis-
played as a two-dimensional augmented reality overlay superimposed in the 
laparoscopic video feed while the distance from the laparoscope tip to target is 
shown in numbers. When implemented in clinical use, it might be hard to get a 
good idea of how deep the target structures really lie. Therefore, the augmented
reality visualization may in the future be enhanced by dynamic augmented cues 
(e.g., small arrows indicating both direction and distance) or more depth percep-
tion cues (e.g., as shown by Bichlmeier et al. [37] and Kutter et al. [38]).
CONCLUSION
In a phantom setup, both pre- and intraoperative SPECT data sets can be used 
to accurately navigate the da Vinci robot-integrated fluorescence laparoscope 
toward surgical targets. Hereby, a basis is generated for future robot-assisted 
navigation toward fluorescent lesions.
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ABSTRACT
Real-time visualization of fluorescence imaging can guide surgeons during tissue 
resection. Unfortunately tissue induced signal attenuation limits the value of this 
technique to superficial applications. By positioning the fluorescence camera via 
a dedicated navigation setup we reasoned that the technology could be made 
compatible with deeper lesions, increasing its impact on clinical care. Such an 
impact would benefit from the ability to implement the navigation technolo-
gy in different surgical settings. For that reason we evaluated whether a single 
fluorescence camera could be navigated toward targeted lesions during open 
and laparoscopic surgery. A fluorescence camera with scopes available for open 
and laparoscopic procedures was integrated with a navigation platform. Lymph 
nodes identified on SPECT/CT (single photon emission computerized tomogra-
phy/computerized tomography) or freehand single photon emission computer-
ized tomography acted as navigation targets and were displayed as augmented 
overlays in the fluorescence camera video feed. The accuracy of this setup was 
evaluated in a phantom study of 4 scans per single photon emission computer-
ized tomography imaging modality. This was followed by 4 first in human transla-
tions into sentinel lymph node biopsy procedures for penile (open surgery) and 
prostate (laparoscopic surgery) cancer. Overall the phantom studies revealed a 
tool-target distance accuracy of 2.1 mm for SPECT/CT and 3.2 mm for freehand 
single photon emission computerized tomography, and an augmented reality 
registration accuracy of 1.1 and 2.2 mm, respectively. Subsequently open and 
laparoscopic navigation efforts were accurate enough to localize the fluores-
cence signals of the targeted tissues in vivo. The phantom and human studies 
performed suggested that the single navigation setup is applicable in various 
open and laparoscopic urological surgery applications. Further evaluation in 




Navigation of Fluorescence Cameras during Soft Tissue Surgery
INTRODUCTION
Due to its real-time intraoperative visualization capabilities fluorescence guided 
surgery is increasingly gaining popularity as a surgical guidance technology [1,2] 
that is applicable during open and laparoscopic surgery [3,4]. Despite its clear 
benefits, tissue induced signal attenuation [5] limits the technology to superfi-
cial applications (less than 1 cm deep) at known locations [6]. This means that le-
sions embedded in tissue, e.g. fat, are more difficult to detect [7]. Perhaps even 
more importantly, this superficial nature prohibits surgical planning, meaning 
that prior to the start of the procedure the surgeon is blind to the location of the 
lesion as well as the targeting capabilities of the tracer. 
 In contrast to fluorescence imaging, nuclear medicine allows for highly 
sensitive in-depth and noninvasive imaging. For that reason technologies such 
as SPECT/CT and positron emission tomography/CT are considered the standard 
for total body molecular imaging. These 3D scans, which display targeted tissues 
in the anatomical context, are ideal to provide virtual road maps for in-depth 
surgical planning [8]. 
 In an attempt to connect surgical guidance with preoperative planning 
the tracer ICG-99mTc-nanocolloid was introduced in SN biopsy procedures for 
prostate cancer, among other conditions [9]. Incorporating a radioactive label 
(99mTc) and a fluorescent label (ICG), this hybrid tracer enables preoperative SN 
localization with SPECT/CT and intraoperative guidance with fluorescence imag-
ing. Analogous to global positioning system navigation devices in traffic, surgical 
navigation in preoperatively acquired patient scans can effectively be used to 
position surgical tools intraoperatively [10]. Unfortunately tissue displacement 
and deformation between scan acquisition and the navigation process can dete-
riorate the precision of the navigation procedure [11,12]. This can be overcome 
using intraoperative imaging modalities such as fhSPECT to generate a virtual 
map of the patient [13]. 
 In the past we proposed and found that the in-depth shortcomings of 
fluorescence guidance could be compensated for when a dedicated navigation 
setup was used to position the fluorescence camera within a 10 mm vicinity 
of the fluorescent target. Subsequently fluorescence imaging could detect the 
lesion in real time and correct for minor navigation inaccuracies. This concept 
was demonstrated for open surgery using a m-PDE fluorescence camera (Ham-
amatsu, Hamamatsu City, Japan) [14], laparoscopic surgery using a laparoscopic 
Tricam SLII fluorescence setup [15] and robot-assisted laparoscopic surgery us-
ing a Firefly fluorescence camera (da Vinci Surgery) [16]. 
 Since different clinical indications as well as different hospital standards 
may demand open or laparoscopic surgery, we reasoned that it would be ben-
eficial to allow for the navigation of a clinical grade fluorescence camera that is 
applicable during open and laparoscopic surgery. Enabling navigation in different 
surgical settings could also benefit the dissemination of this novel fluorescence
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guided surgery concept. 
 The Image1 STM H3-Z FI fluorescence camera can be equipped with dif-
ferent scopes and thereby serve in different surgical settings as an exoscope for 
open surgery and a laparoscope for laparoscopic surgery [9,17]. The navigation 
accuracy of this setup was thoroughly evaluated in a phantom study followed by, 
which is to our knowledge, a first in human translation to open (penile cancer) 
and laparoscopic (prostate cancer) SN procedures.
METHODS
Navigation Hardware
Figure 1 shows the navigated fluorescence guided surgery setup, consisting of a 
declipse SPECT navigation system and a IMAGE1 S H3-Z FI fluorescence camera 
[9] with 3 fluorescence scopes, including a VITOM II 0-degree exoscope, and 
0-degree and 30-degree HOPKINS II 10 mm laparoscopes. To allow for position 
and orientation tracking all tracked objects (e.g. patient, fluorescence camera 
and gamma probe) were fitted with optical reference targets which were visi-
ble to the navigation system near infrared OTS (Figure 1) [10]. To ensure object 
tracking during navigation a line of sight must be maintained between the OTS 
and the individual reference targets.
SPECT/CT and fhSPECT Acquisition
Navigation of the fluorescence camera was based on targets defined in SPECT/
CT or fhSPECT imaging data. SPECT/CT was performed with a SymbiaTM TruePoint
SPECT/CT system. FhSPECT was performed with a SOE 311 gamma probe (Eu-
rorad, Eckbolsheim, France) for phantom and open surgical scans while a CXS-
OP-SZL-45 laparoscopic gamma probe (Crystal Photonics, Berlin, Germany) was 
used for laparoscopic scans [18].
Integration of Fluorescence and Navigation Systems
After integration with the navigation system 2 types of real-time guidance were 
provided in the fluorescence camera video feed. 1) A 2D AR overlay of the SPECT
based targets for navigation (e.g. SNs), which is a visual overlay in the camera 
video feed, could be switched on and off. It helped position the fluorescence 
camera and establish possible discrepancies between SPECT based navigation 
and fluorescence based identification of the lesions. 2) A 3D numerical value 
depicting the distance from the calibrated instrument tip (i.e. the laparoscope 
or the gamma probe) to the middle of the targeted tissue supporting the iden-
tification of lesions positioned beyond the in-depth detection limits of the fluo-
rescent signal.
 The navigation workflow for the exoscope was somewhat different than 
for the laparoscopes. While the laparoscopes were dynamically positioned on 
top of the area of interest, the exoscope was fixed in an arm. This difference
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Figure 1. Schematic overview of navigation setup. (a) Typical setup implementation with OTS 
directed toward patient and optical reference target attached to patient and fluorescence camera 
with latter shown without scope. (b) Implementation in exoscopic or laparoscopic application. (NIR 
= near infrared).
means that in the laparoscopic setup the distance to the navigation targets was
measured with respect to the laparoscope tip. However, for the static exoscope 




The accuracy of the proposed navigation setup was evaluated in a rigid phantom 
setup for the 2 types of guidance provided, including 1) 3D tool distance accu-
racy and 2) 2D AR registration accuracy. By comparing the geometrical target lo-
cation (i.e. the center of the radioactive source) with respect to the navigational
targeted location we determined the accuracy of SPECT/CT and fhSPECT based 
navigation using all 3 camera-scope combinations with 4 examples for each 
scanning modality. The supplementary material describes the measurement 
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Navigation of Fluorescence Cameras during Soft Tissue Surgery
In Vivo 
A proof of concept evaluation of the navigation setup was performed in 4 pa-
tients scheduled for SN biopsy. These procedures included 2 laparoscopic pros-
tate cancer related procedures using the 30-degree laparoscope and 2 open sur-
gery penile cancer related procedures using the exoscope (see Table).
 ICG-99mTc-nanocolloid administration and subsequent preoperative SN 
mapping were done as previously described [9,19].In prostate cases tracer was 
deposited in the peripheral zone of the prostate and in penile cancer cases trac-
er was administered peritumorally. Intraoperatively conventional guidance to 
the SNs was performed using a combination of typical radio and fluorescence 
tracing [9,19]. The fhSPECT scans served as input for the navigation setup. The 
OTS was positioned next to the patient and the PRT was attached to the patient 
with sterile tape (see Table).
 Validation of navigation in vivo was waived by the institutional review 




Figure 2 shows the measurements obtained for tool distance accuracy. Supple-
mentary Table 1 shows the numerical values. For SPECT/CT based navigation the 
total 3D mean accuracy was 1.50, 2.59 and 2.33 mm for the 0-degree laparo-
scope, the 30-degree laparoscope and the gamma probe/exoscope work flow, 
respectively. When navigation was based on fhSPECT, mean accuracy was re-
duced for all scopes used, including 2.28 mm for the 0-degree laparoscope, 3.50 
mm for the 30-degree laparoscope and 3.74 mm for the gamma probe/exoscope 
work flow. However, the unpaired samples t-test did not reveal a significant dif-
ference in any of these settings (p = 0.172, 0.113 and 0.0548, respectively).
Figure 2. Overview of 3D tool distance accuracy measurements. (a) Phantom measurement setup 
with integrated PRT and space to fit radioactive sources. (b-c) Distance measured between true 
target location and navigated locations visualized by 0-degree and 30-degree laparoscopes, and 






















































































Figure 3 shows the findings of AR registration accuracy. Supplementary Table 2 
shows the numerical values. In this case the total 2D mean accuracy for naviga-
tion based on SPECT/CT was 1.39, 0.67 and 1.20 mm for the 0-degree laparo-
scope, the 30-degree laparoscope and the exoscope, respectively. For fhSPECT 
based navigation the mean accuracy was 2.57 mm for the 0-degree laparoscope, 
2.00 mm for the 30-degree laparoscope and 1.96 mm for the exoscope. Unlike 
the tool distance accuracy results these findings for SPECT/CT and fhSPECT sig-
nificantly differed in all 3 groups (p = 0.028, 0.020 and 0.032, respectively). Since 
camera settings tend to vary during procedures, we studied how altering the 
distance to the target and the focus of the camera influenced this AR registration 
accuracy. The supplementary material provides these results.
In Vivo Measurements
Figure 4 shows an overview of the application of the navigation setup for laparo-
scopic surgery. Patient 1 was scheduled for SN biopsy of the prostate prior to ra-
diotherapy [20]. Unfortunately no tracer drainage was noted in the lymphatics, 
possibly due to poorly executed tracer administration. Therefore, extended LN 
dissection was performed. In the absence of radioactive LNs the fhSPECT based 
navigation was directed toward the prostate. Patient 2 underwent a diagnostic 
SN procedure prior to radiotherapy [20]. In this patient prostate draining SNs 
were found, of which 1 was chosen as a target for the navigation process. No 
tracking problems were encountered. Navigation was successful in each case, 
including the fluorescence signal confirmation as detected by the laparoscope 
(see Table).
 Figure 5 shows the application of the exoscope navigation setup for 
open surgery. Patient 3 underwent SN biopsy combined with penile amputation. 
Two SNs in close proximity to each other were mapped preoperatively and ex-
cised as 1 specimen intraoperatively. Navigation to these SNs, which was based 
on fhSPECT, was considered successful (see Table). Patient 4 was treated with SN
biopsy combined with partial penile amputation. Navigation was pursued for 
the marked SN. Navigation was considered successful, showing well registered 
AR overlay of fhSPECT and an appropriate distance estimation from the gamma 
probe to the target (Figure 5). Fluorescence imaging confirmed the location of 
the SN (see Table). During each open surgery application, operating room lights 
had to be turned off temporarily to achieve successful fluorescence imaging.
 After pathological investigation, no malignancies were found in the ex-
cised LNs of all patients included in this study. 
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Figure 3. Overview of 2D AR registration accuracy measurements. (a) Phantom measurement 
setup with integrated PRT and 2D measurement grid. True target location represents center to 
place radioactive sources. AR navigation target (green dot) is generated by navigation system. (b) 
Example of measurement with AR SPECT hotspot overlay (blue and purple shape with green dot 
at weighted center) in fluorescence camera video feed. (c-d) Visualization of distances measured 
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In this proof of concept study we evaluated a navigation setup that facilitates the 
translation from preoperative planning (SPECT/CT) to intraoperative guidance 
(fhSPECT, navigation and fluorescence based lesion identification). By directly 
linking nuclear medicine based, in-depth imaging with superficial fluorescence 
guidance the weaknesses of the individual techniques could be overcome. Navi-
gation of a single camera setup for open and laparoscopic surgery allowed for an
in-depth (greater than 10 mm) extension of applications for which fluorescence 
guided surgery may be beneficial. The presented generic setup should also ben-
efit operating room logistics, device operating experiences and purchase costs.
 Overall the phantom navigation studies showed a tool distance accura-
cy of 2.1 in SPECT/CT based studies and 3.2 mm in fhSPECT based studies, and 
AR registration accuracy of 1.1 and 2.2 mm, respectively. Considering the typi-
cal size of the targeted lesion, e.g. a SN with a typical diameter of 5 to 10 mm 
[21], the size of the instrument tip, including the 11 mm diameter of the gamma 
probe and the 10 mm diameter of the laparoscope, and the fluorescence signal
penetration of about 10 mm [6], accuracy was considered sufficient for clinical 
translation. Contributors to these inaccuracies included OTS imprecisions, opti-
cal and geometrical system calibrations, and SPECT scan resolution and fidelity.
 Although neither SPECT modality resulted in significant differences in 
tool distance accuracy measurements, a significant difference was observed for 
AR registration accuracy measurements. As described by van Oosterom et al, 
theoretically the quality of SPECT/CT should be higher than that of fhSPECT. Due 
to its intraoperative nature and short acquisition time, fhSPECT should be better 
for soft tissue induced deformations [16].
 The clinical relevance of the phantom studies was confirmed by imple-
menting the technology in open and laparoscopic urological surgery. While tis-
sue movement influenced navigation accuracy, it was high enough to localize 
the fluorescence signals of the targeted tissues in vivo. The exoscope was fixed 
in an arm, making camera positioning less flexible but maintaining a focused 
and steady video image. In this setting we noted that the distance between the 
exoscope and the targeted tissue required a balance between a minimum focus 
distance (approximately 15 cm), the preferred tissue magnification (i.e. surgical 
context) and the achieved fluorescence imaging sensitivity (supplementary ma-
terials).
 In addition, the exoscope experienced slight imaging interference 
caused by the near infrared OTS light, a feature that was reported earlier for the
m-PDE fluorescence camera [14]. However, in our study this interference did not 
negatively influence the exoscopic procedures and it did not influence the lap-
aroscopic procedures at all since the intra-abdominal placement of the camera 
shielded it from extra-abdominal light sources. While it was successful in the 
studies that were performed, maintaining a line of sight between the OTS and
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Figure 4. In vivo laparoscopic evaluation of navigation setup for prostate cancer. (a) Overview of 
operating room layout with PRT (1) and OTS (2). (b) Freehand SPECT based 2D AR navigation target 
and 3D tool-target distance in fluorescence camera video feed with fluorescence laparoscope in 
white light imaging mode. (c) Laparoscope is brought closer to target and switched to fluorescence
imaging mode. (d) AR navigation overlay is turned off, showing clear view of fluorescence signal 







the individual reference targets can be complex in a robotic setting and/or in a 
crowded operating room. Future engineering will hopefully limit dependence on 
an OTS for object tracking by using vision based machine learning methods such 
as deep learning, for example [22].
 A larger patient study including different surgical indications and ran-
domized blinding to different features of the surgical guidance process should be
performed to identify features with the strongest influence on surgeon perfor-
mance (e.g. surgery time or the number of otherwise missed lesions). These 
features could include the different forms of preoperative mapping, navigation 
guidance, gamma guidance and fluorescence guidance. Such a trial would also 
demonstrate how often navigation inaccuracies exceed the less than 10 mm tis-
sue penetration of fluorescence signals.
 Since the navigation target was determined based on SPECT and fluores-
cence imaging results showing the same lesion, the current navigation technolo-
gy depends on using hybrid tracers. In this study navigation was directed toward 
SNs or the primary tumor site using the hybrid tracer ICG-99mTc-nanocolloid in ex-
perimental studies performed in prostate [9] and penile cancer [19] cases. Trans-
lation to other SN procedures performed with the same tracer should be trivial, 
for example for head and neck cancer [23,24], breast cancer [25] and cervical 
cancer [26]. At the same time the identical tracer and navigation concept could 
be applied in hybrid radio guided occult lesion localization procedures [27].
 In addition, in light of recent developments toward tumor-receptor tar-
geted hybrid tracers [28,29] an interesting future application includes the ap-
plication of this navigation concept for intraoperative localization of the prima-
ry tumor and metastases, e.g. in renal cancer [30]. In these cases the in-depth 
tracking capability could help ensure negative surgical margins during resection 
and could be connected with, for example, CT based navigation approaches [12].
CONCLUSIONS
In this study we investigated a single navigation setup applicable to various open 
and laparoscopic urological procedures. Phantom experiments were performed 
to determine the accuracy of navigation while first in human evaluations under-
lined the translational efficacy of the setup. By combining the complementary 
imaging information from nuclear and fluorescence imaging the setup allowed 
for successful in vivo localization of the targeted tissues during penile and pros-
tate cancer related surgery. To strengthen these preliminary results, further 




Navigation of Fluorescence Cameras during Soft Tissue Surgery
Figure 5. In vivo open surgery evaluation of navigation setup for penile cancer. (a) Navigation 
system with OTS (1) and the fluorescence camera imaging tower located at right of operating 
table. (b) Overview of operating table with camera reference target (2), gamma probe reference 
target (3) and PRT (4). (c) Surgical site from perspective of fluorescence camera in white light 
mode. (d) 2D AR overlay and 3D tool-target distance shown in fluorescence camera video feed. 
(e) Gamma probe is moved closer to sentinel lymph node and camera is switched to fluorescence 
imaging mode. (f) AR navigation overlay is turned off, showing clear view of fluorescence signal 
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SUPPLEMENTARY METHODS
Integration of fluorescence camera and navigation system
The fluorescence camera setup included an IMAGE1 S H3-Z FI Three-Chip FULL 
HD camera head, an IMAGE 1 S CONNECT module, an IMAGE 1 S H3-LINK link 
module and a prototype D-LIGHT P light source [1]. The fixation arm used for the 
VITOM exoscope setup was a VITOM mechanical holding system (KARL STORZ 
Endoskope).The video output of the fluorescence setup was fed into the navi-
gation system using an approach that makes use of the digital visual interface 
(DVI) output of the fluorescence camera read-out unit and the DVI input of an 
Epiphan frame grabber (DVI2PCIe, Epiphan Systems, Ottawa, Ontario, Canada) 
integrated inside the navigation system [2,3]. This video feed was then integrat-
ed in a custom version of the declipseSPECT 6.0 (SurgicEye) software [2,3], that 
was specifically tailored towards the requirements of this study. First of all, a 
number of calibration steps were performed to map all relevant features per 
camera-scope combination. To allow for visualization of the distance from the 
scope- or gamma probe-tip to the navigation target, the relative geometry of 
the instrument tip to instrument reference target was calibrated. For this step, 
geometrically fitting calibrators were designed using computer-aided design 
software (SolidWorks, Dassault Systèmes, Vélizy-Villacoublay, France). Subse-
quently, these were 3D printed in acrylonitrile butadiene styrene (ABS) plastics 
using a Dimension Elite 3D printer (Stratasys, Eden Prairie, MN, USA), with ac-
companying CatalystEX 4.4 slicer software (Stratasys). To allow for an AR overlay 
of the SPECT-based navigation targets in the original camera video feed, two 
optical checkerboard calibrations were performed to map the camera system 
parameters, similar as described before [3]. 
 To prevent any sterilization issues and to minimize the time needed 
during surgery, all system calibrations were performed at least one day prior 
to the procedure. During the procedure, sterile versions of the PRT (patient/
phantom reference target), the CRT (camera reference target) and GPRT (gam-
ma probe reference target) were used. The PRT was attached with sterile tape, 
choosing an available and relatively rigid anatomical location of the patient.
Evaluation of navigation accuracy
Evaluation of the tool distance accuracy
The 3D tool distance accuracy was evaluated using a rigid phantom setup as 
shown in Figure 2. The base of the phantom was fabricated out of an acrylic 
plate harboring three integrated metal fiducials with OTS-visible retroreflective 
plastic spheres on top, resembling a PRT. Next to the PRT, the phantom provided 
space to allow for insertion of radioactive 57Co disk sources. Four SPECT/CT scans 
and four fhSPECT scans were acquired of this setup using one 57Co disk source 
(Eckert & Ziegler Strahlen- und Medizintechnik, Berlin, Germany) of ~1.7 MBq, 
resembling a reasonable activity for a SN during a SN biopsy procedure [3]. A 57Co
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disk source was chosen due to the relatively long half-life of 57Co (271.7 days) 
and the fixed and known geometry of the disk, while providing gamma rays close 
to the energy of 99mTc gamma rays (main energy peaks of 122 keV versus 140 keV 
respectively). After scan acquisition, the 57Co source was removed and the spe-
cific instrument or scope tip was fitted to match the geometrical ‘true target lo-
cation’ (i.e. the exact center of the radioactive source) using a custom designed 
acrylic spacer for the chosen tool. Using the custom navigation software, the 3D 
distance between the tip and virtual navigational target was recorded, providing 
a measure for the 3D tool distance accuracy during navigation. The mean of 
600 measurements was acquired per tool tip for every individual SPECT/CT and 
fhSPECT scan.
Evaluation of the augmented reality registration accuracy
The 2D AR registration accuracy was evaluated using the same rigid phantom 
as for the tool distance accuracy measurements (Figure 3). However, instead of 
using the custom spacers to fit tool tips to the geometrical target location, a grid 
pattern plate was placed with its origin at the geometrical ‘true target location’ 
(Figure 3a). The grid pattern consisted of a 60 x 60 mm 2D grid, spanning a mea-
surement scale from -30 to +30 mm, in two coronal directions, with a scale inter-
val of 0.5 mm. Consequently, the accuracy of the AR navigational target overlay 
in the fluorescence camera video feed could be determined by simply directing 
the camera to the grid pattern, while discerning the distance from the AR target 
to the grid origin. Depending on the scope used, the total camera setup was 
positioned straight above the geometric target location with a chosen working 
distance of 70 cm for the exoscope, 7.5 cm for the 0o laparoscope and 7.5 cm 
for the 30o laparoscope. Prior to the phantom measurements, these respective 
distances were also used to focus and calibrate the specific camera-scope com-
binations. For every measurement, a screenshot was taken, allowing for accura-
cy measurements in the recorded images. Since the threshold of the AR target 
overlay can be adapted to preference, the center of the 5-6 mm diameter green 
navigation target circle was chosen for the error measurements (Figure 3a-b).
Evaluation of 2D augmented reality registration accuracy for changing 
optical parameters
As mentioned above, the optical characteristics of the scope-camera setups 
were calibrated at a chosen working distance during for the AR registration accu-
racy measurements. To analyze how alteration of this working distance and the 
corresponding adjustment of the camera focus influenced the AR registration 
accuracy, an additional evaluation was performed. The 2D AR registration mea-
surements, as described in the section above, were repeated at two different 
distances: for every camera-scope combination, the accuracy was measured at 
the original calibrated and focused distance and at a closer distance. Measure-
ments at this closer distance were acquired with both a fixed-focus setting and
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a refocused setting. For the VITOM exoscope however, a fixed-focus setting was 
not possible at the closer distance, since the measurement image was too unfo-
cused to use. Both the 0 and 30o laparoscopes were moved from 7.5 cm tot 2.0 
cm and the exoscope was moved from 70 to 14 cm.
Exoscope fluorescence detection sensitivity
To provide a steady and focused image of the operating field, the VITOM exo-
scope camera combination was fitted in the Storz holding mechanism and placed 
at a chosen distance to the targeted tissue. Typically, this working distance rang-
es roughly from 10 – 75 cm [4-7]. To investigate the influence of the working 
distance chosen with respect to the fluorescence imaging capabilities, the flu-
orescence sensitivity was evaluated between 15 and 85 cm. For this purpose, 
a black 96-wells well plate was used (Cellstar, Greiner Bio-One, Frickenhausen, 
Germany), containing a 1 to 1 dilution series ranging from 5.0 mg/mL (6.45 × 
10−3 M) to 9.31 ng/mL (1.20 × 10−11 M) ICG (Pulsion Medical Systems, Munich, 
Germany) dissolved in human serum albumin (Albuman 200 g/L; Sanquin, Am-
sterdam, The Netherlands). A total of 30 wells was used. All measurements were 
taken with the operating room lights switched off.
SUPPLEMENTARY RESULTS
Evaluation of navigation accuracy
Evaluation of the tool distance accuracy
A graphical representation of the 3D tool distance accuracy measurements is 
shown in Figure 2 and supplemental Figure S1, while the mean accuracy values 
are shown in Supplemental Table S1.
Evaluation of the augmented reality registration accuracy
The results of the 2D AR registration accuracy measurements are visualized in 
Figure 3b-c, while the mean values are found in supplemental Table S2.
Evaluation of 2D augmented reality registration accuracy for changing 
optical parameters
The acquired results of the 2D AR registration accuracy for changing optical pa-
rameters are given in Supplemental Table S3. Displacement and refocus of both 
0o and 30o laparoscopes yielded only a minor difference in 2D AR accuracy. These 
differences were so small that they would probably not be noticed in clinical 
practice. For the exoscope setup, however, the distance and focus adaptations 
were quite severe and the changes in accuracy were more substantial going from 
1.20 to 17.40 mm (p-value 0.000) and from 1.96 to 18.22 mm (p-value 0.000) for 





































































































































































































































































































































































































































Exoscope fluorescence detection sensitivity
As expected, the exoscope fluorescence imaging sensitivity dropped when ap-
plied at larger distances with respect to the fluorescence object of interest. 
Supplemental Figure S2 shows a clear difference between the number of wells 
still detected with fluorescence at distances ranging from 15-85 cm. One should 
note that the Storz system seems to use an automatic image brightness, scaling 
the overall image brightness to the brightest signal found within the image, in-
cluding strong reflections or strong fluorescence sources; hence visuals of the 
wells are not always consistent. Subjectively, we believe fluorescence is still visi-
ble at well 17 (distance 15 cm) and well 11 (distance 85 cm). These wells contain 
9.84 x 10-8 and 6.30 x 10-6 M ICG solutions respectively. Using the normalized 
fluorescence intensity for such an ICG dilution range, as found by Van den Berg 
et al. [8], gives roughly a 10 fold difference in fluorescence intensity between a 
working distance of 15 and 85 cm. 
Supplemental Figure S2. Overview of well-plate images captured at different target distances 
using the exoscope fluorescence imaging mode. Every well visualizes the fluorescence signal seen 
at the different ICG concentrations and different exoscope-to-well-plate distance. 
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ABSTRACT
Fluorescence guidance facilitates real-time intraoperative visualization of the 
tissue of interest. However, due to attenuation, the application of fluorescence 
guidance is restricted to superficial lesions. To overcome this shortcoming, we 
have previously applied three-dimensional surgical navigation to position the 
fluorescence camera in reach of the superficial fluorescent signal. Unfortunate-
ly, in open surgery, the near-infrared (NIR) optical tracking system (OTS) used 
for navigation also induced an interference during NIR fluorescence imaging. In 
an attempt to support future implementation of navigated fluorescence camer-
as, different aspects of this interference were characterized and solutions were 
sought after. Two commercial fluorescence cameras for open surgery were stud-
ied in (surgical) phantom and human tissue setups using two different NIR OTSs 
and one OTS simulating light-emitting diode setup. Following the outcome of 
these measurements, OTS settings were optimized. Measurements indicated 
the OTS interference was caused by: (1) spectral overlap between the OTS light 
and camera, (2) OTS light intensity, (3) OTS duty cycle, (4) OTS frequency, (5) 
fluorescence camera frequency, and (6) fluorescence camera sensitivity. By op-
timizing points 2 to 4, navigation of fluorescence cameras during open surgery 
could be facilitated. Optimization of the OTS and camera compatibility can be 
used to support navigated fluorescence guidance concepts.
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INTRODUCTION
Fluorescence guidance has demonstrated value in the field of oncologic surgery 
where it helps provide real-time visualization of the lesion of interest [1]. Due 
to its depth restrictions, however, the utility of fluorescence guidance is cur-
rently limited to superficial lesions [2]. To compensate for this shortcoming, we 
have previously introduced the clinical use of dual-modality or rather hybrid 
tracers [3]. These tracers directly link preoperative identification of radioactive 
lesions at the department of nuclear medicine (e.g., using three-dimensional 
(3-D) single-photon emission computed tomography/x-ray computed tomog-
raphy (SPECT/CT) or positron emission tomography/CT (PET/CT) data sets) to 
the intraoperative detection of fluorescent lesions. Through this connection, it 
has become possible to create surgical navigation setups that realize position-
al tracking of fluorescence cameras in pre- or intraoperative 3-D imaging data 
sets (4-6). Combined with futuristic virtual and augmented reality-based com-
puter-assisted surgery techniques, these approaches extend the use of fluores-
cence guidance toward lesions that lie beyond the depth-related fluorescence 
detection limits (i.e., >1 cm deep). 
 Initial studies, using a near-infrared (NIR) optical tracking system (OTS) 
and tracking fiducials placed on both the fluorescence camera and the patient, 
helped to demonstrate the potential of this navigated fluorescence camera con-
cept in a variety of settings [4,5,7,8]. Unfortunately, in some of the open surgical 
procedures, the OTS caused an interfering flickering signal that prevented fluo-
rescence imaging (see Figures 1–3) [4]. Intriguingly, we observed that this OTS 
interference differed substantially between the two open surgery cameras we 
have studied [4,5]; while the interference completely obstructed fluorescence 
imaging with one system, the effect was only minor for navigation of the other 
system. Therefore, the aim of this study was to investigate, which features influ-
enced the interference and to identify possible engineering solutions to support 
further implementation of the navigation concept with fluorescence cameras.
METHODS
Navigation and Tracking Systems
Our “standard” navigation setup was based on the declipse SPECT navigation de-
vice (SurgicEye GmbH, Munich, Germany; see Figure 1). This navigation system 
incorporates a Polaris Vicra OTS (OTSvicra; Northern Digital Inc.,Waterloo, Canada) 
to allow for object position and orientation tracking of geometrically unique ref-
erence targets using a fixed pulsed NIR light source (20 Hz; center wavelength 
(CWL) of 863 nm; full-width-at-halfmaximum (FWHM) of 49 nm) [4,9]. The pulse 
on-time per period was about 1.8 ms, resulting in a duty cycle of roughly 4% (see 
Appendix A).
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Figure 1. Illustration of in vivo navigated fluorescence camera during penile cancer-related sen-
tinel lymph node biopsy. (a) Overview of navigated setup in the operating room. (b) 3-D rendering 
of SPECT/CT patient scan, with patient tracking fiducials (PRT) and lymph node targeted for nav-
igation (LN) visible. (c) Two-dimensional slice showing the navigated LN. (d) Augmented reality 
overlay of the patient scan in the operating room. (e) Augmented reality overlay of the patient 
scan in the fluorescence camera video feed, displaying the LN location (purple) and the estimated 
distance toward it. Due to the OTS interference, fluorescence imaging is obstructed, predominantly 
showing white background in the video feed. (f) Same navigated fluorescence camera image with-
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 Next to the declipseSPECT integrated OTSvicra, a prototype OTS (OTSorthos; 
Orthos prototype, Advanced Real-time Tracking GmbH, Weilheim i.OB, Germa-
ny) was used. This system allows for manual customization of the pulse frequen-
cies in the 10 to 60 Hz range (CWL: 885 nm, FWHM: 108 nm). The pulse-on time 
per period was about 0.4 ms, which results in a duty cycle of 0.8% at 20 Hz. To 
allow for automatic triggering of the pulse frequency, either an analog video 
signal or digital transistor-transistor-logic signal could be connected via the Bay-
onet Neill–Concelman (BNC) input connector.
 In addition to both these OTSs, a light-emitting diode (LED)-based illu-
mination setup was created, simulating the light source of an OTS. This allowed 
for controlled variations to be made in both the tracking pulse frequency and 
duty cycle during the experiments. This configuration consisted of three 850 nm 
LEDs (CWL: 845 nm, FWHM: 33 nm; HE1-220AC, Harvatek Corp., Hsinchu City, 
Taiwan) connected to a multichannel universal LED controller (Mightex Systems, 
Pleasanton, California).
Fluorescence Camera Systems
Two open surgery conformité européenne (CE) marked fluorescence camer-
as were used for this study. First, a PDE camera (Hamamatsu Photonics K.K., 
Hamamatsu, Japan; European specifications) using a ring of LEDs (CWL: 755 nm, 
FWHM: 10 nm) to excite the NIR fluorescent dye indocyanine green (ICG). The 
light detected by this charge-coupled device (CCD) camera is filtered by a >820
Figure 2. Video example of OTS-induced inter-
ference during in vivo navigation of fluores-
cence camera for penile cancer-related senti-
nel lymph node biopsy. With this fluorescence 
camera, interference completely obstructs flu-
orescence imaging. Fluorescence and interfer-
ence signals are both in white (Video 1 [URL: 
https://doi.org/10.1117/1.JBO.23.5.056003.1]).
Figure 3. Video example of OTS-induced inter-
ference during in vivo navigation of fluores-
cence camera for penile cancer-related senti-
nel lymph node biopsy. With this fluorescence 
camera, interference is clearly visible when low 
fluorescence intensities are observed. Howev-
er, fluorescence imaging is still possible. Fluo-
rescence and interference signals are both in 
blue (Video 2 [URL: https://doi.org/10.1117/1.
JBO.23.5.056003.2]).
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Figure 4. Spectral environment. (a) The excitation light used by the PDE and VITOM camera and 
the ICG absorption spectrum. (b) The ICG spectrum and the light spectrum employed by the OTSvi-
cra.  Spectral transmission window of the PDE and VITOM is estimated from the literature [10,12].
nm long pass filter [10]. The resulting video-feed was delivered as an analog 50 
Hz interlaced video signal. Second, a VITOM exoscopic camera setup (IMAGE1 S
H3-Z FI Three-Chip FULL HD camera head and VITOM® II NIR/ICG Telescope 0 
deg; KARL STORZ Endoskope GmbH & Co. KG, Tuttlingen, Germany; European 
specifications). In this setup, fluorescence excitation occurs using a prototype 
D-LIGHT P filtered Xenon light source (CWL: ~740 nm, FWHM: 120 nm).11 The 
light collected by the CCD camera was filtered to allow light in the 390 to 670 nm 
and > 800 nm range to be collected.12 The resulting video-feed was delivered as 
a digital 50 Hz progressive video signal. A summary of the fluorescence camera 
and tracking system characteristics is shown in Table 1 and Figure 4.
Surgical Fluorescence Phantom and Human Tissue
A surgical fluorescence phantom was fabricated for the experiments. This setup 
consisted of a previously described, siliconebased phantom [8] with two fluores-
cent beads incorporated (see Appendix B). In addition, surgically excised human 
tissue was used. ICG-nanocolloid (dissolved in saline) was prepared as previous-
ly described [13]. Four 0.1 mL injections, with effectively 40 μg/mL ICG, where 
used for the injection site, where 0.1 mL with 1% of the injected dose was used 
for the sentinel lymph node [13].
Characterization of the Tracking Interference
All fluorescence camera recordings were performed using an Epiphan frame 
grabber (DVI2PCIe, Epiphan Systems Inc., Ottawa, Ontario, Canada) integrated 
within the declipseSPECT navigation system. To quantify the OTS-induced inter-
ference, the acquired recordings were analyzed using MATLAB® (The MathWorks 
Inc., Natick, Massachusetts). To evaluate the intensity of the interference signals
in the fluorescence imaging recordings, the mean pixel intensity (MPI) per video 
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 With MPI in counts, t is the video frame number, pi is the individual pixel 
value, and N is the total number of pixels in one frame. To quantify the dynamic 
character of these interference patterns, a “severity of dynamic interference val-
ue” (SDIV) was proposed. To include rapid changes in intensity, while excluding 
gradual changes, this SDIV was formulated as the standard deviation (σ) of the 
first derivative of MPI; i.e., a stable video illumination would result in a low SDIV 
while a highly dynamic flickering in the video would result in a high SDIV:
(2)
 With SDIV in counts/frame or counts/s, J is the total number of video 
frames, MPI’ is the first derivative of MPI, and MPI’ is the average thereof.
Interference Effect for a Modular Tracking Frequency and Duty 
Cycle
To quantitatively measure the effect that a variable OTS pulse frequency and 
duty cycle have on the observed interference during fluorescence imaging, the 
LEDs were used. To generate light reflection, the LED setup was pointed at a flat 
surface using a 15 cm distance and the camera systems were placed at a 17 cm 
distance (Figure 5). These distances were chosen to maximize the captive nature 
of the most sensitive setup while preventing saturation of the camera CCD chips. 
At each LED setting (frequencies: 5 to 100 Hz, duty cycles: 1% to 90%), 2 s video 
recordings were generated and analyzed (i.e., MPI and SDIV values) for both flu-
orescence cameras. These experiments were performed in duplicate. 
Interference in a Surgical Phantom and Human Tissue
To simulate surgical application, the two navigated fluorescence camera systems 
were sequentially positioned right above the surgical phantom using a distance 
of 15 cm. Subsequently, either the OTSvicra or OTSorthos was also placed above the 
surgical phantom using a distance of 130 or 30 cm. To illustrate the difference in 
interference in the “standard” navigation setup, video recordings were produced 
and analyzed (i.e., MPI and SDIV values) with the OTSvicra turned off and on. Fur-
thermore, using the BNC synchronization input of the OTSorthos, the video signal 
of the PDE was sampled, allowing for synchronization of the tracking frequency 
with the PDE acquisition frequency. To illustrate the effect of synchronized NIR 
optical tracking during surgery, video recordings were acquired with the OTSorthos 
turned off and on, using a tracking frequency of 20 (unsynchronized) and 25 Hz 
(synchronized). These recordings were also analyzed for the above-mentioned 
MPI and SDIV values. Furthermore, the most important measurements, i.e., 
PDE fluorescence imaging with “no tracking,” “OTSvicra tracking at 130 cm” and
89
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Figure 5. Schematic overview of the measurements with the LED setup. (a) Setup for the PDE 
camera and LED setup, both pointed at a black surface. (b) Analogy of the clinical usage of the nav-
igated PDE. (c) Setup for the VITOM and LED setup, both pointed at the black surface. (d) Analogy 
of the clinical usage of the navigated VITOM.
“synchronized OTSorthos tracking at 130 cm,” were also recorded using the human 
tissue setting.
Gated Tracking Pulse and Fluorescence Imaging for PDE
To create an alternating gated setup, a tracking pulse should only be sent when-
ever there is no fluorescence image capture (Figure 6). We assumed the PDE 
camera would have a “dead-imaging-moment” long enough to send out this 
tracking pulse, without it being detected by the camera. This was investigated 
by building and programming a small electronic circuit to sample the frequency 
timing of the PDE video signal and trigger the OTSorthos tracking pulse. This circuit 
was built around an LM1881N video processing chip and an Arduino Uno micro-
controller (Arduino AG, Italy).
Figure 6. Gated tracking pulse and fluorescence imaging. In a sequential fashion, optical tracking 
pulses are only emitted when the fluorescence camera is not acquiring a fluorescence image.
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Interference in a Surgical Phantom Setup
Table 2 and Appendix C demonstrate the interference the 20 Hz OTSvicra induces 
for the different fluorescence cameras. This interference is the result of the light 
emitted from the OTS, overlapping with the spectral detection window for which 
NIR fluorescence cameras are traditionally designed (>800 nm). More specifi-
cally, the spectral emission of the OTS overlaps with the fluorescence emission 
of the clinically approved NIR dye ICG (emission max at 820 nm) and more ex-
perimental Cy7-analogs (emission max between 795 and 825 nm) (Figure 4) 
[4,14,15]. For both systems, the MPI and SDIV values rose when the OTSvicra was 
turned on (Table 2); a rise of 142.6 counts (PDE) versus 18.5 counts (VITOM) for 
the mean MPI values and 1757.5 counts/s (PDE) versus 410.0 counts/s (VITOM) 
for the SDIV values was recorded. As illustrated in Appendix C, the interference 
in the PDE setup was so severe that it inhibited the differentiation of the fluo-
rescent beads with respect to their surroundings. Using the VITOM setup, the 
dynamic OTSvicra light was also clearly visible; however, it did not limit the delin-
eation of the fluorescent beads.
Interference Effect for a Modular Tracking Frequency and Duty Cycle
Next to the spectral overlap between the light emitted by the OTS and the 
spectral detection window of the surgical fluorescence cameras, exposure to 
the variations in LED light pulse frequencies and duty cycles influenced the
Table 2. Quantitative analysis of the surgical fluorescence phantom measurements with the OTS-
vicra and OTSorthos. Mean MPI and SDIV values calculated for the PDE and VITOM, with and without 

















PDE without OTS - - 38.7 0.2 5.0
PDE with OTS 20 130 181.3 70.5 1762.5
VITOM without OTS - - 27.5 0.2 0.5
VITOM with OTS 20 130 46.0 16.6 415.0
OTSorthos
PDE without OTS - - 32.6 0.2 5.0
PDE with OTS 20 130 42.2 2.6 65.0
PDE with OTS 25 130 54.8 0.1 2.5
PDE with OTS 20 30 88.0 40.7 1017.5
PDE with OTS 25 30 147 0.3 7.5
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Figure 7. Visualization of the severity of dynamic interference for the fluorescence cameras using 
the LED setup. (a) The SDIV results for the PDE in 3-D-view (left) or top-view (right). (b) The SDIV 
results for the VITOM in 3-D-view (left) or top-view (right).
interferences (Figure 5). Plotting of the MPI and SDIV revealed the LED settings 
affected the two cameras differently (Figure 7 and Appendix D). Of both cam-
eras, the PDE proved most sensitive to the NIR LED light, yielding substantially 
higher MPI values at identical settings; e.g., a mean MPI of 59.3 counts for the 
PDE and 26.9 counts for the VITOM at a frequency of 20 Hz and duty cycle of 
3.2%. As can be seen in Appendix D, the intensity of the MPI decreased with 
decreasing duty cycles (i.e., duty cycles approaching 0%). Figure 7 reveals the 
duty cycle settings also influenced the SDIV values, showing a decrease in the 
intensity of the dynamic interference when duty cycle values approached either 
0% or 100%. For both cameras, minimal dynamic interference (i.e., low SDIV val-
ue) was observed at tracking pulse frequencies of 25, 50, and 75 Hz, which is in 
line with recording frame rates of 25 frames per second. Unfortunately, a stable 
interfering background illumination remained (i.e., stable nonzero MPI values). 
These results indicate that the mismatch between the frequency of the camera 
recording frame rate and the OTS tracking light pulse cause the dynamic charac-
ter (i.e. flickering) of the interference.
Synchronized Tracking Frequency for
the PDE in Both Phantom and Human Tissue
Given the above-reported findings, we reasoned that using an alternative OTS 
with controllable tracking frequency could help solve or reduce the severe flick-
ering effects. Using the surgical phantom setup, Table 2 and Appendix C illus-
trate that a 20-Hz OTSorthos already reduced the interference intensity fourfold 
compared to what was observed for the OTSvicra: mean MPI values of 42.2 counts 
versus 181.3 counts, respectively. This improvement is most likely a combination 























































































Figure 8. Evaluation of optical tracking during fluorescence imaging for human tissue. (a) Excised 
human tissue with the PDE camera situated 15 cm above the tissue. (b) Fluorescence imaging with-
out any tracking. Both injection site (IS) and sentinel lymph node (LN) are visible. (c, d) Example 
video frames for fluorescence imaging during tracking with the (c) OTSvicra and (d) synchronized 
OTSorthos.
When the OTSorthos pulse frequency was matched with the PDE recording fre-
quency (at 25 Hz), SDIV values approached zero and the dynamic character of 
the interference was completely eliminated (Table 2 and Appendix C), thus pro-
viding comparable SDIV values with the OTSorthos turned on and off. However, 
mean MPI values differed between 54.8 counts with the OTSorthos turned on and 




mean MPI = 205.4 counts; 
SDIV = 3501.6 counts/s
No tracking:
mean MPI = 28.6 counts;
SDIV = 0.7 counts/s
OTSorthos:
mean MPI = 44.0 counts;
SDIV = 1.5 counts/s
Setup:
PDE positioned above 
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background, differentiation between fluorescent beads and background in the 
phantom setup was possible. Figure 8 clearly shows that similar results are found 
when this concept is applied to human tissue; where fluorescence imaging was 
rendered unfeasible during tracking with the OTSvicra while fluorescence imaging 
became possible during tracking with the synchronized OTSorthos. 
Gated Tracking Pulse and Fluorescence Imaging for PDE
In an attempt to completely remove the interference during fluorescence im-
aging, including the background illumination, an alternating gated tracking and 
fluorescence imaging setup was pursued. Unfortunately, it was not possible to 
identify a “dead-imaging-moment” capable of harboring the OTSorthos tracking 
pulse. Consequently, we were not able to get rid of the stable background illu-
mination.
DISCUSSION
In this study we have investigated possible solutions to solve the interference 
issues found during the navigation of clinical fluorescence cameras using NIR op-
tical tracking in open surgery. The interference was caused by a number of fea-
tures: (1) the spectral overlap between the ICG emission light and the NIR OTS 
light, (2) the OTS light intensity, (3) the OTS duty cycle, (4) the OTS frequency, 
(5) the fluorescence camera recording frequency, and (6) the camera sensitivity. 
As we have also observed during our previous studies [4,5,8], this combination 
of features means that the severity of interference varied between the type of 
fluorescence camera used. More specifically, the observed interference with the 
OTSvicra completely obstructed fluorescence imaging with the PDE camera while 
its influence on the imaging output of the VITOM camera was only minor.
 Matching the tracking light pulse frequency with the specific camera 
imaging frequency, or a multiplication thereof, supported a drastic decrease in 
the dynamic character of the OTS interference. This approach did not solve the 
stable background signal. Further reduction of this background signal could be 
realized by minimizing the OTS pulse intensity and duty cycle. It appears that 
gating of the OTS tracking pulse and fluorescence image capture will provide 
outcome. For this to work, a fluorescence camera with a (controllable) long 
enough “dead-imaging-moment” is needed. As shown in Figure 4 and Table 1, 
there is little room to decrease the spectral overlap by separating the current 
OTS spectrum from the emission of dyes that fluoresce in the NIR spectrum. 
This said, successful use of non-NIR dyes for surgical guidance has been report-
ed, e.g., for fluorescein (emission maximum at 530 nm), 5-aminolevulinate/
protoporphyrin IX (emission maximum at 635 nm), and Cy5 (emission max-
imum at 670 nm) [12,16–18]. When such dyes are used in combination with 
clinically available far-red fluorescence camera systems [12,19], no overlap with 
the OTS will occur, allowing navigated camera positioning during open surgery. 
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 Instead of changing the fluorescent dye used to create surgical guidance, 
one could also opt for using an alternative OTS with a light spectrum that does 
not overlap with the surgical fluorescence cameras. Unfortunately, most (clini-
cal grade) systems use the NIR spectrum to prevent disturbance of the visible 
operating room lighting [20]. Research grade OTS systems are already available 
that employ, e.g., CWL 940 nm NIR wavelengths [20], which is higher than the 
OTS spectra used in this study. Next to NIR optical tracking, other tracking tech-
niques might also provide outcome for the navigation of fluorescence cameras 
(e.g., electromagnetic tracking, mechanical tracking, and vision-based tracking) 
[6,9,21,22]. Of these methods, vision-based tracking seems to be optimally suit-
ed for fluorescence cameras when combined with (fluorescent) skin fiducials, 
detectable with the camera [23]. Most realistically a combination of tracking 
technologies will provide outcome [24,25].
 Next to the fluorescence cameras that are currently available in the clin-
ic, this research also supports the navigation of future surgical fluorescence im-
aging devices; e.g., fluorescence goggles and head-mounted displays [26].
CONCLUSION
We have characterized the different aspects underlying the OTS interference 
during the navigation of NIR fluorescence cameras and have identified engineer-
ing routes that help solve these issues. With that a basis has been created to en-
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APPENDIX A: SPECTRAL AND TEMPORAL CHARACTERIZATION
A Horiba Jobin Yvon VS140 linear array fiber spectrometer (Horiba Ltd., Kyoto, 
Japan) with a 1-m optical fiber (M15L01, Thorlabs Inc., Newton, New Jersey) was 
used to spectrally characterize the excitation light of the different fluorescence 
cameras and the OTSs used.
 To determine both the OTS pulse frequency and its duty cycle, a light-to-
voltage setup was used. This setup consisted of an optical light-to-voltage sensor 
(TSL 250R, TAOS Inc., Plano, Texas), an analog 50 MHz oscilloscope (no. 2225, 
Tektronix Inc., Beaverton, Oregon), and a direct current power supply (PS613 HQ 
POWER, Velleman NV, Gavere, Belgium). An example for the OTSvicra is shown in 
Figure 9.
APPENDIX B: SURGICAL FLUORESCENCE PHANTOM DETAILS
The fluorescent beads incorporated in the surgical fluorescence phantoms were 
created by mixing an ICG solution with an epoxy resin (epoxy resin C, R&G Fa-
serverbundwerkstoffe GmbH, Waldenbuch, Germany) using the following ratio: 
10:6:1 for epoxy resin, epoxy hardener, and ICG solution, respectively. The ICG 













solution comprised of 1 mg/mL ICG dissolved in methanol. The effective ICG 
concentration in the beads was therefore 60 μg/mL, which roughly presents a 
clinically relevant and detectable ICG concentration [8].
APPENDIX C: VISUALIZATION OF OTS-INDUCED INTERFERENCE 
DURING THE IN VIVO AND PHANTOM APPLICATION
An example of the OTS-induced interference during in vivo application of the 
navigated PDE fluorescence camera is shown in Figures 1 and 2. This is based on 
data published by KleinJan et al., where the navigated PDE camera was demon-
strated during sentinel lymph node biopsy in five penile cancer patients [4]. In-
terference observed in the surgical fluorescence phantoms is illustrated for the 
OTSvicra in Figures 10 and 12, and for the OTSorthos in Figures 11 and 13.
APPENDIX D: DETAILED OVERVIEW OF THE MPI MEASUREMENTS 
FOR A MODULAR TRACKING FREQUENCY AND DUTY CYCLE
A detailed overview of the MPI measurements obtained at different tracking 
frequency and duty cycle settings for the LED setup are shown for both the PDE 
and VITOM camera in Figure 14.
Figure 10. Video example of OTSvicra-induced 
interference in the surgical fluorescence phan-
tom navigation of PDE fluorescence camera 
(Video 3 [URL: https://doi.org/10.1117/1.
JBO.23.5.056003.3]).
Figure 11. Video example of OTSorthos-induced 
interference in the surgical fluorescence phan-
tom navigation of PDE fluorescence camera 
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Figure 12. Video images of OTSvicra-induced interference during fluorescence imaging in the open 
surgical phantom. Top to bottom shows video image sequences of the surgical fluorescence phan-
tom for the PDE without the OTSvicra, PDE with the OTSvicra, VITOM without the OTSvicra, and VITOM 
with the OTSvicra. The OTSvicra was positioned at a distance of 130 cm.
Figure 13. Video images of OTSorthos-induced interference during fluorescence imaging in the 
open surgical phantom. Top to bottom shows video image sequences of the surgical fluorescence 
phantom for the PDE without the OTSorthos and with the OTSorthos at different settings and distances.
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Figure 14. Mean pixel intensity for interference induced by the LED setup at various pulse fre-
quency and duty cycle settings using both the PDE and VITOM.
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In vivo bioluminescence, fluorescence, and single-photon emission computed 
tomography (SPECT) imaging provide complementary information about bio-
logical processes. However, to date these signatures are evaluated separately 
on individual preclinical systems. In this paper, we introduce a fully integrated 
bioluminescence-fluorescence-SPECT platform. Next to an optimization in logis-
tics and image fusion, this integration can help improve understanding of the 
optical imaging (OI) results. For this purpose, an OI module was developed for a 
preclinical SPECT system (U-SPECT, MILabs, Utrecht, the Netherlands). The appli-
cability of the module for bioluminescence and fluorescence imaging was eval-
uated in both a phantom and in an in vivo setting using mice implanted with a 
4T1-luc+ tumor. A combination of a fluorescent dye and radioactive moiety was 
used to directly relate the optical images of the module to the SPECT findings. 
Bioluminescence imaging (BLI) was compared to the localization of the fluores-
cence signal in the tumors. Both the phantom and in vivo mouse studies showed 
that superficial fluorescence signals could be imaged accurately. The SPECT and 
bioluminescence images could be used to place the fluorescence findings in 
perspective, e.g. by showing tracer accumulation in non-target organs such as 
the liver and kidneys (SPECT) and giving a semi-quantitative read-out for tumor 
spread (bioluminescence). With that, the fully integrated multimodal platform 
developed provided complementary registered imaging of bioluminescent, flu-
orescent, and SPECT signatures in a single scanning session with a single dose 
of anesthesia. In our view, integration of these modalities helps to improve data 
interpretation of optical findings in relation to radionuclide images.
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INTRODUCTION
Studies of human disease in animal models often provide an essential link be-
tween chemistry, fundamental research at the molecular level, and the develop-
ment/evaluation of new diagnostic and therapeutic methods. Molecular imag-
ing modalities such as single-photon emission computed tomography (SPECT), 
positron emission tomography (PET), bioluminescence, and fluorescence pro-
vide a means to generate a view into the in vivo situation [1,2]. 
 SPECT and optical technologies are complementary in terms of resolu-
tion, speed, quantitative accuracy, and tracer availability [3-5]. Independent of 
the source depth, modern small animal SPECT systems can be used for longitu-
dinal and quantitative imaging studies of dynamic processes in small structures 
(resolution <0.25 mm) [6]. Alternatively, optical imaging provides rapid and 
low-cost non-radioactive imaging and enables longitudinal studies of superfi-
cial lesions. The resolution of fluorescence imaging also enables the (ex vivo) 
microscopic visualization of molecular/cellular processes [7]. Potentially, a vast 
amount of optical tracers from molecular cell biology can be translated to in vivo 
use. Alternative to a use in combination with dedicated tracers, optical imaging 
can also be used to detect transfected (tumor) cell lines that contain e.g. lucifer-
ase or one of the fluorescent proteins [8], enabling the (longitudinal) monitoring
of disease spread and progression in animal models. The main disadvantages for 
optical techniques are the significant scatter and absorption of photons by tis-
sue/structures in the animal body. Fluorescence techniques additionally suffer 
from tissue autofluorescence, resulting in an unwanted background signal. These 
negative features can be partly overcome by using emissions in the near-infra-
red (NIR) spectrum, but unfortunately optical imaging cannot equal the detailed 
view and quantitative accuracy that SPECT provides at larger depths. One of the 
great challenges today is to place these two modalities in perspective and to de-
termine the added value of optical imaging within the field of nuclear medicine 
[9].
 When multimodal tracers with both a radioactive and fluorescent signa-
ture are used, a single tracer can provide ‘best of both worlds’. Such tracers are 
reported with a peptide, monoclonal antibody, or nanoparticle basis [10-12]. 
Combined radioactive and fluorescence imaging has already provided added val-
ue in clinical surgical guidance studies [13,14].
 Next to the development of multimodal tracers that combine two signa-
tures, SPECT and optical modalities can also be combined on a single device with 
a single user interface. In this way, logistics, including anesthesia, are simplified 
and may improve animal welfare. Because animal positioning is no longer an 
issue with respect to co-registration of the imaging results, the complementary 
value of the different modalities can be exploited to its full extent; e.g. biolumi-
nescent tumor cell localization combined with tracer distribution imaging (fluo-
rescence and/or nuclear).
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 While other groups mainly focus on integrating nuclear imaging with 
three-dimensional (3D) fluorescence optical tomography (FOT) imaging [15-18] 
or fluorescence-mediated tomography (FMT) [19], we consider optical imaging, 
both bioluminescence and fluorescence, as intrinsically superficial technology, 
currently most suitable for planar imaging. Today, planar imaging is applied in 
the far majority of optical imaging studies in preclinical research since optical 
tomography is still highly challenging due to the ill-posed nature of optical data 
caused by strong light absorption and diffusion [20]. Therefore, we pursued 
integration of planar optical imaging with SPECT. We developed and tested a 
low-cost prototype system consisting of an add-on planar bioluminescence/flu-
orescence optical module for a dedicated small animal SPECT device (U-SPECTII, 
MILabs B.V., Utrecht, the Netherlands) [21-24].
METHODS
Optical module for small animal SPECT
The prototype optical imaging (OI) module was fitted onto the U-SPECT-II [21,22] 
installed at the LUMC (Leiden, the Netherlands) as is shown in Figure 1. The opti-
cal module consists of three main components: 1) a light tight ‘dark box’ (Figure 
1.5), 2) a very sensitive CCD camera (Figure 1.3), and 3) a bright light source (Fig-
ure 1.6). Details about these components will be given in later paragraphs. The 
dark box was designed in such a way that when the module is in ‘open’ position, 
the handling of the animals in the bed of the U-SPECT is not hampered. When 
the module is ‘closed’, the CCD camera on top of the box is shielded from ambi-
ent light and can produce a total-body topview bioluminescent image of the an-
imal via a mirror (Figure 1.11). For photographic and fluorescence imaging, the 
animal is illuminated by the light source via two optic fibers (Figure 1.4) entering 
the box and small mirrors (Figure 1.10) reflecting the light onto the bed (Figure 
1.1). Excitation and emission light filters, well adapted to the spectral profile of 
the fluorescent dye under study, can be added to the system.
 For SPECT scans, the animal bed is moved by an XYZ stage into the 
U-SPECT (Figure 1.9) collimator. For the OI position, the bed is held in the same 
position as used for placing an animal in the bed (U-SPECT ‘bed eject position’). 
Alternatively, by mounting the OI module on a separate ‘docking station’, it can 
also be used as an independent optical imaging device. The docking station al-
lows for parallel use of the SPECT and OI module.
Dark box
The dark box uses a rail system to slide over the table, enabling animal place-
ment. The sliding mechanism consists of a U-profile mounted on the box and 
rails (Figure 1.8) mounted on the table that contains the XYZ stage to move the 
bed mounted at the front side of the USPECT. When the box slides to its closed 
position, it is lowered by about 1 cm. In this way, the U profiles lock over the rails. 
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Figure 1. Overview of the U-SPECT-BioFluo platform. (1) Animal bed. (2) Excitation filter box. (3) 
Camera. (4) Optical fiber bundle. (5) Dark box. (6) Light source. (7) Black ABS-plastic insert. (8) 
U-profile light lock. (9) U-SPECT. (10) Mirrors for excitation light. (11) Mirror directing light from the 
bed to the camera. (12) Lens hood and emission filter holder. (13) Camera lens.
Blackboard paint has been applied on the rails and the U-profile to ensure the 
light tightness in locked position. 
 To further block ambient light, all joints on the box have been sealed 
with Sikaflex-221 (Sika AG, Baar, Zug, Switzerland) sealant. Blackboard paint is 
applied to the inside of the box to avoid light reflections. A black ABS-plastic in-
sert (Figure 1.7) has been fitted to cover the entrance of the U-SPECT to prevent 
leakage of ambient light into the dark box and to avoid reflections from the me-
tallic SPECT entrance. This insert was made with a tight fit to the entrance of the 
existing scanner, leaving maximum space to handle the animals on the bed. With 
the insert in place, the U-SPECT vision cameras can still be used to select the 
region of interest (ROI) in the U-SPECT acquisition software [21,22]. Remaining 
light leaks measured inside the closed black box were closed using tape sealants.
Camera, lens, and mirror
To allow for the detection of weak bioluminescence and fluorescence signals, 
an Andor iKon-M 912BV scientific CCD camera (Andor Technology plc., Belfast, 
UK) with a very low dark current level was used for recording OI images. This 
camera is based on a CCD77-00 (e2v Technologies Ltd., Essex, UK) with 512 × 
512 pixels (24 × 24 μm) and has a quantum efficiency between ~50% and ~95% 
in the wavelength region of 400-900 nm. With the 16-bit camera read-out at 
a rate of 50 kHz, the read noise was below 2 counts/pixel. By means of an air-
cooled Peltier element, the CCD operating temperature was set to −65°C, re-


















the accompanying Andor Solis software.
 The CCD camera was equipped with a Fujinon (Fujifilm Corp., Tokyo, Ja-
pan) CF25HA-1 lens (Figure 1.13). This lens has a fixed focal length (F) of 25 mm. 
To collect as much of the emitted luminescence as possible, we selected a lens 
whose diaphragm could be set as large as F/1.4. An emission filter holder (50 
mm diameter; Figure 1.12) was mounted in front of the lens. A lens hood was 
integrated with the filter holder to avoid stray light entering the lens/filter com-
bination.
 A mirror was placed above the animal bed (Figure 1) to direct the emit-
ted light to the CCD camera and generate a top-view image of an entire mouse. 
The selected Edmund Optics enhanced aluminum mirror (Edmund Optics Inc., 
Barrington, NJ, USA) has a high reflective index in the wavelength region of in-
terest: between ~85% and ~98% for wavelengths larger than 450 nm. 
Fluorescence excitation light
To excite fluorescent dyes, an illumination setup was constructed to expose the 
whole animal (bed in OI position) with a relatively high intensity of (excitation) 
light at the appropriate wavelength.
 An MI-150 fiber optic illuminator (Edmund Optics Inc., Barrington, NJ, 
USA) with a 150-W EKE halogen light bulb produced a high intensity bundle of 
light (450 to 800 nm), covering our wavelength range of interest for fluorescence 
imaging. Light from the illuminator was guided to an excitation filter box (Figure 
1.2) using a 0.25 inch glass fiber bundle guide. In the filter box, the spectrum of 
the excitation light can be tailored to a particular dye using a 12.5-mm diameter 
filter. After the filter, the light was split into two fiber bundles that enter the dark 
box next to the camera. The light from the fibers was reflected by two small mir-
rors above the bed to illuminate the mouse from two directions. Light leakage at 
the fiber bundle entrance points was prevented by applying cable glands.
Imaging with U-SPECT-BioFluo
With the U-SPECT-BioFluo device bioluminescence, fluorescence, and SPECT 
scans of a mouse can be made in a sequential fashion. The SPECT measurement 
settings are setup as described earlier for the U-SPECT [21,22]. To perform the 
optical measurements, the OI module is closed and the animal bed is moved 
to the OI position. After positioning, grayscale photographs and bioluminescent
and/or fluorescent images can be recorded by the CCD camera and stored with 
the Solis software for further offline analysis with Matlab (MathWorks Inc., 
Natick, MA, USA).
Grayscale photograph
Grayscale images are recorded by the CCD camera to provide an anatomical 
context for the bioluminescence, fluorescence, and SPECT images. The grayscale 
images are recorded under white light illumination without the use of emission
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and excitation filters. To avoid saturation of the CCD image for our minimal ex-
posure time (50 ms), the lens diaphragm is set to F/22 and the iris of the light 
source is set to a minimum. The F/22 diaphragm allows for sharp photographs of 
the animal in OI position.
Bioluminescence imaging
The bioluminescence images are recorded without the use of excitation light 
and an emission filter. To provide total darkness in the module, the fiber optic 
illuminator is switched off and a light stop is put in the excitation filter box to 
block light entering the module via leaks in the illuminator. To collect a maximum 
of bioluminescent photons in a reasonable exposure time (<90 s), the largest 
possible lens diaphragm (F/1.4) is used.
Fluorescence imaging
During fluorescence imaging, the object or animal is continuously illuminated 
using an appropriate excitation filter for the dye under study. With a specific 
emission filter in front of the CCD camera lens, only the emitted fluorescent sig-
nal is recorded by the camera.
 The CCD exposure time was kept to a minimum by using the largest pos-
sible lens diaphragm (F/1.4) and fully opening the iris of the illuminator. During 
imaging, the exposure time was adjusted to obtain images in which the brightest 
fluorescence spots have pixel values larger than half the full pixel ADC range.
Illumination calibration
The measured images are corrected for the non-uniform illumination pattern at 
the mouse bed by making calibration measurements. This is done by making an 
image (without emission filter) of the illumination pattern using a flat sheet of 
white paper in the OI position. The corresponding iris, diaphragm, and excitation 
filter are used for the grayscale or fluorescence calibration. The exposure time 
has to be adjusted to avoid CCD saturation. Since the bioluminescent images do 
not require illumination, they do not require such a calibration.
Image processing
The optical images from the CCD camera are processed offline with Matlab. Both 
the fluorescence and photographic calibration images are blurred with a Gauss-
ian filter of 7.30 mm full width at half maximum (FWHM) to suppress small scale 
non-uniformities of the calibration paper sheet itself. The resulting calibration 
images are subsequently normalized by scaling their maximum pixel value to 1. 
The photographic and fluorescent images are corrected for the non-uniform il-
lumination by dividing them by the corresponding normalized calibration image.
 3D SPECT images are reconstructed from the SPECT list-mode data with 
MILabs reconstruction software version 2.38. Proper energy and background 
windows are set and data is reconstructed to an isotropic voxel grid of 0.2 mm
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using a pixel-based ordered subset expectation maximization (POSEM) algo-
rithm [25] which includes compensation for distance-depending blurring [26]. 
No attenuation correction is applied. For comparison to the optical images, a 
(2D) SPECT sum image is made by summing the voxel values along the verti-
cal direction. For anatomical reference, the bioluminescence, fluorescence, and 
SPECT sum images are shown in color on top of the grayscale photographic im-
age for pixel values above an adjustable threshold. For bioluminescence and 
fluorescence, this is straightforward as the same CCD camera is used to record 
these images. Overlay of the SPECT sum image was done by matching the mouse 
contours to the grayscale images of the mouse.
Performance characterization
To evaluate the multimodal imaging capabilities of the U-SPECT-BioFluo setup, 
pilot experiments were performed using a phantom and tumor-bearing mice 
injected with a multimodal tracer. Optical images were also acquired and pro-
cessed on an IVIS Spectrum with Living Image software (Caliper Life Sciences 
Inc., Hopkinton, MA, USA). Bioluminescence imaging on the IVIS was done with 
open filter settings.
 The fluorescent dye CyAL-5.5b (λex,max = 674 nm; λem,max = 693 nm) [27] was 
used for the phantom and the multimodal tracer. For the fluorescence measure-
ments on the IVIS, the (built-in) 640-nm excitation and 680-nm emission filters 
were selected. Their bandwidths were respectively 30 nm and 20 nm. However, 
for the OI module we selected a commercial filter (Edmund Optics TechSpec Flu-
orescence Bandpass, Barrington, NJ, USA) with a center wavelength of 692 nm 
and wider bandwidth of ~40 nm to match the dye’s emission peak and to detect 
a larger part of the emission spectrum. From the same filter series another filter 
with ~40 nm bandwidth was used to excite this dye. To minimize the spectral 
overlap of the excitation and emission filters, an excitation center wavelength 
of 624 nm was selected. The excitation light spectrum of the filter was largely 
overlapping the dye’s absorption spectrum. Both commercial filters have a 93% 
transmission within their passbands and a blocking factor >106 for wavelengths 
outside their passbands. This blocking factor is lower for non-perpendicular in-
cident light. So, some excitation light reflected by the object and incident on the 
emission filter might still pass that filter causing the so-called excitation light 
leakage background in fluorescence images.
Phantom measurements
A phantom was generated, via a slightly modified procedure as described by Plei-
jhuis et al. [28], to evaluate the attenuation and resolution for the fluorescence 
and SPECT signals as function of tissue depth. This phantom (Figure 2) consisted 
of a cylinder of tissue simulating gel, in which a capillary, uniformly filled with a 
fluorescence/SPECT compound, was inserted under an oblique angle.
 The gel consisted of a 1% (w/w) agarose solution that was prepared by
111U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, 
and fluorescence imaging platform
6
Figure 2. Schematic diagram of the tissue simulating gel phantom. (1) Phantom. (2) Fluorescent 
and radioactive capillary.
dissolving agarose (Roche, Basel, Switzerland) in 50 mL water under continuous 
heating and stirring. After cooling down to 40°C, 170 μM hemoglobin from bo-
vine blood (Sigma Aldrich, St. Louis, MO, USA) was added to the solution to ob-
tain an optically tissue equivalent gel [28]. The solution was poured into a 50-mL 
tube (Falcon, BD Biosciences, San Jose, CA, USA). After further cooling and solid-
ification, the tube was removed and the gel was given blunt ends using a scalpel.
 A 200-μM CyAL-5.5b solution was mixed 3:1 with a 99mTc-eluate (~1.3 
GBq/mL). A glass capillary (inner diameter 0.9 mm) containing 50 μL of this mix-
ture and closed by epoxy glue [29] was inserted into the gel. Prior to inserting 
the capillary in the phantom, we used the blue coloration to visually confirm that 
the fluorescent dye (CyAL-5.5b) was uniformly distributed in the capillary.
 The phantom was placed in the U-SPECT-BioFluo bed, and a grayscale 
and a fluorescence image were recorded. Subsequently, a 20-min SPECT scan 
was made with the ROI containing the entire phantom. At last, fluorescence 
measurements were made on the IVIS for control.
In vivo measurements
Mouse scans were performed to interpret the different bioluminescent, fluores-
cent, and SPECT images for a practical preclinical case series of four animals. Tu-
mor lesions were generated in Balb/c nude mice (6 to 8 weeks of age) by trans-
planting 4 T1-luc + tumor cells (0.25·105), with firefly luciferase gene expression, 
into the fourth mammary fatpad [30].
 For fluorescence and SPECT imaging, the previously reported multimod-
al tracer 111In-MSAP-RGD [30], containing the above mentioned CyAL-5.5b dye, 
was used. Twenty-four hours prior to imaging, the mice were injected intrave-




Figure 3. Protocol timeline for in vivo measurements. The injection moments of 111In-MSAP-RGD 
(CyAL-5.5b dye), D-Luciferin, and subsequent imaging periods are indicated.
 For bioluminescence imaging, the mice were injected intraperitoneal-
ly with 150 mg/kg D-Luciferin (Xenogen Corp., Alameda, CA, USA) in PBS. Ten 
to twenty minutes after this injection, the mice were placed in the transparent 
U-SPECT-BioFluo bed and first imaged on the IVIS. Afterwards, the bed with the 
mouse was immediately clicked on the stage of the U-SPECT-BioFluo for optical 
imaging followed by 30 min of SPECT imaging. The mice were anesthetized by 
means of Hypnorm/Dormicum/water (1:1:2; 5 μL/g i.p.). The protocol timeline 
is shown in Figure 3. These animal experiments were performed in accordance 
with Dutch welfare regulations and approved by the ethics committee of the 
Leiden University Medical Center under reference 2013/12189.
RESULTS
After installing the optical module on the U-SPECT, the optical image pixel size 
for the top-view image of the bed was found to be 0.36 mm. We verified the 
light tightness of the closed dark box by recording an image with a large lens 
diaphragm and an exposure time of 60 s, but without any optical filters or light 
source. This measurement resulted in a zero mean ambient light background 
level (standard deviation: 1.3 counts/pixel).
Phantom measurements
In Figure 4, the fluorescence and SPECT imaging results of the cylindrical phan-
tom with the thin capillary source are shown both for the U-SPECT-BioFluo (500 
ms exposure time) and the IVIS (1 s exposure time). Optical images obtained with 
U-SPECT-BioFluo and with IVIS are very similar. For SPECT reconstruction from list 
mode data, a 20% wide energy window has been set around the 140 keV 99mTc 
photopeak. The background windows for triple window scatter correction [31] 
were set to 124 to 136 keV and 166 to 184 keV. POSEM with 16 subsets and 6 
iterations was performed for reconstructing 3D SPECT images. The SPECT images 
were subsequently blurred with a 3D Gaussian low pass filter (FWHM 0.47 mm). 
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Figure 4. Phantom imaging results. (a) Fluorescence (500 ms exposure time) and SPECT imaging 
on the U-SPECT-BioFluo. (b) Fluorescence imaging on the IVIS (1s exposure time).
 By adjusting the color scale threshold of the fluorescence image, sharp 
identification of the most superficial part of the capillary can be exchanged for a 
slight increase in the in-depth visibility. For the low threshold image, the thresh-
old has been set at about the background level of the phantom which is due to 
e.g. excitation light leakage through the emission filter, fluorescence emission 
light scatter, and autofluorescence of the phantom [32].
 In Figure 4a, the SPECT signal is also shown. In the top-view image, the 
3D reconstructed SPECT data are vertically summed for 1:1 comparison with 
the fluorescence measurement. In the side view, the SPECT data are summed 
horizontally. In Figure 5a, the fluorescence and SPECT signal strength as a func-
tion of the capillary depth are shown. Line profiles (~1 mm wide) along the 




Figure 5. Effects of depth-dependent attenuation. (a) Fluorescence signal (phantom background 
level subtracted) and SPECT signal of capillary versus depth in gel phantom. The maximum SPECT 
and fluorescence signals have been normalized to 1. (b) The positions of the axial line profiles are 
indicated in the top-view image of the phantom.
modalities (Figure 5a). The axial position along these line profiles was convert-
ed into the capillary depth by using the inclination angle of the capillary deter-
mined from the SPECT side-view image Figure 4a. Both Figures 4a and 5 clearly 
demonstrate that while the SPECT signal barely suffers from attenuation in this 
phantom, the fluorescence signal of the uniformly distributed dye (CyAL-5.5b) is 
decreasing with depth. The IVIS and our OI module show a similar attenuation 
behavior; at 7 mm the signal has already dropped by ~30%, and at 14 mm it is 
close to the fluorescence background level of the phantom. This decrease can be 
attributed to the light attenuation and scatter by hemoglobin and water in the 
phantom. A similar attenuation is observed in tissue [33].
 The resolution curves of the fluorescence and SPECT signals (Figure 6a-
c) were obtained by making ~1-mm wide line profiles in the top-view images 
orthogonal to the capillary corresponding to different depths (Figure 6d). Again, 
the depths have been obtained from the capillary inclination angle. For compar-
ison, these curves have been normalized to their maximum signal. Like the sig-
nal strength, the resolution of the fluorescence images also shows severe depth 
dependence. At 6 mm depth, the width of the fluorescence profile was still close 
to that of the SPECT profile, namely ~1.2 mm (FWHM). At 14 mm depth, the 
resolution decreased to ~1.7 mm (FWHM) and the peak value was just 2.5 times 
the background. Both widths are largely determined by the 0.9 mm diameter of 
the capillary itself. Around 22 mm depth, the fluorescence signal can no longer 
be distinguished from the background.
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Figure 6. Comparison of image blurring for SPECT and fluorescence. (a,b,c) SPECT and fluores-
cence line profiles orthogonal to the capillary at different depths in the phantom. The maximum 
signal of each profile has been normalized to 1. (d) The positions of the line profiles are indicated 
in the top-view image.
In vivo measurements
Figure 7 presents the imaging results obtained from the different modalities in 
both U-SPECT-BioFluo and IVIS. Figure 7a shows respectively the biolumines-
cence, fluorescence, and SPECT sum images recorded with U-SPECT-BioFluo. The 
exposure time for the bioluminescence measurement was 60 s and for the fluo-
rescence measurement 300 ms, as the fluorescent signal was much stronger. On 
the IVIS (Figure 7b), the exposure times were respectively 30 s and 1 s. The IVIS 
images are similar to those of the in-house developed OI. The bioluminescence 
images clearly show the viable tumor component, where luciferase converts 
D-Luciferin in bioluminescent light.
 In the U-SPECT-BioFluo bioluminescence images in Figure 7a, one can 
notice some hot pixels that may be caused by absorption of 111In-based gamma 
radiation in the CCD chip. This radiation was emitted by the radioactive compo-
nent of the multimodal tracer 111In-MSAP-RGD. A median filter of 4 × 4 pixels 
has been applied to remove these hot pixels. For the POSEM reconstruction (16 
subsets and 6 iterations) of the SPECT scan, a 20% wide energy window has been 
set around the 171 keV 111In photopeak. Background windows of 151 to 167 keV 
and 205 to 226 keV were chosen for the scatter correction. A 3D Gaussian filter 






 Looking at the figures, it becomes clear that the signal-depth related 
effects severely limit the diagnostic utility of the optical images. Nevertheless, 
the superficially located mammary tumors could be depicted using both opti-
cal technologies. Other than in the phantom setup, here the effect of fluores-
cence threshold changes was minimal. However, in the image representing the 
summed SPECT slices, the threshold was set at such a level that a tiny part of 
tumor seems to be ‘missing’ with respect to the optical images. We believe that 
the intensity of the signal of deeper located cells in SPECT can cause slightly dif-
ferent locations of the tumor compared to the tumor as is visualized by optical 
imaging: Optical imaging mainly displays the surface of the tracer distribution, 
while the SPECT shows deeper structures in the mouse very clear as well which 
affects also the sum image. On the other hand, the SPECT images revealed a 
substantial uptake of 111In-MSAP-RGD in other regions of the mouse, e.g. the 
liver and kidneys, a finding that correlates with previously reported biodistri-
bution studies [30]. The difference in detectability between the different mo-
dalities also becomes apparent when one zooms in on the tumor itself: SPECT 
images in Figure 7c show heterogeneity of tracer uptake (e.g. an area with less 
accumulated tracer) that can not be seen in fluorescence images. Earlier studies 
confirm that microSPECT enables to visualize and quantify tracer heterogeneity 
in tumors [24,34].
DISCUSSION
The rise of optical techniques for molecular imaging purposes has resulted in a 
demand for dedicated modalities. One of today’s challenges lies in placing op-
tical findings in perspective to nuclear medicine technologies. There is a trend 
to combine nuclear medicine with supplementary read-outs provided by other 
modalities. One very practical solution is to integrate multiple modalities on a 
single platform to prevent deformation issues. For this reason, we developed 
an optical module that can be provided as an add-on to the U-SPECT-II modality 
for preclinical nuclear medicine. Using luciferase-gene-modified tumor cells and 
multimodal tracers that combine radionuclear and optical properties [10-12], 
we incorporated bioluminescence and fluorescence imaging in a 3D SPECT im-
aging setting.
 This initial pilot study underlined that the prototype design (see Figure 
1) provided such a small CCD image background that both bioluminescence and 
fluorescence imaging could be successfully achieved. We used commercially 
available 40 nm wide bandpass filters specifically tailored to the excitation and 
emission spectra of the CyAL-5.5b dye with wavelengths only slightly different 
from the ones used on the IVIS. This small difference may explain the difference 
in the fluorescence attenuation profiles shown in Figure 5: Since the absorption 
coefficient for hemoglobin is higher at 624 nm than at 640 nm, the excitation 
light is somewhat more attenuated in the phantom on our setup than on the
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Figure 7. Imaging results for a mouse with a 4T1-luc+ tumor. Bioluminescence images are ob-
tained by D-Luciferin injection. Fluorescence and SPECT images are obtained by injection of multi-
modal tracer 111In-MSAP-RGD. (a) U-SPECT-BioFluo. Bioluminescent images both with and without 
median filter applied. (b) IVIS. (c) U-SPECT-BioFluo: 1-mm thick horizontal SPECT slices (anterior 
to posterior). Organs have been indicated in the SPECT images. White circles indicate the tumor 
location in the slices.
IVIS. For future studies with different dyes other commercial filters can be incor-
porated. The current halogen excitation lamp and CCD camera of the prototype 





Reasoning that accurate evaluation of the pharmacokinetics and distribution of 
a new (optical) imaging tracer is of paramount importance for any form of future
clinical translation, we have used the in-depth information provided by SPECT to 
place the optical findings in perspective. In the present study we illustrate that, 
using a phantom setup and a multimodal angiogenesis tracer (111In-MSAP-RGD) 
in an orthotopic mouse mammary tumor model, the SPECT/bioluminescence/
fluorescence combination proposed in this paper may help prevent misconcep-
tions of the tracer’s specificity that could otherwise have resulted from using an 
optical evaluation only. The genetically engineered bioluminescent signal was 
confined to the tumor spread, while the fluorescent and radioactive emissions 
were used to define the distribution of the multimodal tracer used in this study. 
While the SPECT images show the complete distribution profile of the tracer 
used [30], the fluorescence images of both our in-house developed OI module 
as well as the IVIS images, only detected superficial emissions originating from 
the tumor. SPECT images clearly show tracer uptake e.g. in the liver (see Figure 
7). In this case, possible toxicity issues due to unwanted uptake and retention in 
organs would have been missed with fluorescence imaging.
 Where the preclinical SPECT findings are constant with depth, both the 
optical detectability and resolution degrade as functions of depth (see Figures 
5 and 6). Factors contributing to the degradation of optical signals are signal 
attenuation and scattering - both increase with depth and occur for both the 
excitation light and emitted signal. In the case of fluorescence imaging, ‘leakage’
of excitation light through the filters and autofluorescence (depends on the tis-
sue type) may raise the background signal. Even with NIR fluorescent dyes such 
as indocyanine green (ICG), these effects have shown to limit the use of fluo-
rescence to superficial applications [32]. This said, the added value of optical 
imaging in superficial surgical guidance and/or pathological imaging situations is 
obvious and is driving the development of optical imaging tracers or multimodal 
tracers that contain an optical component [11,12].
 In a future version of the OI module, the filter placement could be au-
tomated to enable fast switching between different fluorescent emissions, e.g. 
for multispectral imaging. This could then be combined directly with multi-iso-
tope capabilities of SPECT, to allow for simultaneous evaluation of even multiple 
multimodal tracers. With UV transparent and more sensitive optics (e.g. larger 
aperture or deeper CCD cooling), it may become possible to detect much weaker 
signals such as the Cerenkov luminescence emitted by PET tracers [32]. As the 
U-SPECT-II can be adapted to perform collimated imaging of PET tracers (VECTor, 
[35,36]), this might even enable combined Cerenkov and PET imaging studies, 
which may help in the interpretation of Cerenkov findings. In addition, the used
SPECT can be equipped with CT, further expanding the integration of imaging to 
a triple or quadruple imaging platform [37].
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CONCLUSION
We evaluated a prototype optical add-on module that integrates optical imaging 
with a dedicated small animal SPECT system. This combination allows for com-
plementary and registered imaging of bioluminescent, fluorescent, and SPECT 
signatures in a single scan session. The high-resolution and highly quantitative 
(3D) SPECT information about tracer kinetics and/or biodistribution can improve 
the interpretation of the fluorescence and bioluminescence images.
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ABSTRACT
Within image-guided surgery, ‘hybrid’ guidance technologies have been used to 
integrate the complementary features of radioactive guidance and fluorescence
guidance. Here, we explore how the generation of a novel freehand fluores-
cence (fhFluo) imaging approach complements freehand SPECT (fhSPECT) in a 
hybrid setup. Near-infrared optical tracking was used to register the position 
and the orientation of a hybrid opto-nuclear detection probe while recording 
its readings. Dedicated look-up table models were used for 3D reconstruction. 
In phantom and excised tissue settings (i.e., flat-surface human skin explants), 
fhSPECT and fhFluo were investigated for image resolution and in-tissue signal 
penetration. Finally, the combined potential of these freehand technologies was 
evaluated on prostate and lymph node specimens of prostate cancer patients 
receiving prostatectomy and sentinel lymph node dissection (tracers: indocy-
anine green (ICG) + 99mTc-nanocolloid or ICG-99mTc-nanocolloid). After hardware 
and software integration, the hybrid setup created 3D nuclear and fluorescence 
tomography scans. The imaging resolution of fhFluo (1 mm) was superior to that 
of fhSPECT (6 mm). Fluorescence modalities were confined to a maximum depth 
of 0.5 cm, while nuclear modalities were usable at all evaluated depths (<2 cm).
Both fhSPECT and fhFluo enabled augmented- and virtual-reality navigation to-
ward segmented image hotspots, including relative hotspot quantification with 
an accuracy of 3.9% and 4.1%. Imaging in surgical specimens confirmed these 
trends (fhSPECT: in-depth detectability, low resolution, and fhFluo: superior 
resolution, superficial detectability). Overall, when radioactive and fluorescent 
tracer signatures are used, fhFluo has complementary value to fhSPECT. Com-
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INTRODUCTION
Intraoperative tissue identification is often of paramount importance to achieve 
an effective and minimal invasive surgical procedure. One of the most frequently 
used surgical guidance methods encompasses the use of radioactive tracers that 
specifically accumulate in targeted tissues (e.g. tumorous tissue [1]), facilitating 
complete resection of the targeted tissue (e.g. clear tumor boundaries [2,3]) and 
sparing of healthy tissue (e.g. lymphatics [4]). Since the high penetration depth 
of gamma rays allow for sensitive detection of the tracer-targeted tissues deep 
within the patient anatomy, radioguided surgery can be considered the ‘gold 
standard’ for interventional molecular imaging [5]. These nuclear medicine qual-
ities enable surgical planning via 3D preoperative imaging (e.g. single-photon 
emission computed tomography/X-ray computed tomography (SPECT/CT)) and 
intraoperative in-depth guidance via handheld gamma ray detection probes or 
mobile gamma cameras [6]. The latter can even be extended to 3D intraopera-
tive tomographic imaging via freehand SPECT (fhSPECT) imaging [7,8]. Surgical
guidance has a large visual component, a feature that is lacking in traditional 
radioguidance procedures.
 Fluorescence guidance has emerged as an optical alternative for surgical 
guidance and is rapidly being adopted in many different interventional settings 
[9]. Unfortunately, fluorescence guidance can only be used for superficially lo-
cated lesions, since light suffers from severe attenuation, scatter and reflection 
in tissue. This restricts fluorescent penetration to a maximum of roughly 1 cm 
deep in tissue [10]. This limits in-depth visibility, but prevents shine-through of
underlying tracer distributions and as such facilitates the identification of su-
perficial lesions located in close proximity to high background signals [11,12]. 
Moreover, when used superficially, fluorescence imaging can be performed with
a superior spatial resolution when compared to gamma ray detection [11], even 
enabling (real-time) microscopic investigation [13,14]. Although 3D fluorescence 
imaging in the form of a fluorescence tomography setting has been reported for 
pre-interventional breast cancer diagnosis [15], to our knowledge, 3D or pseudo 
3D fluorescence imaging has not yet been attempted in an image-guided surgery 
setting.
 To further improve the accuracy of image-guided surgery, it seems log-
ical to make use of hybrid strategies that combine radioactive and fluorescent 
signatures [16], thereby creating a best-of-both-worlds scenario. Multiplexing 
of the complementary signatures allows for surgical guidance concepts that 
harbor the advantages of the individual technologies, e.g. 3D preoperative ra-
dionuclide imaging and intraoperative optical guidance [16,17]. Acquiring both 
radioactive and fluorescent signals for (intraoperative) tissue identification can 
be achieved by applying two separate tracers, but more ideally is achieved using 
a single tracer that contains both the complementary emission types, yielding 
a so-called ‘dual-modality’ or ‘hybrid’ tracer. Extensive use of free indocyanine
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green (ICG) in combination with 99mTc-nanocolloid [10,18–20] or the hybrid trac-
er ICG-99mTc-nanocolloid in clinical sentinel lymph node (SN) biopsy trials [11, 
12,21–23], has underlined the value of the hybrid surgical guidance concept.
 This successful clinical exploration of the hybrid surgical guidance con-
cept has provided the basis for the development and clinical evaluation of a 
range of intraoperative hybrid detection modalities [24], [25]. The first reported 
clinically applied hybrid modality, which is now also commercially available, is 
the so-called opto-nuclear probe (Eurorad S.A., Eckbolsheim, France) [26–28]. In 
this device, numeric and acoustic gamma tracing is combined with numeric and 
acoustic tracing of the fluorescent dye ICG with a one channel optical detector. 
To our knowledge, fully integrated image-based hybrid gamma and fluorescence 
cameras have only been reported in the preclinical setting so far [29–31]. How-
ever, to study the potential of such an image-based hybrid modality during sur-
gery, clinical studies have been performed in a setting wherein a tailored bracket 
was used to physically connect a gamma probe or a portable gamma camera to 
a fluorescence exoscope [32]. Key advantages of the hybrid modalities appeared 
to be: 1) the ability to use in-depth radioguidance to guide positioning of fluo-
rescence imaging; 2) logistical simplification in the operating room. 
 Alternative to hybrid imaging devices, hybrid surgical navigation con-
cepts have been used to successfully integrate the nuclear guidance as provided 
by preoperative SPECT or intraoperative fhSPECT images with fluorescence guid-
ance [33–36]. Key advantages of the hybrid navigation approach appeared to 
be: 1) the ability to provide augmented reality displays of radioactive findings in 
a fluorescence video display; 2) virtual- or augmented-reality “video-game like” 
guidance of the fluorescence camera to the lesions (with numerical feedback 
of the distance to the lesion). While a complete hardware integration can also 
provide value when separate tracers are used for the radioactive and fluores-
cent signatures, e.g. separating targeted tissue from healthy tissue [37], success 
of this navigated fluorescence camera approach relies on a direct link between 
SPECT and fluorescence findings, thus requiring a single hybrid tracer.
 Based on the assumption that radioactive and fluorescence guidance 
provide complementary information during surgery, we have now studied the 
integrated use of ICG-99mTc-nanocolloid, the opto-nuclear hybrid detection mo-
dality and a modified fhSPECT navigation platform (see Figure 1). To allow for 
hybrid imaging and navigation, fhSPECT was complemented by a new form of 
(pseudo-) 3D intraoperative fluorescence tomography that we call freehand flu-
orescence (fhFluo). To investigate if and how fhFluo imaging adds complementa-
ry information during surgical guidance, both fhSPECT and fhFluo technologies 
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Figure 1. Schematic overview of the hybrid imaging and navigation modality. (a) Overview of the 
total setup, showing near-infrared (NIR) tracking of both the opto-nuclear probe and the imaging 
objective. (b) Zoom-in of the opto-nuclear probe and imaging objective, displaying the presence of 
both a radioactive (γ) and fluorescent (λExcitation and λEmission) tracer signature in the imaging  bjective. 
(c) Zoom-in of the probe entrance windows for nuclear and fluorescence detection.
METHODS
Integration of the
Opto-Nuclear Probe With the DeclipseSPECT Navigation Device
The hybrid fhSPECT and fhFluo setup depicted in Figure 1 was realized using 
the declipseSPECT navigation device (SurgicEye GmbH, Munich, Germany) [7,8] 
and the opto-nuclear probe [27], capable of both gamma and fluorescence mea-
surements in counts/s. As described by Van den Berg et al., the fluorescence 
measurements are acquired with two acrylic optical fibers, each containing a 
numerical aperture of 0.51 and a diameter of 1 mm. The first fiber is coupled to 
a 785 nm laser for excitation of the fluorescence dye ICG, providing a typical op-
tical power of 3.7 mW/cm2 at the fiber output. The second fiber is coupled to a 
> 810 nm optical filter and an infrared-extended photomultiplier tube (H10721-
20, Hamamatsu Photonics kk., Hamamatsu, Japan) to collect the fluorescence 
emission signals. The resulting system sensitivity for ICG, in terms of minimum 





























enable position- and orientation-tracking of the opto-nuclear probe, the navi-
gation system applies near-infrared (NIR) optical tracking (Polaris Vicra, North-
ern Digital Inc.,Waterloo, Canada) of a four-fiducial reference target, specifically 
designed to attach at the distal end of the probe (see Figure 1b). To geometri-
cally calibrate the position of the gamma- or fluorescence-entrance windows 
with respect to this reference target, thereby tracking both gamma and fluo-
rescence detection locations, individual geometrical calibrators were designed 
using SolidWorks computer-aided design software (Dassault Systèmes SA, Véli-
zy-Villacoublay, France), similar as previously described by Van Oosterom et al. 
[35]. These were 3D printed (acrylonitrile butadiene styrene plastics; Dimension 
Elite 3D printer, Stratasys Ltd., Eden Prairie, MN, USA) and used to calibrate the 
position of the respective detectors relative to the fiducials at the distal end of 
the opto-nuclear probe [35]. An oscilloscope (PicoScope, Pico Technology Ltd., 
Cambridgeshire, UK) housed within the declipseSPECT was used to transfer the 
probe-read-out signals to the declipseSPECT, either via an analogue signal (nu-
clear read-out of the gamma signal) or a digital transistor-transistor-logic signal 
(optical read-out of the fluorescence signal).
 By simultaneously recording the position and orientation of the op-
to-nuclear probe and its 1D probe readings (sample rate of 0.5 s), software al-
gorithms could be used to extrapolate the geometrical source location of the 
readings. A modified version of the declipse 6.0 software (SurgicEye GmbH) was 
used to reconstruct a tomographic 3D volume based on the gamma readings 
(i.e. an fhSPECT scan as previously described [8,38,40]). A tomographic 3D re-
construction of the fluorescence readings (i.e. a fhFluo scan) was realized in 
analogy to the well validated fhSPECT technology. The underlying mathematical 
models used were based on previously validated look-up table (LUT) methods 
[38,39,41]; The LUT model provides an estimate of which voxels in the scanning 
volume could have contributed, and with what kind of weight, to the individ-
ual probe measurements. In line with previous reports, a maximum likelihood 
expectation maximization algorithm was used to approximate the actual tracer 
distribution within the volume [39,42]. For the fhSPECT part, the reconstruction 
model was configured, as previously described, by using a dedicated LUT model 
based on nuclear Monte-Carlo simulations [39]. For fhFluo imaging, however, 
the real-measurements fluorescence LUT model was implemented [39]. This flu-
orescence LUT was obtained by measuring the response of a point source (6 
μg/mL ICG dissolved in epoxy resin with a total volume of about 1.5 μL [43]) in 
air using a sample volume of 11x11x10 mm and a resolution of 1 mm. Subse-
quently, the acquired LUT model was filtered with a Gaussian filter (size: 1 mm 
standard deviation) in order to compensate for measurement and calibration 
inaccuracies, and subsequently normalized.
 During both fhSPECT and fhFluo scan acquisition, the optonuclear probe 
was manually moved over and around the subject (no-tissue contact), there-
by measuring at as many different positions and orientations as possible within
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Table 1. Most important differences in freehand SPECT and freehand fluorescence reconstruction 
and navigation settings.
Reconstruction parameter fhSPECT fhFluo
Number of voxels 392000 392000
Voxel size (mm) 2x2x2 1x1x1
VOI size (voxels) 70x70x80 140x140x20





time (typical range in min)
1-3 1-3
Navigation parameter fhSPECT fhFluo
Minimal scan hotspot size (mm) 1.2 0.6
Scan colormap Green-blue-purple Green-white
Augmented navigation targe size
(mm)
4 4
Augmented navigation target 
color
Red (when targeted)
Gray (when not targeted)
Red (when targeted)
Gray (when not targeted)
a <  5 min acquisition time [8]; Previous clinical experience with fhSPECT during 
surgery suggests total scanning time should be kept roughly below 5 min 
[8,44,45] (see Table 1).
 To geometrically link the position and orientation of the resulting scan 
to the imaged objective, thereby allowing for augmented reality overlay or sub-
sequent navigation, a three-fiducial reference target, also tracked by the afore-
mentioned tracking system, was attached nearby the specimen under study (see 
Figure 1b). When the fhSPECT and fhFluo scans were deployed for 3D surgical 
navigation, the intensity hotspots in the reconstructed tracer distribution func-
tioned as the navigation targets (e.g. SN locations within the specimen). These 
navigation targets were segmented automatically, which occurred based on the 
weighted center of gravity of the intensity hotspots. Subsequent augmented 
and/or virtual reality visualizations where shown from the perspective as ap-
proached by the navigated instrument using the modified declipse 6.0 software.
Patients
Ex vivo human skin explants were obtained from an abdominal skin reduction 
procedure. SN and prostate samples were acquired from five prostate cancer 
patients receiving a combination of robot-assisted laparoscopic SN biopsy, ex-
tended pelvic lymph node dissection (ePLND) and prostatectomy. The prostate 
and dissected SN’s contained either the hybrid tracer ICG-99mTc-nanocolloid or a 
combination of ‘free’ ICG and 99mTc-nanocolloid [19]. All procedures performed
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were in accordance with the ethical approval of our institutions (B18-009, 
NL46580.031.13 and NL57838.031.16) and the Helsinki Declaration.
Reference Modalities
As reference to the hybrid 3D fhSPECT and 3D fhFluo imaging setup, all measure-
ments were also performed with more traditional image-guided surgery modal-
ities [24,25]. This included a handheld gamma camera (CrystalCam with low en-
ergy high resolution collimator and 30 s exposure time; Crystal Photonics GmbH, 
Berlin, Germany) and an open surgery fluorescence camera (FIS-00, Hamamatsu 
Photonics kk., Hamamatsu, Japan). This fluorescence camera is based on the 
previously reported m-PDE prototype system, harboring a CCD camera with > 
820 nm optical longpass filter and a ring of LEDs for ICG excitation (755 nm cen-
ter wavelength; 10 nm full-width-at-half-maximum) [43], [46]. In terms of min-
imum detectable ICG concentration, the sensitivity is reported as < 0.0093 ng/
mL [46].
Image Resolvability and Quantification
To demonstrate the differences in imaging resolvability and resolution charac-
teristics, a resolvability phantom was created. This phantom consisted of a 10 
mm thick polymethylmethacrylate transparent plastic plate, where 12 well pairs 
were drilled with decreasing distances between the edges, ranging from 18 to 
0.25 mm edge-to-edge. Each well was filled with a 170 μL solution of the hybrid 
tracer ICG-99mTc-nanocolloid containing 1.03 x 10−2 mg/mL ICG and 2 MBq 99mTc. 
These values are in the range of a typical SN size and tracer concentration as re-
ported for prostate cancer [47]. All well pairs were repeatedly scanned with the 
fhSPECT, fhFluo, CrystalCam and FIS-00 imaging modalities. The whole experi-
ment was performed in duplicate, resulting in 48 different wells, imaged within 
12 scans per imaging modality (i.e. 4 wells per image). To determine the signif-
icance in differences between relative image-hotspot quantification, a paired 
samples t-test with confidence interval of 95% was used in IBM SPSS statistics 22 
software (International Business Machines Corp., New York, USA).
Signal Penetration in Tissue
The influence of tissue attenuation was determined using human skin tissue 
(roughly a flat surface of 20 x 15 cm with a depth of 5 cm). To allow these inves-
tigations, an Eppendorf tube (Eppendorf AG, Hamburg, Germany) was filled with
ICG-99mTc-nanocolloid (according to the above-mentioned volume and concen-
tration), positioned at different depths from the skin surface (0, 0.5, 1 and 1.5 
cm) and analyzed with the available imaging modalities.
Surgical Specimen Evaluation
In the operating room, excised specimens of the SNs and the prostate (i.e. the 
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Figure 2. Overview of the ICG fluorescence look-up table. (a-c) Maximum intensity projections of 
the look-up table, shown from three different directions, where the y-axis depicts the longitudinal 
axis of the optonuclear probe. (d-f) Horizontal line profiles taken at the middle of the maximum 
intensity projections as shown above.
injection site of the tracer) were subjected to imaging with the fhSPECT, fhFluo, 
CrystalCam and FIS-00 modalities.
RESULTS
Integration of the 
Opto-Nuclear Probe With the DeclipseSPECT Navigation Device
Figure 2 shows a maximum intensity projection of the filtered fluorescence LUT 
model from different sides. The y-axis is depicted as the longitudinal axis of the 
probe. Interestingly, most likely due to the two-fiber setup (i.e. emitting and 
receiving), the acquired LUT model was not symmetrical and the maximum re-
sponse was slightly in front of the probe (y = 1 mm). A curve along the longitu-
dinal axis of the probe revealed a quick detection fall-off (100% at 1 mm, 50% at 
3.3 mm, 10% at 6 mm and 5% at 6.8 mm). These findings are contrary to a typical 
LUT for gamma ray detection (99mTc) [39], which is symmetrical, has maximal 
response at the edge of the probe (y = 0 mm) and displays a more extended de-
tection fall-off (100% at 0 mm, 50% at 5 mm, 10% at 19 mm and 5% at 33 mm).
 Due to the above-mentioned detection differences, the customized 
fhFluo software was configured different to that of the fhSPECT (settings are 
shown in Table 1). To accommodate for the quick detection fall-off and typical 
tissue attenuation of fluorescent signals [9,48], the volume of interest (VOI) used
for the fhFluo scans was limited to a depth of 20 mm, while the fhSPECT VOI 
depth was configured at 160 mm. For both fhSPECT and fhFluo imaging options, 















































































































































































































scan reconstruction was performed ‘on-the-fly’ (i.e. during the 1-3 min scan 
acquisition). To ensure similar software performance, the number of voxels 
(392000) used was equal for both modalities. As a result, the reduced scan vol-
ume of the fhFluo yielded two-fold smaller voxel dimensions as compared to the 
fhSPECT scans.
Imaging Resolvability and Quantification
Figure 3a depicts the distinct differences in the resolvability outcomes obtained 
using the different modalities. The FIS-00 displayed the highest resolution: al-
lowing separation at an edge-to-edge distance of 0.5 mm. The newly introduced 
fhFluo was second best, discriminating sources at 1 mm edge-to-edge. The Crys-
talCam came third with a resolvability of 2 mm, while the fhSPECT came last with 
a resolvability of 6 mm.
 For the freehand imaging options the declipse 6.0 software was able to 
segment separate navigation targets for the tracer sources (depicted as virtual 
red and gray targets within the image hotspots; see Figure 3). Because of this 
segmentation, navigation and relative hotspot quantification became possible 
(see Figure 3b). For the latter, analysis of the fhSPECT images of the resolvability 
phantom yielded an average absolute inaccuracy of 3.9 + 3.3%. The average ab-
solute inaccuracy for the hotspot quantification found in fhFluo was 4.1 + 2.7%. 
A paired-samples t-test revealed no significant difference between the quantifi-
cation inaccuracies of both imaging modalities (p-value of 0.371).
Signal Penetration in Tissue
To study how the different modalities cope with the differences in tissue atten-
uation between radioactive and fluorescent signatures, in-depth detectability 
(< 2 cm) was studied in human skin (see Figure 4). Again, the imaging modali-
ties revealed distinct differences. The sources could be detected at all evaluated 
depths using the two nuclear imaging options (i.e. handheld gamma camera and 
fhSPECT). However, the shapes best seem to match that of the actual source at 
a 0 cm depth. In line with the resolvability experiments, the shape of the source 
was displayed with more detail (i.e. a higher resolution) using the fluorescence 
modalities. This advantage, however, disappeared at a > 0.5 cm depth due to 
clear signs of signal attenuation and diffusion. The FIS-00 camera did show a very 
diffuse fluorescence signal at 1 cm depth, though one could question if such a 
signal would provide valuable guidance during surgery. The observed attenua-
tion and diffusion trends are in line with previous studies reporting the head-to-
head comparison of signal penetrations in a phantom model [48].
Surgical Specimen Evaluation
Studies in surgical specimens containing ICG-99mTc-nanocolloid (see Figures 5 and 
6), demonstrated that the fluorescence imaging modalities (i.e. FIS-00 and fh-
Fluo) created a more detailed image of the (superficial) tracer distribution than
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Figure 3. Freehand SPECT and freehand Fluorescence imaging resolvability, navigation and rela-
tive hotspot quantification. (a) Results for image resolvability, based on two tracer sources located at 
varying distances with respect to each other, including the CrystalCam and FIS-00 reference modal-
ities. A red dotted oval indicates the resolvability limit. (b) Example images of the virtual navigation 
and relative tracer quantification found for the segmented hotspots. The distance displayed is the 































































the nuclear imaging options (i.e. CrystalCam and fhSPECT). Especially in the larg-
er tissues, multiple small foci became visible with fluorescence modalities, while 
the nuclear modalities only showed a low number of large hotspots. When ICG 
and 99mTc-nanocolloid were administered separately, a clear difference in signal 
distribution was observed in the SN and prostate specimens (see Figure 5). This 
is in line with the reported differences in tracer distribution kinetics [49].
 Both fhSPECT and fhFluo allowed for navigation towards the middle of 
the segmented hotspots in augmented- and virtual-reality views (see Figure 6). 
During navigation the numerical distance to the tip of the navigated opto-nu-
clear probe was displayed in real-time. When used for navigation on the larger 
prostate samples, fhSPECT allowed for in-depth navigation towards the large 
hotspot(s) (“tomographic imaging”), while fhFluo allowed for navigation to-
wards multiple superficial hotspots (“pseudo-tomographic imaging”). Combined 
the two technologies provided superior superficial and in-depth tomographic 
imaging.
DISCUSSION
In this study we have evaluated the integrated use of fhSPECT and fhFluo with 
a hybrid navigation concept for application in image-guided surgery. In such a 
setting, the complementary advantages of both nuclear and fluorescence im-
aging could be harnessed in a single setup. Hybrid freehand imaging offered a 
couple of additional features, not provided by more traditional hybrid systems: 
1) 3D insight in to the tracer distribution (see Figures 3b, 4 and 6); 2) AR overlay 
of the reconstructed scan, including guidance features (see Figures 4, 5 and 6); 
3) navigation towards the imaged lesions (see Figures 3b and 6); and 4) hotspot 
quantification within the image (see Figure 3b). Current fhSPECT and fhFluo ac-
quisition times (~1-5 min) are long when compared to 2D handheld gamma cam-
eras (~5-60 sec) or 2D fluorescence cameras (real time). However, by increasing 
both computing power and device sensitivity, future technical refinements (e.g. 
higher sample rates) are likely to reduce these scan times. Furthermore, tissue 
deformation in between the freehand scan acquisition and actual surgical target-
ing can influence the actual navigation accuracy [50]. The true extend of these 
limitations, however, only becomes apparent during clinical implementation of 
the technology. Luckily, the real-time audible and numerical feedback delivered 
by the opto-nuclear probe [27] will help make sure the procedural accuracy is 
not at risk [51].
 Phantom measurements indicated that the surface resolution of the pro-
totype fhFluo option was superior to that of fhSPECT (see Figure 3a) and hotspot 
quantification showed an equal accuracy (see Figure 3b). NIR optical tracking can
obstruct NIR fluorescence imaging setups [34,43]. Interestingly, obstruction of 
the opto-nuclear probe detection only occurred when the detector was posi-
tioned within an unrealistic 15 cm from the optical tracking light source; the
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Figure 4. Signal penetration in tissue for freehand SPECT and freehand fluorescence imaging, in-
cluding CrystalCam and FIS-00 reference modalities. (a) Overview of all modalities. With a tracer 
source located at different depths in human skin, nuclear imaging (CrystalCam and fhSPECT) was 
useable at all depths, fluorescence imaging (FIS-00 and fhFluo) only up to 0.5 cm. However, source 
delineation (i.e. image resolution) was highest with fluorescence imaging at these superficial depths. 
(b) Zoomed-in look at the raw tomographic slices (using Matlab, MathWorks Inc.) of the freehand 
SPECT and freehand fluorescence 3D reconstructions with the tracer source at a depth of 0 cm, 





opto-nuclear probe is typically used at a working distance of 100-250 cm with 
respect to the tracking device. Further optimization of the underlying physical 
detection models is likely to refine future fhFluo reconstructions. For example, 
recently introduced Monte Carlo based software for simulating fluorescence im-
aging setups [52,53] opens the door for high resolution ICG LUTs that even sim-
ulate tissue interaction effects. To prevent tissue deformations the opto-nuclear 
probe is not used in direct tissue contact. Consequently, the simulated LUTs will 
have to rely on a dynamic ratio of air and skin contributions, rendering this ap-
proach a challenging and computationally demanding task.
 Despite the reduced resolution of fhSPECT, this freehand technology 
supports navigation towards deeper lying tracer deposits, a feature that could 
accommodate radical surgical excision through the use of safety margins (com-
monly ~0.5-2 cm [54–57]). In agreement with previous reports on freehand 
beta+ probe imaging (fhBeta+) [58], fhFluo underlines the limitations of using im-
aging signatures that suffer from severe tissue attenuation to establish in-depth 
safety margins. On the bright side, the superficial nature of fhBeta+/− and fhFluo 
does provide a means to study surgical resection planes in detail with limited 
‘shine-through’ effect from background signals [2,41]. In such applications, the 
superior resolution of fhFluo provides valuable detail. As such, fhFluo imaging 
might provide a valuable method for in vivo 3D mapping of surgical resection 
margins, preventing positive margins and disease recurrence. By facilitating in 
vivo application during surgery, possibly in a navigation workflow, resection de-
tails could be provided before excision of the tumor mass. When fhFluo is adapt-
ed for other wavelengths, it may help provide an optical alternative for such 
indications where superficial tissue detection is in demand; e.g. glioblastoma 
surgery using 5-aminolevolinic acid fluorescence [59], or nerve sparing during 
prostatectomy using fluorescein and Cy5 [60]. Even after surgery, such fhFluo 
scans might also provide useful insight and confirmation, allowing for macro-
scopic tomographic depictions of the tracer distribution in targeted structures 
(e.g. tumor location and margins or nerve density), thereby extending what is 
possible using 3D pathology [61].
 Globally, radioguidance is routinely applied during SN procedures, ra-
dioguided occult lesion localization and radioguided seed localization [6]. With 
the increasing use of the hybrid tracer ICG-99mTc-nanocolloid during SN proce-
dures, the proposed hybrid image-guided surgery approach should be direct-
ly implementable in a broad range of indications: prostate cancer [62], penile 
cancer [63], breast cancer [22], various head and neck cancers [11,23] and cer-
vical cancer [21]. While the currently proposed fhFluo system is only applica-
ble during open surgery procedures, the recently introduced laparoscopic op-
to-nuclear probe [28] indicates a translation towards laparoscopic procedures as 
well, similar as laparoscopic freehand SPECT [36,64,65]. In addition, radioguided 
surgery is also increasingly finding its way into receptor targeted tumor resec-
tions, such as the targeting of somatostatin [66] and prostate specific membrane
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Figure 5. Imaging of prostate and sentinel lymph node specimens using freehand SPECT and 
freehand fluorescence, including CrystalCam and FIS-00 reference modalities. (a) Examples of 
imaging when a single hybrid tracer (ICG-99mTc-nanocolloid) is used. (b) Examples of imaging when 
two separate tracers are used (“free” ICG + 99mTc-nanocolloid). A small difference in color is visible 
between the FIS-00 images due to a difference in recording facilities available.
antigen [1] positive tumors. Continuous preclinical developments in to tumor-re-
ceptor targeted hybrid tracers [67,68] indicates that future use of the introduced 
technology can be envisioned when using e.g. PSMA I&F in prostate cancer 
[69], Cy5-111In-DTPA-Tyr3-octreotate for neuroendocrine tumors [70], [111In]-DT-
PA-trastuzumab-IRDye800 in breast cancer [71] or 111In-girentuximab-IRDye-
800CW in renal cancer [17]. As shown in the current study, next to complementing
fhSPECT fhFluoCrystalCam
ICG-99mTc-nanocolloid




























fhSPECT imaging of hybrid tracers, fhFluo can also be used to independently 
visualize fluorescence tracers such as ICG. Multiplexing to discriminate between 
two tracers may be used to e.g. intraoperatively differentiate between healthy 
and diseased lymphatic structures [37].
 Analogous as to how we use our smartphones with global positioning 
system (GPS) navigation to direct ourselves through a map of the city in every-day 
life, surgical navigation based on preoperative patient images (e.g. SPECT/CT) is 
increasingly used to guide lesion localization in the operating room [50]. How-
ever, when we do not use GPS-navigation in combination with dynamic data, 
live updates such as road construction and traffic jams, can render the guidance 
outdated. To this end, navigation extensions based on dynamic intraoperative 
fhSPECT and fhFluo imaging, provide a means to introduce the concept of “live 
updates” in the surgical navigation process. Just as a combination of satellite 
and local internet signals can drastically increase the precision of urban naviga-
tion due to their complementary natures [72], we reasoned the high resolution 
superficial nature of fluorescence can help refine the surgical navigation accu-
racy [33–36], a concept that is now extended with the fhFluo modality. Clinical 
studies are needed to determine if the proposed hybrid navigation setup should 
be pursued in a fully integrated fashion (i.e. fusion of fhSPECT and fhFluo visual-
izations) or in a sequential fashion where fhSPECT and fhFluo scans are acquired 
during different stages of the surgical procedure.
Figure 6. Navigation on prostate and sentinel lymph node samples, based on freehand SPECT 
and freehand fluorescence imaging. (a, c, e and g) Examples of navigation in an augmented re-
ality view. (b, d, f and h) Examples of navigation in a virtual reality view, where the tip of the 
opto-nuclear probe is positioned against the tissue surface. All distances shown are the estimated 
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CONCLUSION
In this study, we introduced a novel method of fluorescence imaging (fhFluo), 
which can be applied during image-guided surgery. We demonstrated that the 
fhFluo approach (“pseudotomographic imaging”) could complement fhSPECT 
(“tomographic imaging”) during hybrid imaging and navigation studies. Having 
both fhSPECT and fhFluo available in a hybrid navigation setup: 1) combined the 
in-depth guidance of nuclear imaging with the high resolution of fluorescence 
imaging, 2) supported the differentiation between tissue attenuation of the dif-
ferent signals, 3) allowed multiplexing of different tracers, and 4) supported aug-
mented and virtual reality multimodal visualization and guidance concepts.
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USING A DROP-IN GAMMA PROBE TECHNOLOGY
Adapted from: van Oosterom MN, Simon H, Mengus L, Welling MM, van der Poel 
HG, van den Berg NS, van Leeuwen FWB
American Journal of Nuclear Medicine and Molecular Imaging, 2016, 6(1):1-17
146 Chapter 8
ABSTRACT
In complex (robot-assisted) laparoscopic radioguided surgery procedures, or 
when low activity lesions are located nearby a high activity background, the lim-
ited maneuverability of a laparoscopic gamma probe (LGP; 4 degrees of freedom 
(DOF)) may hinder lesion identification. We investigated a DROP-IN gamma probe 
(DIGP) technology to be inserted via a trocar, after which the laparoscopic sur-
gical tool at hand can pick it up and maneuver it. Phantom experiments showed 
that distinguishing a low objective from a high background source (1:100 ratio) 
was only possible with the detector faced >90° from the high background source. 
Signal-low-objective-to-background ratios of 3.77, 2.01 and 1.84 were found for 
detector angles of 90°, 135° and 180°, respectively, whereas detector angles of 
0° and 45° were unable to distinguish the sources. This underlines the critical 
role probe positioning plays. We then focused on engineering of the gripping 
part for optimal DIGP pick-up with a conventional laparoscopic forceps (4 DOF) 
or a robotic forceps (6 DOF). DIGPs with 0°, 45°, 90°, and 135°-grip orientations 
were designed, and their maneuverability- and scanning direction were evalu-
ated and compared to a conventional LGP. The maneuverability- and scanning 
direction of the DIGP was found highest when using the robotic forceps, with the
largest effective scanning direction range obtained with the 90°-grip design (0-
180° versus 0-111°, 0-140°, and 37-180° for 0°, 45° and 135°-grip designs, re-
spectively). For the laparoscopic forceps, the scan direction directly translated 
from the angle of the grip design with the advantage that the 135°-gripped DIGP 
could be faced backwards (not possible with the conventional LGP). In the ex 
vivo clinical setup, the surgeon rated DIGP pick-up most convenient for the 45°-
grip design. Concluding, the DIGP technology was successfully introduced. Op-
timization of the grip design and grasping angle of the DIGP increased its utility 
for (robot-assisted) laparoscopic gamma tracing.
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Revolutionizing (robot-assisted) laparoscopic gamma tracing
using a drop-in gamma probe technology
INTRODUCTION
A core development in healthcare has been the integration of medical imaging 
technologies into diagnostic- and therapeutic workflows. Here, the (detailed) 
information gathered with these imaging technologies can provide preoperative
insight into both anatomical (e.g. using computed tomography (CT), magnetic 
resonance (MR) imaging, or ultrasound (US)) and functional (e.g. using single 
photon emission computed tomography (SPECT), positron emission tomography 
(PET), (lympho)scintigraphy, or optical imaging (OI)) patient aspects. Aside from 
their preoperative use, some imaging modalities can also be used in an interven-
tional setting (e.g. CT, US, gamma tracing and -imaging, or OI) where they can 
provide the surgeon with (real-time) information during the procedure.
 To date, one of the key surgical guidance tools is the handheld gamma 
probe. The gamma probe is frequently used in radioguided surgery procedures 
where it provides the surgeon with feedback with respect to the localization 
of radioactive isotopes in the surgical field [1, 2]. Using the handheld gamma 
probe, the intraoperative situation can be directly correlated to preoperative 
imaging findings (SPECT or (lympho) scintigraphy) [3, 4]. Gamma probes have 
been mainly used for procedures such as sentinel node biopsy (isotope: 99mTc), 
radioguided intraoperative margin evaluation (isotopes: 99mTc and 111In), radiogu-
ided seed localization (isotope: 125I) and radioguided occult lesion localization 
(isotope: 99mTc) [1, 5-11].
 Using different detector materials and different collimator geometries, 
gamma probes can be tailored to the procedure specific needs like field of view, 
sensitivity and energy window [1, 2]. The two main types of gamma probe detec-
tors are: 1) scintillation detectors (e.g. (thallium-doped) sodium iodine (NaI(Tl)), 
(thallium-doped) cesium iodine (CsI(Tl)) or cerium-doped lutetium oxyortho-
silicate (LSO)); and 2) semiconductor detectors (e.g. cadmium telluride (CdTe) 
or cadmium zinc telluride (CdZnTe)). Both types of detectors convert incoming 
gamma photons into an analog voltage signal that is eventually presented as an 
acoustic and numerical read-out. The attenuation properties of the collimation 
materials (e.g. lead, tungsten, gold or platinum), and the collimation thickness 
and -length can be used to fine-tune the directional specificity of gamma detec-
tion [1, 2].
 Tissue attenuation of gamma signals like the 140 keV emission of 99mTc 
is limited and since there is no native background signal the readout module 
provides a very good signal-to-noise ratio. This feature generates a powerful tool
enabling the non-invasive identification of small nodules, like sentinel nodes, 
using imaging technologies such as scintigraphy, SPECT(/CT) and gamma tracing. 
However, there also is a downside to this sensitivity, namely that the signal com-
ing from small (diseased) nodules can be obscured by background signals coming
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from the injection site or nearby anatomies harboring non-specific tracer accu-
mulation (e.g. bladder, kidneys or liver). When these signals reside within the 
field of view of the detector, it may render the weaker nodules undistinguishable
from the background. This effect is particularly limiting in an intraoperative set-
ting when using a gamma probe. Attempts have been made to lower this radia-
tion background, for example by temporary shielding the injection site [12]. Yet 
the most practical solution to this problem would be to focus the field of view of
the detector of the gamma probe on the object of interest solely, whereby the 
detector is facing the object of interest, but shielded from the background sig-
nal. In open surgery procedures this can be accomplished for a great variety of 
anatomical locations as placement of the gamma probe can occur with six de-
grees of freedom (DOF; Figure 1a and 1d).
 In an attempt to minimize the invasive nature of surgery, there has been 
a move from open to laparoscopic and, more recently, robot-assisted laparo-
scopic procedures [13]. To maintain radioguidance for e.g. the sentinel node 
biopsy procedure under these changed circumstances, extended laparoscopic 
versions of the traditional gamma probe have been created (Figure 1b) and in-
troduced into the clinic [6, 14, 15]. Requirements for this type of laparoscopic 
gamma probes are that they can be inserted through a single trocar, that their 
length is sufficient to reach the lesion of interest (distance insertion point-lesion 
of interest is typically 0-20 cm), and that the resulting maneuverability covers 
an area with a radius of roughly 15-20 cm. Combined this means that the DOF 
of the laparoscopic gamma probe is much more restricted than those of its pa-
rental version for open surgery (Figure 1d and 1e). More specifically, applying 
the gamma probe technology in a laparoscopic setting reduces the DOF from six 
(three translational and three rotational), to four (one translational and three 
rotational) thereby limiting the detectability of small nodules close to large ra-
dioactive background sources [16, 17].
 One way to compensate for the reduced maneuverability is to alter the 
angle of the detector relative to the tip from 0° to 90° [6]. Unfortunately, differ-
ent anatomical locations may require different angles of detector placement, 
essentially meaning that in a single procedure with radioactive hotspots at dif-
ferent locations, which is common during sentinel node biopsy procedures in 
prostate cancer patients [18], detectors with different angles would be required. 
Another practical disadvantage of a laparoscopic gamma probe is that it tempo-
rarily blocks the trocar that could otherwise be used to insert surgical tools that 
are of value during the resection of these lesions of interest. As a consequence 
the laparoscopic gamma probe has to be moved in and out of the patient multi-
ple times during the procedure, thereby limiting logistics [6, 7].
 In case of robot-assisted laparoscopic procedures, the surgeon is sitting 
at a distant robot control console, rather than standing beside the patient in the 
sterile field. This means that a bedside assistant has to perform laparoscopic gam-
ma tracing under verbal guidance of the surgeon. Next to the above-described
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Figure 1. Degrees of freedom (DOF) of the various gamma probe setups. (a) Typical gamma 
probe for open surgery. (b) Typical laparoscopic gamma probe with different detector angles avail-
able. (c) Novel DROP-IN gamma probe. (d) The open surgery gamma probe is placed in the wound 
area and provides movement with six unrestricted DOF. (e) The laparoscopic gamma probe is in-
serted via a trocar and is restricted to four DOF. (f) The DROP-IN gamma probe in combination 
with a non-articulated laparoscopic forceps. After insertion and picked-up, possible over different 
angles, the probe provides four DOF, inherent to the non-articulated forceps. (g) The DROP-IN gam-
ma probe in combination with an articulated forceps. After insertion and picked-up, possible over 

























































Figure 2. Insertion of the DROP-IN gamma probe through a trocar. (a) The DROP-IN gamma probe 
is introduced into the abdominal cavity by the bedside assistant. (b) After insertion the operating 
surgeon grabs the DROP-IN probe with the available surgical tool.
limitations for the laparoscopic surgical procedures, this aspect obviously limits 
the degree of control for the surgeon on the detection process during robot-as-
sisted procedures. This may lead to confusing feedback, especially when using a 
laparoscopic gamma probe with an angled detector.
 Using the DROP-IN ultrasound technology as an example [19], we rea-
soned that the use of a small-sized wired gamma probe that can be inserted 
(“dropped-in”) through a trocar would provide a flexible mode of gamma tracing 
during (robot-assisted) laparoscopic procedures. Such a modality can be directly 
manipulated using the available surgical tools (Figures 1c, 1f, 1g, 2). Taking gen-
eral engineering restrictions such as detector surface, shielding, trocar-diameter 
compatibility, cable thickness, and patient safety into account, we specifically 
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probe. Of special interest were the modus of gripping and, in an attempt to 
reduce the influence of background signals within the probe field of view, the 
angle of gripping. Subsequently, we evaluated these different approaches in a 
phantom-, ex vivo clinical- and in vivo animal setting.
METHODS
DROP-IN gamma probe
A schematic outline of the DROP-IN gamma probe is given in Figure 1c. The de-
tection and electronic principles of the DROP-IN gamma probe are similar to the 
standard open- and laparoscopic gamma probes of Eurorad S.A. (Eckbolsheim, 
France).
 The engineering process focused mostly on the mechanical aspects of 
the DROP-IN gamma probe. Essentially, with the design of the DROP-IN gamma 
probe the standard gamma probe was split in two parts: the general setup re-
mained very similar, though the fixation of the detector section to the rest of the 
gamma probe was changed from a rigid metal tube to a flexible cable. The head 
section of the DROP-IN gamma probe was designed with a diameter of 12.0 mm 
and a length of 39.8 mm. The detector in the head of the DROP-IN gamma probe
consists of a 5.0 mm × 10.0 mm (diameter × length) CsI scintillation crystal cou-
pled to a 25.0 mm2 silicon photodiode. The circular collimation applied around 
the crystal was fabricated out of densimet 176, a tungsten-nickel-iron alloy. A 4.3 
mm diameter biocompatible cable was used to connect the head of the DROP-IN
gamma probe to the rest of the probe housing and to connect the total DROP-IN 
gamma probe to the control unit Europrobe 3 (Eurorad S.A.). The outer shells 
of the DROP-IN gamma probe were constructed of medical grade 316L stainless 
steel.
Design DROP-IN gamma probe prototypes
Surgical tool of choice
To ensure accurate, reproducible and intuitive gripping of the DROP-IN gamma 
probe, the grip structure was specifically designed to match a surgical tool of 
choice. From the tools frequently used in (robot-assisted) laparoscopic surgery, 
it was believed that, for this initial proof-of-concept study, the two below-de-
scribed models would be most suitable for grasping larger objects like the DROP-
IN gamma probe: 1) An articulated forceps used in robot-assisted laparoscopic 
surgery procedures, the da Vinci ProGrasp® forceps from the EndoWrist Grasp-
ers series (Intuitive Surgical Inc., Sunnyvale, CA, USA). This tool features a double 
wrist joint that contributes to a total of six DOF available for maneuverability of
the DROP-IN gamma probe (Figure 1g); and 2) A non-articulated forceps that is 
used during laparoscopic surgical procedures (KARL STORZ Endoskope forceps, 
#33133 metal handle, #33300 metal outer sheath and #33310 ON forceps insert; 
KARL STORZ Endoskope GmbH & Co. KG, Tuttlingen, Germany). This laparoscopic
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tool delivers four DOF for maneuverability of the DROP-IN gamma probe (Figure 
1f).
DROP-IN gamma probe gripping part design
3D mechanical computer-aided design (CAD) software SolidWorks (Dassault 
Systèmes SA, Vélizy-Villacoublay, France) was used to design and optimize the 
geometries for the gripping process. Limiting these designs were: 1) The 12 mm 
trocar inner diameter: Every structure on top of, or attached to the DROP-IN 
gamma probe was bound to a maximal outer diameter of 12 mm; 2) The <5 mm 
cable diameter: Based on availability, we were constrained to a specific biocom-
patible cable with a 4.3 mm diameter. Since the maximal diameter of the grip-
ping piece is 12 mm, the current cable occupies approximately 36% (4.3/12 mm) 
of the total grip diameter. In the future this cable diameter may become smaller; 
3) Cable placement: Due to the attachment to the electronics inside the DROP-IN 
gamma probe, the cable had to originate from the central probe axis, prevent-
ing a direct off-center connection; 4) Matching forceps designs: The grip design 
had to be specifically tailored to the two forceps of interest. The grip design had 
to ensure a reproducible pickup with an accurate and stable grip with limited 
translational and rotational movement of the probe with respect to the forceps; 
5) Intuitive and facile probe pick-up by the operating surgeon: The grip structure 
had to be designed in such a way that the intraoperative application time was 
short and the surgeon user-experience was positive for both probe pick-up and 
control; 6) Stainless steel processing compatibility: The grip design had to be 
fabricated form medical grade 316L stainless steel; 7) Patient safety: The grip 
design has to have a smooth surface without any sharp edges or structures that 
can potentially lead to unintentional tissue damage during the surgical proce-
dure or when retracting the DROP-IN gamma probe after its use; 8) Sterilization 
procedure: Both the DROP-IN gamma probe geometry and the fabrication pro-
cess used should allow for sufficient probe sterilization and decontamination; 9) 
Maneuverability: The gripping position should allow for flexible detector head 
placement during surgery covering a scanning range as large as possible.
 During the design process we followed specific development steps taking 
into account the above-mentioned limitations (a schematic overview is shown 
in Figure 3): 1) An off-center gripper position, where the probe cable is directed 
from an internal center point to an offcenter exit, was developed. This allows for 
an on-center cable attachment to the electronics inside, while providing clear-
ance around the gripping structure facilitating convenient probe pick up (Figure 
3a); 2) The shape of the gripper was optimized with oblique angles to allow for a 
stable, reproducible, and conveniently grasped grip (Figure 3b); 3) To get a more 
robust design without any sharp angles, and to promote better probe extraction 
through the trocar, the optimized gripper conformation was integrated in a solid 
block (Figure 3c and 3d); 4) To further improve the ease and reproducibility of 
gripping, the walls surrounding the grip were modified so that the forceps would
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Figure 3. Grip design development steps. (a) Off-center gripper and off-center cable exit, facili-
tating convenient probe pick-up, while maintaining on-center cable origin inside. (b) Optimizing 
the shape of the gripper to the forceps, providing a convenient and reproducible probe pick-up. (c) 
Integration of the design in robust solid block design without sharp edges (view 1). (d) Integration 
of the design in solid block (view 2). (e) Modification to the walls surrounding the grip structure, 
promoting ease and reproducibility of gripping. (f) 0° grip structure displayed when grasped by 
the forceps.
lock itself onto the central gripping structure (Figure 3e). In addition, these 
rounded geometries should facilitate probe extraction through the trocar even 
further; and 5) The grip design was modified so that it could be applied in angles 
ranging between 0° and 135° with respect to the detector in the head of the 
DROP-IN gamma probe.
DROP-IN gamma probe gripping part generation
For initial tests of the grip structure, prototypes were 3D printed in either 
polylactic acid (PLA) or acrylonitrile butadiene styrene (ABS) plastics. The 
choice of material was simply a matter of 3D printer availability and did 
not impact the designed structures. 
 PLA prototypes were printed with a slightly modified 3D Touch 3D 
printer (Bits from Bytes, 3D Systems Inc., Rock Hill, USA) and the accom-
panying Axon 2 slicer software (Bits from Bytes, 3D Systems Inc., Rock Hill, 
USA). Extruder temperatures were set ranging from 195-200°C with print 
resolution at 0.125 mm for the grip designs.
 ABS prototypes were printed on the Dimension Elite 3D printer (Strata-
sys Ltd., Eden Prairie, MN, USA), with accompanying CatalystEX 4.4 slicer soft-
ware (Stratasys Ltd., Eden Prairie, MN, USA). Designs were printed at tempera-
tures of 260°C and a print resolution of 0.017 mm. The plastic prototypes were 





collimation and detector are normally located; and 2) The specifically designed 
gripping part.
 To further approximate the functioning of a working DROP-IN gamma 
probe, the probe cable was put into place and the weight was increased by fill-
ing the hollow base with lead. The resulting plastic prototypes weighed approx-
imately 11 g. Note that these plastic prototypes did not house the detection 
electronics.
 After initial plastic prototype evaluation, the most promising designs 
were fabricated out of stainless steel by Eurorad S.A. to test if the design allowed 
for metal powder sintering techniques. The real functioning DROP-IN gamma
probe prototypes weighed about 36 g each.
Evaluation process
Gamma probe detection angle evaluation
To evaluate the effect of gamma probe maneuverability on the resolvability of 
two radioactive sources in close proximity to each other, a “1 cm-grid-phantom” 
setup was used [20].
 Two 99mTc based radioactive sources were made to resemble a typical 
injection site and nearby lymph node for a case of prostate cancer for which a 
100:1 ratio in tracer uptake was chosen. The background source (resembling 
the injection site) was prepared in an entirely and homogenously filled 500 μL 
Eppendorf tube containing ~200 MBq of radioactivity calibrated for the time of 
study. The low intensity objective (resembling the lymph node) was prepared 
with ~2 MBq of radioactivity in a 200 μL Eppendorf tube calibrated for the time 
of study. To immobilize the height of the radioactivity of this low intensity objec-
tive in the tube, the tube was filled 67% with a green colored resin (AG® Anion 
Exchange Resin, Life Science, Bio-Rad Laboratories B.V. Veenendaal, The Nether-
lands) and subsequently topped with a fitting piece of tissue paper containing 
the required radioactivity after which a final layer of resin filled the remaining 
space.
 Two different setups were used to investigate the effect of different 
gamma-ray detection angles. In the first setup both the ~2 MBq source and the 
gamma detector were fixed on the grid with a 1 cm distance between the source 
and the front of the probe (Figure 4a1). The ~200 MBq source was then moved 
in half a circle (0-180 degrees) with a fixed radius of 5 cm with respect to the ~2 
MBq source. This setup simulated the movement of the gamma probe around 
a hot nodule hindered by a background signal and is referred to as the “back-
ground-angle-setup”.
 In the second setup the gamma detector head was fixed at five different 
angles (0°, 45°, 90°, 135° and 180°) while both radioactive sources were moved 
passing the detector with the same 5 cm distance between both sources (Figure 
4b1). The distance from the gamma probe head to the source path was 1 cm.
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Figure 4. Gamma detector angle evaluation in the background-angle-setup (a) and the detec-
tor-angle-setup (b). (a1) Schematic image of phantom measurements setup. The ~2 MBq source 
is at a fixed distance of 1 cm with respect to the front of the detector. The ~200 MBq source is at a 
fixed distance of 5 cm with respect to the ~2 MBq source. (a2) Resulting gamma probe signal plot-
ted versus the angle of the ~200 MBq source. Error bars plotted with the orange curve indicate ±1 
standard deviation. (b1) Schematic image of phantom measurements setup. The ~200 MBq and ~2 
MBq sources have a fixed distance of 5 cm. The fixed distance from the detector to the source path 
is 1 cm. (b2) Resulting gamma probe signal plotted for five different detector angles (0°, 45°, 90°, 
135° and 180°) when the two sources move along the position-axis. (b3) Zoom-in on the additional 
peak detected (indicated with red circle and arrow) when the detector is placed at 90°, 135° and 
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This setup provided a quantifiable form of feedback on the relation between the 
angle of detector placement and the influence of a background signal, and what 
influence this effect has on the resolvability of the two separate sources and is 
referred to as the “detector-angle-setup”.
 The readout for both setups was based on the count rates reported by 
the Europrobe 3 control unit. For every measurement the count scale was set 
to 10,000 and a counting time of 1 s was selected. For every evaluated point, 
the mean was taken of three consecutive 1 s measurements. Every complete 
measurement session was performed in triplicate with three different radioac-
tive source pairs. All signals measured were corrected for radioactive decay with 
respect to the initial activity. For presenting the data, every separate session was 
normalized to the signal measured with only the low intensity object present 
at a 1 cm distance in front of the gamma probe detector head. These resulting 
signals were used to calculate the mean and standard deviation as shown in the 
graphs.
DROP-IN gamma probe prototype evaluation
A basic laparoscopic phantom was fabricated to simulate the setup of a (ro-
bot-assisted) laparoscopic prostatectomy procedure (Figure 5a). The phantom 
consisted of a 38.7 cm diameter, 46.0 cm long PVC tube with a wall thickness of 
1.1 cm. The bottom was removed to create a level surface inside the phantom, 
resulting in a phantom height of 31.0 cm. Five pieces of ~3 mm thick rubber 
were fitted to mimic the stretch nature of skin and subsequently, holes were 
punctured and five 12 mm trocars were put in to place.
 Initial evaluation of the designed and printed plastic DROP-IN gamma 
probe prototypes was performed with the laparoscopic phantom using a motor-
ized articulated forceps (Figure 5). The generated motorized forceps setup was 
similar as described before (Integration of force feedback into minimally invasive 
robotic surgery 2007, https://www.youtube.com/watch?-v=OtFy1AF8SbQ) and 
consisted of: 1) A Pro-Grasp® forceps (Intuitive Surgical Inc.); 2) Four 12 V direct 
current (DC) transmission electro motors (20G-150, Igarashi Motoren GmbH, 
Burgthann-Ezelsdorf, Germany); 3) Four 3D printed coupling rings to couple the 
torque of the motor shaft to the four forceps wheels; 4) An acrylic plastic hous-
ing to mount all components together; and 5) A small electric circuit build to 
control all four forceps wheels in two directions.
 After the phantom evaluation, the plastic prototypes were evaluated by 
a surgeon (HGvdP) who is specialized in (robot-assisted) laparoscopic radiogu-
ided surgery procedures. Evaluation of the designed prototypes was performed 
ex vivo with the Prograsp® forceps in combination with the da Vinci Si surgical 
robot system (Intuitive Surgical Inc.) and the KARL STORZ Endoskope laparoscop-
ic forceps (KARL STORZ Endoskope GmbH & Co KG) in a typical operation room 
setup.
 In both the phantom and ex vivo surgical setting, the grip structure of
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Figure 5. Laparoscopic phantom with motorized articulated forceps. (a) Articulated forceps. (b) 
Electro motors. (c) Red PLA coupling rings. (d) Acrylic housing. (e) Laparoscopic phantom. (f) Elec-
tric control circuit.
every designed prototype-in combination with the respective forceps-was eval-
uated for: 1) Convenience of the probe pick-up: This was rated from ‘very poor’ 
(--), to ‘poor’ (-), to ‘medium’ (o), to ‘convenient’ (+), to ‘very convenient’ (++); 
2) Scanning range available for gamma ray detection: Multiple orientations of 
probe pick-up were evaluated. The axial axis, in-line with the gamma probe scan-
ning direction, was defined as the 0° axis (see also Figure 4a1). The orthogonal 
axis, perpendicular with the gamma probe scanning direction, was defined as 
the 90° axis (see also Figure 4a1). The orientation of pick-up influences the re-
sulting scanning range available for gamma ray detection. This was measured in 
degrees with respect to the axial axis; and 3) Probe fixation in forceps grip: Both 
the fixation of the grasped DROP-IN probe in the forceps and the reproducibility 
of this grip was evaluated. 
First ex vivo and in vivo evaluation of
a fully functioning DROP-IN gamma probe prototype
In addition to the evaluations as described above, a functioning DROP-IN gamma 
probe prototype was fabricated and used for a first ex vivo human tissue- and in 
vivo animal model evaluation. This DROP-IN gamma probe incorporated the first 
grip design prototype and was labeled as design 0 (Table 1).
 Design 0 was firstly evaluated in an ex vivo clinical setup (Figures 6 and 
7a). This setup consisted of a radioactive prostate and a radioactive sentinel 




These human tissue samples were obtained from a patient that underwent a 
robot-assisted radical prostatectomy combined with sentinel node biopsy and 
an extended lymph node dissection as previously described [13]. Next to a gam-
ma tracing evaluation in this setup, the surgeon evaluated the above-described 
three criteria (convenience of probe pick-up, scanning range, and probe fixation 
in the forceps grip).
 Secondly, design 0 was evaluated in an in vivo porcine animal model 
(Figure 7b). Due to the facility-restricted use of radioactive sources in animals, 
evaluation of the DROP-IN gamma probe purely focused on evaluation of the 
convenience of probe pick-up, probe maneuverability and probe fixation in the 
forceps.
RESULTS
Gamma probe detection angle evaluation
In Figure 4a2 the results are shown for the measurements of the background-an-
gle-setup, where a high-background source was moved around a fixed detector 
head-objective setup. The orange line was obtained when both the background 
and the objective sources were present in the setup. These measurements clear-
ly underline how background signal positions in a <75° angle relative to the gam-
ma probe detector head can lead to background counts that significantly exceed 
those emitted by the objective alone (blue line). In Figure 4b2 the measurements 
performed in the detector-angle-setup are presented. In the areas presented by 
the dashed line the detector was saturated. Only with the >90° positioning of 
the detector (90°, 135°, and 180°) a distinct peak of the ~2 MBq objective could 
be differentiated from the background signal (Figure 4b3). Calculating the ratio 
between the low objective peak and the lowest signal in-between the low ob-
jective peak and high background peak, the signal-low-objective-to-background 
ratio, resulted in 3.77, 2.01 and 1.84 for detector angles of 90°, 135° and 180°, 
respectively. This result further underlines the influence the angle of the detec-
tor-placement has on the diagnostic accuracy of gamma detection. Combined 
these results suggest that being able to turn the gamma probe detector head 
away from a high activity background source in an angle exceeding 90° improves 
the detection of a low activity objective.
DROP-IN gamma probe prototype evaluation
Table 1 provides an overview of the evaluated DROP-IN gamma probe prototype 
designs. During the evaluation process a 0° laparoscopic gamma probe served 
as reference.
 Since the gamma photon scanning section is located at the front end 
of the probe head, and the most commonly used (laparoscopic) gamma probes 
have a 0° scanning configuration, we designed and fabricated the initial DROP-IN 
gamma probe with an axial grip design: design number 0. From the ex vivo and
159
8
Revolutionizing (robot-assisted) laparoscopic gamma tracing



























































































































































































































































































































































































































































Figure 6. Maneuvrability of the DROP-IN gamma probe evaluated in ex vivo tissue setup with 
prototype design 0. (a-c) DROP-IN gamma probe gamma tracing of a tiny sentinel node that is 
lying directly next to the prostate. (d-f) DROP-IN gamma probe gamma tracing of the prostate. By 
changing the angle under which the DROP-IN gamma probe looks at the radioactive sources, these 
can be discriminated from each other.
in vivo experiments of this DROP-IN gamma probe, we found that gripping could 
be challenging. As can be seen in Figure 7, this was due to the central location 
of the connector cable, partly obstructing facile forceps placement over the grip 
design. Therefore, the resulting DROP-IN gamma probe prototype was rated 
‘poor’ (-) for probe pick-up. When picked-up with the nonarticulated forceps, 
this DROP-IN probe design gave the same maneuverability as the rigid laparo-
scopic gamma probe. However, in combination with the articulated forceps, ma-
neuverability was largely extended due to the extra DOFs available (see Figure 
6). While both the rigid laparoscopic gamma probe and the nonarticulated for-
ceps DROP-IN probe combination had a fixed scanning direction of 0°, the extra 
DOF with the articulated forceps allowed for a variable scanning direction of 
0-125° with respect to the axial axis. Moreover, the fixation and reproducible 
gripping of this DROP-IN gamma probe were found challenging due to the round 
shapes of the grip design. The fixation and reproducibility errors were found to 
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Figure 7. Ex vivo and in vivo gripping of DROP-IN gamma probe design 0. (a1-a2) 0° grip facing 
the radioactive prostate using the articulated forceps as seen when looking through the surgical 
goggles (surgeon view; a1) or when looked at from the side (filmed by camera; a2). (a3-a4) 90° 
grip facing the radioactive prostate using the articulated forceps as seen when looking through the 
surgical goggles (surgeon view; a3) or when looked at from the side (filmed by camera; a4). (b1-
b2) In vivo (porcine model), gripping and maneuverability of prototype design 0 were evaluated 
using an articulated forceps (surgeon view).
 The main focus of grip design 1, compared to design 0, was to optimize 
the central gripping structure for convenience of probe pick-up (see Figure 3a-b). 
This was done using a (double sided) pyramid shaped geometry that allowed the 
forceps to slide to a fixed end-position. To maintain a diameter <12 mm the cable 
had to be directed from the central probe axis to an off-center exit point at the 
probe back end. The resulting DROP-IN gamma probe prototype was rated ‘con-
venient’ (+) for probe pickup. The scanning range delivered with the nonarticu-
lated forceps setup was equal to that of design number 0 (0° with respect to the 
axial axis). The scanning range delivered with the articulated forceps setup was 
found to be 0-111° with respect to the axial axis. The fixation and reproducibility 
errors were found to be ~5° and ~1.5 mm, respectively. During probe retraction 
through the trocar, this grip design could act as a small hook on the trocar, hin-
dering the extraction process.
 Grip number 2 was designed to further reduce the fixation and repro-
ducibility errors, while improving the retraction process and maintaining usabil-
ity (see Figure 3c-e). This was achieved using tightly fitted oblique walls sur-
rounding the grip structure, which allowed the forceps to always slide back to a 
fixed end-position. To better place these oblique walls, and at the same time in-
crease the mechanical durability of the grip structure, the design was integrated 
into a solid block. The resulting DROP-IN gamma probe prototype was still rated 
‘convenient’ (+) for probe pick-up by the surgeon. The scanning range delivered




with both the nonarticulated forceps and the articulated forceps setup was 
equal to that of design number 1 (0° and 0-111° with respect to the axial axis, 
respectively; Figure 8b1 and 8b1). With this design the fixation and reproducibil-
ity errors were reduced to a negligible amount of ~0° and ~0 mm respectively. 
Probe retraction through the trocar was found to be more convenient compared 
to design number 1.
 After optimization of the grip convenience, fixation and reproducibility, 
the goal of design number 3, 4, and 5 was to optimize the scanning range ob-
tained with the DROP-IN gamma probe. By changing the grip orientation with 
respect to the axial axis, the three designs delivered 45° (design 3), 90° (design 4) 
and 135° (design 5) versions of the DROP-IN gamma probe. For all three designs 
the grip structure and the oblique walls had to be tailored to the specific forceps
orientation and openings-angle, resulting in minor variations of the design. Pro-
totype number 3 was rated ‘very convenient’ (++) for probe pick-up, due to the 
easiest approach. Prototypes 4 and 5 were rated ‘convenient’ (+) for probe pick-
up. Grasped with the non-articulated forceps, design number 3 and 4 showed a 
scan direction of 45° and 90°, respectively. Design number 5 allowed for a 135° 
scan direction, allowing to position the gamma probe detector head in a back-
wards direction (Figure 8b4). Although the grip structure of design number 5 
was not specifically designed for two-way grasping, it was also possible to grasp 
this DROP-IN gamma probe prototype in a second direction of 45°. If further 
developed, this may add an extra functionality to this design: The ability to look 
in both a forward and backwards direction. In combination with the articulated 
forceps, the scanning range for these three designs was found to cover 0-140°, 
0-186°, and 37-235° with respect to the axial axis (Figure 8c2-c4), respectively. 
With the 135° grip orientation it was thus no longer possible to scan in a straight
forward 0° direction. Figure 8a displays the obtained scanning ranges made pos-
sible with the different rigid laparoscopic gamma probe versions.
 As designed, all DROP-IN gamma probe prototypes fitted through the 12 
mm trocar. The use of the biocompatible cable and the medical grade stainless 
steel housing allowed the DROP-IN probe to be sterilized with ethylene oxide 
(ETO) sterilization methods. Complete sterilization results in overcoming the 
need for e.g. sterile draping which can interfere with reproducible and facile 
gripping of the probe.
DISCUSSION
The application of the current rigid laparoscopic gamma probes has proven to 
be challenging during complex surgical procedures such as sentinel node biopsy 
for prostate cancer [13] and gastrointestinal cancer [16,17] or radioguided local-
ization of 111In-prostate specific membrane antigen (PSMA) positive lesions [21]. 
One of the main limitations are the limited DOF that the current laparoscopic 
gamma probe setup has, rendering it difficult to accurately place the gamma
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Figure 8. Effective scanning range available with the rigid laparoscopic gamma probe versions 
(a) and the different DROP-IN gamma probe designs in combination with the laparoscopic non-
-articulated forceps (b) and the robotic articulated forceps (c). (a1-a3) Illustrate the 0°, 45° and 
90° laparoscopic gamma probe versions respectively. (b1-b4) Illustrate design number 2 (0° grip), 
3 (45° grip), 4 (90° grip) and 5 (135° grip) in combination with the non-articulated forceps, respec-
tively. For design number 5, an additional 45° application is shown in transparent. (c1-c4) Illustrate 
design number 2 (0° grip), 3 (45° grip), 4 (90° grip) and 5 (135° grip) in combination with the arti-
culated forceps, respectively. In all these articulated forceps combinations the effective scanning 

























detector. In this paper, the phantom experiments with the background-an-
gle-setup and the detector-angle-setup clearly illustrate the diagnostic benefit 
of detector maneuverability with respect to a high and low radiation source. 
Being able to turn the detector away from the high activity background source 
(typically produced by the injection site) allowed us to distinguish the low activ-
ity objective. Based on these results we therefore hypothesize that a small sized 
DROP-IN gamma probe, in combination with the right laparoscopic surgical tools 
can have great benefits in laparoscopic radioguided surgery applications.
 Similar to the small sized DROP-IN ultrasound probe presented in the 
field of intra-abdominal ultrasound [19], the DROP-IN gamma probe was de-
signed to be inserted through a trocar, after which it can be picked-up and ma-
nipulated by the (robotic) tools of the operating surgeon, as was illustrated in 
the porcine animal model. The two laparoscopic tools used for this proof-of-
concept showed a clear difference in the DROP-IN probe maneuverability. The 
greatest DOF, and therefore maneuverability, was found with the articulated 
ProGrasp® forceps, allowing to scan (with grip design number 4) in both a for-
ward 0° direction (for scanning while approaching the surgical site) and a back-
wards 180° direction (for placing the DROP-IN gamma probe in between the high 
background objective and low objectives), while also allowing the directional 
scanning angles in between (1-179°).
 Although instruments with more DOF will give higher flexibility, the 
DROP-IN gamma probe can also be of value in combination with more conven-
tional non-articulated laparoscopic tools. For example, the combination of grip 
design number 5 and the non-articulated KARL STORZ Endoskope laparoscopic 
forceps allowed backwards directed scanning (135°), which is impossible with 
current rigid laparoscopic gamma probes. This 135° scanning direction facil-
itates the placement of the DROP-IN gamma probe in-between high activity 
background signals and low activity objectives, while possibly allowing forward 
facing detection (45°) when using the reversed gripping modus. 
 In the ideal situation gamma probes have no limitations on maneuver-
ability, harboring the freedom to scan in every direction of the abdominal cavity, 
focusing on (low) objective radiation while avoiding (high) background radiation. 
In this study, only the angle of the grip was changed with respect to the DROP-IN 
gamma probe, grasping the entire probe over different angles and so creating 
an as-large-as-possible scan direction range. Just as with the rigid laparoscopic 
gamma probe, it would also be possible to place the detector itself at different 
angles in the gamma probe [1,2]. Adjusting this element of the probe could open 
up additional interesting possibilities; for example: if a 45° detector placement 
would be combined with the 135° probe grip, that could also be grasped over 
45°, it would be possible with the nonarticulated laparoscopic forceps used in 
this study, to scan in a direction of 0° and 180° with the same DROP-IN gamma 
probe. The DROP-IN gamma probe technique as described in this study, is there-
for not limited to the tools used in this study. Slight adaptations to the grasping
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part will allow versions of the DROP-IN gamma probe to complement other ded-
icated surgical tools.
 Because the DROP-IN gamma probe technology is controlled with the 
surgical tools the surgeon has at hand during the procedure, positioning should 
be intuitive directly following the movement of the surgical tools. The impact of 
this feature will be most prominent in robot-assisted laparoscopic procedures 
where the surgeon is positioned away from the operating table. Additionally, 
during robot-assisted laparoscopic procedures, the surgeon has often three ro-
bot arms available with which can be worked. With these three arms, the arm 
holding the DROP-IN gamma probe can be positioned in such a way that the 
surgeon can monitor the removal of the target lesion in real-time as performed 
by the two other arms. The latter is similar to that used during open surgery [22]. 
Contrary to the rigid laparoscopic gamma probe, with the <5 mm diameter cable 
of the DROP-IN probe it will be possible to share a trocar (typically 12-14 mm) 
with different laparoscopic tools (typical diameter: 6 mm). This avoids the need 
of an extra trocar, and allows the probe to stay in the abdominal cavity during 
the entire procedure. This particular feature helps to further minimize the im-
pact on the surgical procedure. 
 Besides providing acoustic radioguidance, (laparoscopic) gamma probes 
have also been used to produce a freehand SPECT scan in the operating room 
for example during parathyroidectomy and sentinel node biopsy procedures for 
breast and head and neck cancer [23-27]. In this technique a surgical navigation 
or tracking system is used to record every position of the gamma probe (or small 
handheld gamma camera) during scanning, thereby linking the measurements 
found to the corresponding location in space. To perform a freehand SPECT scan, 
it is important that sufficient information is acquired from different positions 
and orientations with respect to the tissue of interest [28]. For this reason, we 
imagine that the availability of DROP-IN gamma probes may enable a superior 
form of intra-abdominal freehand SPECT [29].
 The DROP-IN probe technology isn’t restricted to gamma radiation only, 
but can possibly also be extended to other forms of molecular imaging. With the 
proper adjustments, DROP-IN probes might be applied to the fields of for exam-
ple beta radiation [2, 30], Cherenkov [31], (lifetime) luminescence [32] and even 
optoacoustic imaging [33].
CONCLUSION
The DROP-IN gamma probe technology increases the degrees of freedom with 
which laparoscopic gamma tracing can be performed. Herein the angle of grip-
ping has proven to be the most critical engineering feature. Tailoring the grip 
design and angle helped in improving reproducible and easy grasping, while 
increasing the detection range and reducing the negative influence that back-
ground signals can have during gamma tracing procedures.
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ABSTRACT
The purpose of this review is to provide an overview of the developments made 
for virtual- and augmented-reality navigation procedures in urological interven-
tions/surgery. Recent findings show that navigation efforts have demonstrated 
potential in the field of urology by supporting guidance for various disorders. 
The navigation approaches differ between the individual indications, but seem 
interchangeable to a certain extent. An increasing number of pre- and intra-op-
erative imaging modalities has been used to create detailed surgical roadmaps, 
namely: (cone-beam) computed tomography, MRI, ultrasound, and single-pho-
ton emission computed tomography. Registration of these surgical roadmaps 
with the real-life surgical view has occurred in different forms (e.g. electromag-
netic, mechanical, vision, or near-infrared optical-based), whereby the combi-
nation of approaches was suggested to provide superior outcome. Soft-tissue 
deformations demand the use of confirmatory interventional (imaging) modali-
ties. This has resulted in the introduction of new intraoperative modalities such 
as DROP-IN US, transurethral US, (DROP-IN) gamma probes and fluorescence 
cameras. These noninvasive modalities provide an alternative to invasive tech-
nologies that expose the patients to X-ray doses. Whereas some reports have 
indicated navigation setups provide equal or better results than conventional 
approaches, most trials have been performed in relatively small patient groups 
and clear follow-up data are missing. However, the reported computer-assisted 
surgery research concepts do provide a glimpse in to the future application of 
navigation technologies in the field of urology.
KEY POINTS
• At present, soft-tissue deformations demand the use of interventional imag-
ing or tracing modalities that confirm the real-world surgical target location.
• Due to their dose exposure, intraoperative use of X-ray-based imaging de-
vices is undesirable, and technologies that provide a noninvasive alternative 
(e.g. gamma probes, US, and fluorescence) are much in demand.
• Early clinical studies have demonstrated the potential of virtual reality and 
augmented reality models (2D and 3D) to improve the surgical (navigation) 
accuracy.
• To date, a plurality of surgical navigation approaches has become available, 
thereby covering a range of urological interventions.
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INTRODUCTION
The impact of computer technologies on life in the western civilization is an 
undeniable fact. One of the many advancements that has been created is the 
availability of navigation systems. Using, for example, smartphones, we are now 
able to accurately determine our geographic location and navigate ourselves ef-
ficiently from point A to point B, while even dynamically responding to devia-
tions from the plotted route (Figure 1). Such navigation is made possible using 
a combination of urban roadmaps and satellite-based tracking systems such as 
the global positioning system (GPS). We, and others, have reasoned that a sim-
ilar navigation concept, when translated to surgical interventions, could great-
ly impact healthcare. Building on the advancements made in medical imaging 
technology, anatomy and/or disease-related images of individual patients can 
be created. Such images can, subsequently, be used to provide detailed and in-
teractive surgical roadmaps [1]. This computer-assisted surgery (CAS) concept 
creates the potential to increase the accuracy of lesion identification, and with 
that improves the surgical accuracy, logistics, and decision-making (Figure 1) [2]. 
Herein, surgical roadmaps can be used in different forms: they can be presented
separately in the operating room or next to the laparoscopic-feed to allow the 
operating urologist to study the targeted tissue in detail during the procedure; 
they can be presented via virtual reality displays that provide, for example, 
Figure 1. Analogy comparing navigation in everyday life with navigation during surgery. Similar 
to navigation approaches applied during everyday life (a), a surgeon can use a combination of 
guidance technologies to guide himself or herself quickly and efficiently to the surgical target [e.g. 
tumor, (metastatic) lymph node or kidney stone] (b). These technologies can follow each other in 
consecutive order: disease description (‘Descriptive’), two-dimensional preoperative imaging (‘2D 
map’), three-dimensional preoperative imaging (‘3D map’), ‘GPS-like’ virtual reality navigation 
(‘VR navigation’), ‘GPS-like’ augmented reality navigation displays (‘AR navigation’) and intraoper-
















distance-to-target estimations; they can be presented as augmented reality over-
lays onto the real-world environment using (laparoscopic) video-feeds (Figure 1).
 While rough navigation on a general anatomic map was already at-
tempted as early as 1889, ‘modern patient-specific’ navigation (that is naviga-
tion based on individual patient scans) has only been used since 1986 [2]. At 
present, the field of surgical navigation offers a plurality of navigation concepts 
and methods. Most of these have been applied in neurological and orthopedic 
surgery, where the rigidity of the surgical field supports the alignment between 
the surgical roadmap and the actual surgical field. Soft tissues are, however, sub-
ject to movement – a feature that inherently complicates the registration pro-
cess [3]. Nevertheless, due to their high potential, soft-tissue related navigation 
efforts have been explored in a translational research setting, as discussed in a 
number of reviews relevant for the topic [1–7]. During the past years, naviga-
tion in the field of urology has rapidly expanded, including novel indications and 
first-in-human applications. To provide a structured report of these evolutionary 
progressions, we have classified them into navigation for disorders in the urinary 
system or reproductive organs.
URINARY SYSTEM
Navigation efforts for urinary disorders are mainly focused on nephrolithotomy 
(urolithiasis) and nephrectomy (renal cell carcinoma). For these applications, 
(cone-beam) computed tomography (CT) – the modality proposed for these indi-
cations in the European Association of Urology guidelines – is the main modality 
used for the creation of the roadmap that provides the basis for the navigation-
process [8,9].
Navigation during percutaneous nephrolithotomy
Rassweiler et al. [10,11] has clinically applied navigation technologies during 
nephrolithotomy using a futuristic iPad tablet-assisted guidance approach (Figure 
2a). Using CT-derived roadmaps, this approach provides a movable two-dimen-
sional augmented reality ‘window into the body,’ thereby facilitating the optimal 
access site for needle puncture. Roadmap-to-patient registration was realized 
using a vision-based tracking setup, encompassing the two-dimensional cam-
era of the iPad and radiopaque colored fiducial markers, placed on the patient’s 
skin. During needle puncture, fluoroscopy allowed adjustments to be made from 
the plotted needle course. A comparison to traditional ultrasound-fluoroscopy 
combinations, yielded a similar outcome, but also revealed that significantly 
higher X-ray doses and longer puncture times occurred with the iPad approach 
[11]. Incorporation of electromagnetic needle tracking was proposed as a future 
refinement. In a porcine study, Rodrigues et al. demonstrated that the incorpo-
ration of an electromagnetic sensor at both the needle and catheter-tip allowed 
needle placement to be performed by relying on the electromagnetic tracking
175
9
Computer-assisted surgery: virtual- and augmented-reality displays 
for navigation during urological interventions
Figure 2. VR and AR technologies for navigation in the urinary system. (a) iPad-assisted percu-
taneous access to the kidney during nephrolithotomy, providing CT-based AR ‘window in to the 
body’ [12]. (b) CT-based VR model of renal cell carcinoma, to be used parallel to (RA)LPN, provid-
ing insight in the tumor-surrounding vasculature [13]. (c) AR overlay of kidney and tumor models 
(including intra-abdominal fiducials) in the real-time fluoroscopy images for (RA)LPN [14]. (d) AR 
overlay of tumor model in the real-time laparoscopic-feed using metabolizable and fluorescent 
fiducials [15]. 
and vision of the ureteral fiberscope only [16]. After placement of the cathe-
ter tip next to the kidney or ureter stone via ureterorenoscopy, electromagnetic 
tracking supported real-time monitoring of the needle tip and stone relative to 
each other, abandoning the need for fluoroscopy. Integration of electromagnetic
needle tracking and the iPad approach could thus help limit the X-ray dose while 
allowing visualization of the needle trajectory with respect to the organ models 
[17] (Figure 3a). In a similar percutaneous setup, interventional radiology (that 
is ablations of lesions in the kidney) indicated that electromagnetic-based nav-
igation of ultrasound devices in preinterventionally acquired CT or MRI image 
planes improves the accuracy of needle placement [19–21]. Hence, the future 
use of US navigation could also help to further refine the needle-tracking tech-
nology.
 Despite the potential advantages of electromagnetic tracking, fluoros-
copy and (cone-beam) CT devices were shown to reduce the electromagnet-






has partially overcome this electromagnetic-tracking inaccuracy in static envi-
ronments [22]. Unfortunately, such technologies do not (yet) apply for dynamic 
surgical environments [e.g. moving (robot-assisted) surgical tools] [1].
Navigation during nephrectomy
During (robot-assisted) laparoscopic partial nephrectomy [(RA)LPN], various 
forms of CAS have been applied. Furukawa et al. [13] used a CT-based three-di-
mensional virtual reality roadmap of the kidney, tumor, and vasculature that fa-
cilitates selective arterial clamping presented in the surgeon’s console parallel to 
the laparoscopic feed using the TilePro function (Figure 2b). A comparison of this 
approach with traditional clamping procedures not only indicated virtual reality 
assistance was feasible, it was also shown to reduce the decrease in estimated 
glomerular filtration rates early after surgery [24]. Here, the use of an iPad can 
help facilitate the interaction with the virtual reality model, thereby improving 
the intraoperative appreciation of the hilar vascular anatomy [25]. Alternative-
ly, Wang et al. [26] describe the use of a manually positioned two-dimensional 
augmented reality overlay, presenting a CT-model in the laparoscopic feed (i.e. 
static screenshots). Comparisons between patients receiving augmented reality
guidance and those that went without, suggested the technology could help re-
duce the operating time and reduce blood loss values. For open liver surgery, 
similar manual two-dimensional augmented reality overlays have been helpful 
in localizing multiple tumor lesions within the organ [27]. Ukimura and Gill [21] 
used a near-infrared (NIR) optical tracking system (OTS) to support the automat-
ic alignment of such augmented reality CT models in the two-dimensional lap-
aroscopic feed, during (non-robotic) LPN. Although they indicate the navigation 
accuracy was sufficient for determination of the resection line, the need for a 
technology able to correct for tissue deformations was also mentioned.
 For intra-abdominal vision-based tracking, colored and radiopaque nee-
dle-shaped fiducials were fixed in the kidney surface as to support the alignment
of the cone-beam CT models with the two-dimensional real-time laparoscopic 
and two-dimensional fluoroscopy feed (Figure 2c) [14]. Though the navigated 
setup was successful, the increased X-ray dose was considered to be a limitation 
for wider implementation. Whereas the use of intra-abdominally placed fidu-
cials did seem to support image registration, others have reported some limita-
tions related to such an approach: fiducials could potentially physically hinder 
the tumor resection; visualization of the fiducials in the surgical environment 
could be challenging; and both placement (before navigation) and removal (after 
navigation) adds to the invasiveness of the procedure [1]. As alternative, metab-
olizable fiducials (CT-opaque and fluorescent) have been suggested (Figure 2d) 
[15]. Extension with fluorescence, however, does rely on the surgical procedures 
to be performed with a laparoscope capable of fluorescence imaging.
 To increase the acceptance of US guidance during RALPN, an innovative 
DROP-IN US probe was designed [28,29] (Figure 4). This DROP-IN probe can be
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Figure 3. VR and AR technologies for needle-navigation to prostate lesions. (a) CT-based VR mod-
el of the prostate displaying current needle track with respect to different organ models [17]. (b) 
MRI-based navigation for targeted biopsy of the prostate displayed over the real-time TRUS imag-
es [12]. (c) MRI-only-guided VR navigation for targeted biopsy in a phantom study [18]. 
positioned with superior degrees of freedom, using laparoscopic tools. Via lap-
aroscopic vision-based tracking of a chequered-pattern fiducial on the DROP-IN 
US (comparable to those used for crash test dummies), the two-dimensional US 
images could be directly projected as augmented reality overlay in the laparo-
scopic feed (Figure 4a). Combined with tracking of the robotic arms, this helped 
realize a three-dimensional navigation in a phantom setup (Figure 4b-c) [30,31].
REPRODUCTIVE ORGANS
For the reproductive organs, navigation efforts have been reported for the pri-
mary tumor and lymphatic involvement. In this application, next to ultrasound 
and MRI, also single-photon emission computed tomography (SPECT/CT), radio-
tracing, and fluorescence imaging have been used during the guidance process.
Navigation towards the primary tumor lesions
Transrectal US (TRUS)-guided biopsy in prostate cancer is commonly performed 
based on the lesion location defined by preoperative MRI images [32]. Recently, 
next to research systems, three-dimensional MRI-based navigation of TRUS has 
become commercially available (Figure 3) [33]. For registration, electromagnet-
ic tracking, mechanical tracking, and image-based registrations have been used 
[33]. To enhance the insight into the relevant anatomy (e.g. prostate–bladder in-
terface, seminal vesicles, distal prostate boundary, lesion location, biopsy tracks,
neurovascular bundles, and urethra), TRUS-based navigation has also been ap-
plied in robot-assisted laparoscopic prostatectomy (RALP). Using US vision-based 





Figure 4. DROP-IN US technology. (a) In-vivo application during (RA)LPN [28]. An AR overlay is 
shown directly in the laparoscopic-feed, displaying the real-time ultrasound imaging within the an-
atomical context. (b) Tracked DROP-IN ultrasound was used to generate a 3D model of the tumor 
(c) for navigation in a phantom (RA)LPN setup [30]. 
automatically followed the position of the robotic tools, displaying the relevant 
US plane in the surgical console using the TilePro function [34]. Similar to such 
an automatic TRUS setup, robotic US acquisition has shown promising results 
for reproductive assistance and guidance for interventions in the abdomen [35]. 
The intraoperative use of three-dimensional virtual reality displays (based on 
preoperative TRUS and MRI) parallel to the laparoscopic-feed during RALP was 
said to further refine the resection accuracy in the vicinity of the cancer lesion, 
yielding 90% negative surgical margins [36] (Figure 5a). Such virtual reality mod-
els have also been suggested to facilitate nerve-sparing during pelvic surgery 
[38]. To enhance the urologist’s preoperative appreciation of the patient anato-
my (i.e. ‘virtual therapy concept’), the virtual reality models were also three-di-
mensionally printed [39]. To further increase the information integration, for 
example, the neurovascular bundle and the biopsy proven cancer region, the 
use of direct augmented reality overlays in the two-dimensional laparoscopic 
feed have been studied (Figure 5b-c) [21,37]. The first study used a NIR OTS for 
the registration, thereby supporting the identification of an appropriate resec-
tion line. The second study used vision-based tracking of fiducial pins (colored 
and echogenic) placed in the prostate surface to realize the augmented real-
ity alignment. In the latter setup, to prevent tumor spillage, the fiducial pins 
had to be removed together with the prostate itself. Unfortunately, both setups 
suffered from surgery-induced tissue deformations [21,37]. Lanchon et al. used 
transurethral US (TUUS) as alternative for TRUS [40]. In a phantom study using 
(US) vision-based tracking of fiducial pins, augmented reality models, formed us-
ing motorized TUUS, were displayed on the two-dimensional laparoscopic feed. 
Alternatively, the above mentioned DROP-IN US probe technology may in the 
future also support US navigation during prostatectomy [28,29]. In indications, 
where electromagnetic tracking is feasible, perhaps also commercially available 
US-navigation setups, as applied in interventional radiology, may find their way 
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Figure 5. VR and AR technologies during prostatectomy. (a) A TRUS/MRI-based VR model to be 
used in parallel to the laparoscopic view [36]. Different structures are shown: prostate (pink), ure-
ter (blue), neurovascular bundles (yellow), biopsy-proven tumor lesion (red), and tumor biopsy 
cores (green (tumor negative) and red (tumor positive) cylinders). (b) After placement of intraab-
dominal fiducials (colored and echogenic pins in the prostate surface), (c) TRUS-based AR overlay 
of the prostate (green) and neurovascular bundles (blue) could be shown during (RA)LP [37].
Navigation for the management of lymphatic disease
Navigated approaches have successfully been used to identify lymph nodes sus-
pected to harbor metastases. Uniquely, in these procedures, nuclear molecular 
imaging approaches, namely preoperative SPECT/CT and intraoperatively ac-
quired freehand (fh)SPECT [41], have provided the roadmaps for navigation.
 The PSMA-specific tracer 111In-PSMA-I&T has supported the radio-guided 
resection of metastasis-harboring lymph nodes during open salvage procedures 
[42]. Preoperative PET/CT or PET/MRI using 68Ga-PSMA-HBED-CC supported pa-
tient selection and procedural planning. Intraopertively, fhSPECT was success-
fully applied to display the lesion location in two-dimensional augmented reality 
and support three-dimensional virtual reality navigation of a gamma probe (NIR 
OTS tracking) [42] (Figure 6). The acoustic readout of the gamma probe support-
ed compensation of navigation inaccuracies when present. A similar navigation 
approach, using SPECT/CT, was used to identify (sentinel) lymph nodes that ac-
cumulated indocyanine green (ICG)-99mTc-nanocolloid [44]. In addition to acous-
tic gamma-tracing, non-integrated NIR fluorescence imaging was used as confir-
matory modality. To integrate fluorescence imaging in the navigation workflow, 
SPECT/CT- or fhSPECT-based navigation of the fluorescence camera itself was 
applied in both prostate and penile cancer patients [43,45,46]. In these studies, 
an augmented-reality-SPECT(/CT) overlay was presented in the two-dimensional 
fluorescence camera feed and supported the detection of the injection site (pri-
mary tumor) and sentinel lymph nodes (Figure 6). Fluorescence imaging allowed 
for high-resolution real-time correction of deformation-induced navigation inac-
curacies. Phantom studies indicated this same navigated fluorescence camera 
concept could become an integral part of robot-assisted procedures [47].
 In an attempt to improve the radio-guidance during laparoscopic inter-
ventions, a DROP-IN gamma probe was developed, and evaluated during early 
B CA
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robot-assisted porcine surgery and on ex-vivo clinical specimens [48] (Figure 7a). 
To connect this technology to the CAS concept, in a phantom setup, a combina-
tion of chequered pattern vision-based, NIR OTS, and mechanical tracking, sup-
ported the generation of DROP-IN fhSPECT-images and the according navigation 
approaches (Figure 7b) [49].
DISCUSSION
During the past decade, a lot of exciting and promising CAS developments have 
opened the way for navigation setups to be used in urology. 
 Registration of (preoperative) imaging datasets with the surgical view 
helps to generate virtual reality and augmented reality environments that sup-
port the navigation process in two- or three-dimensions. The greatest limitation 
for these navigation setups so far is the registration accuracy and resulting navi-
gation precision. This is also the area where further technical improvements are 
urgently needed. A consequence of the current inaccuracies is the requirement
that virtual reality and augmented reality navigation approaches have to be 
benchmarked against the real-world surgical environment. This is especially crit-
ical when the surgical procedures are performed in soft-tissue structures that 
suffer from surgically induced deformations. In that sense, navigation proce-
dures do not replace the surgeon’s expertise, but rather improve the procedural 
accuracy and efficiency by increasing both insight in the anatomy/disease and 
the focus on the anatomies critical for surgery. In the end, the urologist is still 
required to make his/her expert call on the execution of the procedure. The 
quality of the virtual reality and augmented reality displays, however, can greatly
influence the value of navigation approaches. Therefore, improved visualization 
methods that determine which virtual data are displayed during different phases 
of the surgical procedure (i.e. relevance-based virtual reality/augmented reality) 
[50], or visualization methods that facilitate improved augmented reality inte-
gration into the real-world surgical view (e.g. three-dimensional depth percep-
tion) [1] should be considered.
 To link the navigation process to the real-world surgical environment, 
some form of real-time imaging feedback is instrumental. When the targets can-
not be defined by eye, dedicated intraoperative imaging modalities provide out-
come, for example, fluoroscopy, US, gamma tracing/imaging, or fluorescence 
imaging. The modality of choice, then, is predominantly defined by the char-
acteristics of the target and the modality’s neutrality with regard to enhanced 
patient burden. This means that invasive approaches, for example, X-ray mo-
dalities or the requirement of placing invasive fiducial markers, should ideally 
be replaced by the non-invasive alternatives that have become available during 
recent years.
 The intraoperative imaging modality should also be able to accurately 
track the visualization of the targeted tissue with respect to a navigation reference
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Figure 6. VR and AR technologies for navigation in the management of lymphatic disease. (a) 
Intraoperative setup of navigated gamma probe (using NIR OTS tracking) towards metastatic LNs 
during open salvage prostatectomy (navigation based on fhSPECT) [42]. (b) SPECT/CT-based nav-
igation of a fluorescence camera towards sentinel LNs in penile cancer. AR SPECT/CT overlay was 
shown in the 2D camera-feed. (c) 3D VR navigation of a gamma probe towards sentinel LNs in 
prostate cancer. (d) fhSPECT-based navigation of a fluorescence laparoscope towards sentinel LNs 
in prostate cancer, using an AR overlay directly shown in the 2D laparoscopic-feed [43]. (e) AR 
overlays guided the fluorescence laparoscope to the vicinity of the LN. (f) Fluorescence imaging 
(fluorescence is shown in blue) confirmed the precise target location (g) not clearly visible by eye.









Figure 7. DROP-IN gamma probe technology. (a) Ex-vivo application of the DROP-IN gamma 
probe, scanning LN package and prostate. (b) Tracked DROP-IN gamma probe (using a combina-
tion of tracking techniques) to create fhSPECT images for navigation purposes in a laparoscopic 
phantom LN setup [49].
frame (i.e. the position of the target with respect to the navigated tools). Again, 
the indication and operating room setup define the most ideal tracking approach. 
That said, a combination of tracking techniques will most likely provide the high-
est accuracy [49,51]. For needle-based procedures, electromagnetic tracking 
and/or the more experimental fiber bragg grating tracking techniques will possi-
bly work best [52]. Electromagnetic tracking, however, currently suffers from the 
use of metal equipment in the surgical environment. Hence, for surgical resec-
tions, a combination of NIR OTS, mechanical-tracking, and vision-based-track-
ing (e.g. using machine learning methods such as deep-learning) seems to hold 
most promise [53]. These preferences may, however, change when the individ-
ual technologies evolve.
CONCLUSION
Although there is still a lot of room for refinement, we believe the presented 
navigation efforts provide the first steps towards a promising future for comput-
er-assisted urological surgery. This is strengthened by parallel developments in 
medical imaging devices, disease-specific tracers (e.g. 99mTc-PSMA-I&S) [42], and 
surgical tools. The up rise of robot-assisted procedures, thereby, provides a valu-
able platform for the integration of new modalities, for example, fluorescence 
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In the quest to achieve precision surgery, the work described in this thesis in-
troduces several novel (hybrid) detection and navigation modalities. All the 
presented engineering efforts focused on optimal detection and localization of 
cancer-related tissue using the complementary tracer signatures of either nucle-
ar and fluorescence radiation, or a combination thereof, using so-called hybrid 
tracers. These newly developed image-guided surgery technologies were eval-
uated in different settings, ranging from phantom work to pre-clinical and even 
clinical studies.
 Part one of this thesis covered several surgical navigation concepts. In 
chapter 2 the general concepts for a typical surgical navigation workflow were 
introduced. Important requirements are: 1) some form of imaging, providing a 
3D map of the disease; 2) computer-aided planning using the patient map; 3) 
registration of the patient map to the actual patient on the operating table; 4) 
position and orientation tracking of the patient and surgical tools in the operat-
ing room; and 5) navigation of the surgical tools towards the tissue of interest. 
This all constitutes to a workflow wherein the surgeon knows exactly where the 
surgical tools are on the patient map, relative to the targeted tissue. Apart from 
the fields of neurosurgery, radiotherapy and perhaps orthopedic surgery, the 
application of navigation remains experimental, mainly due to the inability to 
cope with, or compensate enough for, tissue-deformation-induced inaccuracy of 
the navigation workflow. Nevertheless, the studies shown, combined with the 
advances in the underlying technology, suggest that the use of surgical naviga-
tion will be much more widespread in the near future.
 Chapter 3 demonstrated the concept of using nuclear-based navigation 
to position the robot integrated fluorescence laparoscope within the vicinity of 
the targeted lesion during robot-assisted laparoscopic surgery, using the hybrid 
tracer ICG-99mTc-nanocolloid, which is both radioactive and fluorescent. Phantom 
evaluations showed a navigation accuracy of 2.25 mm (coronal plane) and 2.08 
mm (sagittal plane) when navigation was based on preoperative SPECT/CT scans. 
When navigation was based on freehand SPECT (fhSPECT) scans, these accura-
cies were 1.92 mm (coronal plane) and 2.83 mm (sagittal plane). In comparison 
to the <1 cm detection limit of fluorescence imaging, this would indicate that the 
navigation inaccuracies could be compensated using the real-time fluorescence 
feedback as provided by the fluorescence laparoscope. Therefore, these initial 
phantom experiments suggest that SPECT-based navigation of the robot-inte-
grated fluorescence laparoscope has the potential to aid fluorescence-guided 
surgery procedures for lesions positioned deep within the patient anatomy.
 In chapter 4, the navigated fluorescence camera concept was translated 
to a system applicable for both open and laparoscopic surgery, using a detachable 
exoscope and laparoscope respectively. Initial phantom evaluations revealed 
an overall tool-to-target distance accuracy of 2.1 mm for SPECT/CT-based and
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3.2 mm for fhSPECT-based navigation. The augmented reality registration accu-
racy was found to be 1.1 and 2.2 mm, respectively. Evaluations in open (penile 
cancer) and laparoscopic (prostate cancer) navigation were successful and accu-
rate enough to localize the fluorescence signals of the targeted tissues in vivo. 
This proof-of-concept study suggest that the single hybrid navigation setup stud-
ied is applicable in various open and laparoscopic surgical applications.
 The studies evaluated in chapter 3 and 4, combined with the work of 
KleinJan et al. [1], revealed that using near-infrared optical tracking, obstructed 
fluorescence imaging of open surgery fluorescence cameras. Chapter 5 thor-
oughly investigated the different components of this interference aspect and 
recommended possible solutions. The different measurements performed indi-
cated that interference was caused by: (1) spectral overlap between the opti-
cal tracking system (OTS) light emitted and the fluorescence camera detection 
range, (2) OTS light intensity, (3) OTS duty cycle, (4) OTS emission frequency, (5) 
fluorescence camera measurement frequency, and (6) fluorescence camera sen-
sitivity. Optimization of points 2-4 already indicated OTS and fluorescence cam-
era compatibility can be used to support the navigated fluorescence guidance 
concept, even in open surgical procedures.
 Part two of this thesis introduced several detection modalities, further 
supporting the translation of molecular imaging towards intraoperative guid-
ance. Chapter 6 described the engineering of a multimodal animal imaging plat-
form, capable of imaging bioluminescence, fluorescence and SPECT emission 
signatures, optimally supporting preclinical hybrid tracer development. Phan-
tom and in vivo mice evaluations indicated accurate imaging of all three signals 
(i.e. bioluminescence, fluorescence and SPECT). Hereby, the acquired SPECT and 
bioluminescence scans were used to place the fluorescence imaging results in to 
perspective: for example, by showing tracer accumulation in non-target organs 
such as the liver and kidneys (SPECT) and by giving a semi-quantitative read-out 
of the tumor spread (bioluminescence). This revealed the advantages of a fully 
integrated imaging platform, optimally using the complementary scans to im-
prove data interpretation during research.
 Chapter 7 explored how the generation of a novel freehand Fluores-
cence (fhFluo) imaging approach could complement fhSPECT in a hybrid setup. 
Next to the generation of fhSPECT scans, the conceived hybrid modality was 
capable of creating (pseudo-)3D fluorescence tomography scans. The imaging 
resolution of fhFluo (1 mm) was found to be superior to that of fhSPECT (6 mm), 
however, fhFluo was confined to a maximum depth of 0.5 cm, while fhSPECT 
imaging was usable at all depths (evaluated <2 cm). Both fhSPECT and fhFluo 
allowed for augmented- and virtual-reality navigation towards tracer hotspots, 
segmented in the image. Imaging in prostate and sentinel lymph node specimens 
confirmed these trends: fhSPECT has a lower resolution but a more in-depth de-
tectability, while fhFluo harbors a superior resolution, but only supplies superfi-
cial detectability. Overall, using radioactive and fluorescent (hybrid) tracers, this
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chapter showed that fhFluo has complementary value to fhSPECT, rendering a 
unique hybrid imaging/navigation modality.
 Chapter 8 focused specifically on improving detection of the nuclear 
tracer emissions during robot-assisted laparoscopic surgery. To this end, a teth-
ered and highly flexible DROP-IN gamma probe was developed which could op-
timally benefit from the flexible wrists of a (robot-assisted) laparoscopic forceps, 
increasing intra-abdominal maneuverability. In comparison to a conventional 
laparoscopic gamma probe (allowing for movements with 4 degrees of freedom 
(DOF)), a DROP-IN combination allowed for 6 DOF with a robotic forceps. Phan-
tom experiments underlined the importance of this maneuverability, showing 
that distinguishing a low radioactive lesion (e.g. SN) from a high radioactive 
background (e.g. prostate) was only possible with the detector faced >90° away 
from the high background source. Further evaluation in phantom, ex vivo clinical 
(i.e. prostate and SN specimens) and in vivo porcine studies all influenced the 
different prototype designs of the DROP-IN geometry. After thorough investiga-
tion of the probe pick up grip design, the surgeon favored a 45°-grip at the distal 
end of the probe. Introduction and optimization of the first DROP-IN gamma 
probe prototypes indicated a better integration of using radioguidance during 
(robot-assisted) laparoscopic surgery. The clinical potential of this technology 
was recently demonstrated during prostate cancer related robot-assisted lapa-
roscopic SN procedures [2].
 In chapter 9, the outlook of this thesis, the introduced (hybrid) detection 
and navigation modalities were linked to an overview of the general research 
developments made for virtual- and augmented-reality computer-assisted pro-
cedures in urological interventions. Many different approaches were shown for 
both the urinary system (including nephrolithotomy and nephrectomy) and the 
reproductive organs (including primary tumor lesions and lymphatic spread). 
Within these fields, the detailed surgical roadmaps were created with pre- or in-
tra-operative forms of (cone-beam) CT, MRI, ultrasound and SPECT imaging mo-
dalities. Registration of these surgical roadmaps with the real-life surgical view 
was performed using mainly electromagnetic, mechanical, vision or near-infra-
red optical-based tracking techniques, whereby the combination of approaches 
was suggested to provide superior outcome. Unfortunately, soft-tissue defor-
mations remain one of the most challenging obstacles in this field of soft-tissue 
surgery, demanding the use of confirmatory interventional detection modalities. 
This has resulted in the introduction of new intraoperative detection modalities 
such as DROP-IN US, transurethral US, (DROP-IN) gamma probes and fluores-
cence cameras. Although most techniques are evaluated in small patient groups 
and there is still a lot of room for refinement, the presented navigation efforts 
might provide the first steps towards a promising future for computer-assisted 
surgery in urology, hopefully improving surgical accuracy and clinical outcome.
 In conclusion, the different detection and navigation modalities engi-
neered and investigated in this thesis, all used the complementary values of
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nuclear and fluorescence tracer signatures to optimally guide the surgeon during 
the resection of cancer-related tissue. Hopefully, these image guided surgery ap-
proaches can all help to move the field towards a more precise, less invasive and 
more effective surgical procedure. While initial clinical evaluations were tailored 
towards SN procedures in urology (i.e. prostate and penile cancer), all presented 
techniques are of such a nature, that they could easily be applied in many differ-
ent (hybrid) tracer-based surgical procedures. Such procedure already include 
hybrid SN procedures in head and neck cancer [3,4], SN in cervical cancer [5], 
SN in breast cancer [6] and radioguided occult lesion localization procedures [7]. 
Recent developments of tumor-receptor targeted hybrid tracers should open up 
many other applications in the (nearby) future, including localization of the pri-
mary tumor and metastatic spread in renal cancer (e.g. using an 111In-girentux-
imab-IRDye800CW tracer) [8], neuroendocrine tumors (e.g. using a Cy5-111In-DT-
PA-Tyr3-octreotate tracer) [9] and prostate cancer (e.g. using a PSMA I&F tracer) 
[10]. Alternatively, modalities like the introduced DROP-IN technology have also 
proven value during receptor targeted surgery, in specific PSMA guided resec-
tion of lymphatic metastases [11].
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Strevend naar precieze chirurgie, beschrijft dit proefschrift de introductie van 
verschillende nieuwe (hybride) detectie- en navigatie-modaliteiten. Al de gep-
resenteerde technieken focussen op optimale detectie en lokalisatie van kank-
er-gerelateerd weefsel door gebruik te maken van tracers met complementaire 
radioactieve of fluorescente eigenschappen, of een combinatie daarvan in een 
hybride tracer-ontwerp. Deze nieuwe beeldgeleide chirurgie-technologieën zijn 
geëvalueerd in verschillende omgevingen, variërend van fantoomwerk tot prek-
linische en zelfs klinische studies.
 Deel één van dit proefschrift omvat meerdere chirurgische navi-
gatie-concepten. In hoofdstuk 2 werden de algemene componenten voor een 
typisch chirurgisch-navigatie proces geïntroduceerd. De belangrijkste vereisten 
zijn: 1) een methode van beeldvorming voor het genereren van een 3D-kaart 
van de door de ziekte aangedane locaties; 2) computerondersteunde planning 
gebruikmakend van de patiëntenkaart; 3) registratie van de patiëntenkaart met 
de echte patiënt op de operatietafel; 4) positie- en oriëntatie-tracking van de 
patiënt en chirurgische instrumenten op de operatiekamer; en 5) navigatie van 
de chirurgische instrumenten naar de beoogde weefsels in de patiënt. Samen-
gevoegd vormen deze stappen een proces waarbij de chirurg precies weet waar 
zijn instrumenten zijn op de patiëntenkaart, ten opzichte van de vooraf bep-
aalde weefsels. Naast het gebruik in neurochirurgie, radiotherapie en orthope-
dische chirurgie, is het gebruik van navigatie tijdens chirurgie nog van exper-
imentele aard. Dit komt voornamelijk doordat huidige navigatiesystemen niet 
goed genoeg onnauwkeurigheden als gevolg van weefseldeformaties kunnen 
compenseren. Desondanks scheppen de genoemde studies, in combinatie met 
de ontwikkeling van de onderliggende technologie, goede hoop dat het gebruik 
van chirurgische navigatie wijdverspreid zal toenemen in de nabije toekomst.      
 Hoofdstuk 3 demonstreerde het concept om met behulp van nucle-
air-gebaseerde navigatie de fluorescentie-laparoscoop te geleiden naar vooraf 
bepaalde weefsels tijdens robot-geassisteerde laparoscopische chirurgie. Belan-
grijk onderdeel hierin is de hybride tracer ICG-99mTc-nanocolloid, welke zowel 
radioactief als fluorescent is. Fantoom-evaluaties van deze navigatie-opstelling 
lieten een nauwkeurigheid zien van 2.25 mm (coronaal vlak) en 2.08 mm (sagitta-
al vlak) wanneer navigatie was gebaseerd op preoperatieve SPECT/CT scans. Met 
navigatie gebaseerd op freehand SPECT (fhSPECT), waren deze nauwkeurigheden 
1.92 mm (coronaal vlak) en 2.83 (sagittaal vlak). In vergelijking met de <1 cm 
detectie-grens voor fluorescentiebeeldvorming, zou dit betekenen dat de nav-
igatie-onnauwkeurigheden gecompenseerd zouden kunnen worden door geb-
ruik te maken van de nauwkeurige en rechtstreekse fluorescentiebeeldvorming. 
Daarmee wekt dit fantoom-onderzoek de verwachting dat SPECT-gebaseerde 
navigatie van de robotische fluorescentie-laparoscoop, fluorescentie-geleide 
chirurgie kan helpen wanneer laesies diep in de patiënt gepositioneerd zijn. 
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 In hoofdstuk 4 werd het concept van een genavigeerde fluorescen-
tie-camera verder uitgewerkt naar een systeem dat bruikbaar is voor zowel open 
als laparoscopische chirurgie, door gebruik te maken van een verwisselbare exo- 
en laparoscoop. Ook hier werd eerst de navigatie-nauwkeurigheid onderzocht 
in een fantoom-opstelling, resulterend in een algemene instrument-tot-doel 
nauwkeurigheid van 2.1 mm (SPECT/CT navigatie) en 3.2 mm (fhSPECT navi-
gatie). Registratie van de augmented reality navigatie-beelden toonde een nau-
wkeurigheid van 1.1 mm (SPECT/CT navigatie) en 2.2 mm (fhSPECT navigatie). 
De hierop volgende evaluatie tijdens open chirurgie (peniskanker) en laparosco-
pische chirurgie (prostaatkanker) was succesvol en accuraat genoeg om de flu-
orescente weefsels terug te vinden in de patiënten. Hiermee toont deze studie 
aan dat het hybride navigatie-concept mogelijk van waarde is in verschillende 
open en laparoscopische chirurgische toepassingen. 
 In combinatie met eerder gepubliceerd werk van KleinJan et al. [1], 
lieten hoofdstuk 3 en 4 zien dat dichtbij infrarode optische tracking interfereert 
met de fluorescentiebeeldvorming voor open chirurgie. In hoofdstuk 5 werden 
de verschillende componenten van dit probleem grondig onderzocht en de 
mogelijke oplossingen hiervoor aangeboden. De verrichte metingen maakten 
duidelijk dat de interferentie wordt veroorzaakt door een samenspel van: (1) de 
spectrale overlap tussen het licht dat wordt gebruikt door het optische tracking 
systeem (OTS) en het detectie-bereik van de fluorescentie-camera, (2) de OTS 
lichtintensiteit, (3) de OTS arbeidscyclus, (4) de OTS emissie-frequentie, (5) de 
fluorescentie-camera meet frequentie, en (6) de fluorescentie camera gevoe-
ligheid. Optimalisatie van punten 2-4 gaf al aan dat optische tracking weldegelijk 
gebruikt kan worden in het kader van de genavigeerde fluorescentie camera, 
ook voor open chirurgie.
 Deel twee van dit proefschrift introduceerde verschillende detectie-mo-
daliteiten, voortbouwend aan de translatie van moleculaire beeldvorming naar 
intra-operatieve begeleiding. Hoofdstuk 6 beschreef het ontwerp en de con-
structie van een multimodale scanner voor moleculaire beeldvorming in dieren. 
Met de mogelijkheid tot het in beeld brengen van bioluminescentie, fluores-
centie en SPECT straling, bood dit systeem een optimaal platform voor de prek-
linische ontwikkeling van hybride tracers. Fantoom-evaluaties en in vivo mui-
zen-evaluaties onderschreven de kwaliteiten van de drie individuele technieken. 
Hierbij boden SPECT en bioluminescentie een manier om behaalde resultaten 
met fluorescente beeldvorming in perspectief te plaatsen, door bijvoorbeeld 
tracer-opname in achtergrondweefsel zoals de lever en nieren weer te geven 
(SPECT) en verspreiding van de tumor in kaart te brengen (bioluminescentie). 
Dit onderstreepte het voordeel van één compleet geïntegreerd systeem waar 
optimaal gebruik wordt gemaakt van de complementaire-scan eigenschappen 
om data-collectie en interpretatie te verbeteren in het onderzoek.
 Hoofdstuk 7 onderzocht hoe de ontwikkeling van een nieuwe freehand 
Fluorescence (fhFluo) modaliteit complementair kan zijn aan fhSPECT in een
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hybride opstelling. Naast het produceren van fhSPECT scans, gaf dit hybride sys-
teem de mogelijkheid om (pseudo-)3D fluorescentie tomografie-scans te pro-
duceren. De beeldvormende resolutie van fhFluo (1 mm) bleek superieur aan die 
van fhSPECT (6 mm). Echter, de fhFluo beeldvorming was beperkt tot een diepte 
van 0.5 cm, terwijl fhSPECT beeldvorming bruikbaar was op alle geëvalueerde 
diepten (<2 cm). Zowel fhSPECT als fhFluo gaven de mogelijkheid tot augment-
ed- en virtual-reality navigatie richting tracer hotspots, zoals gesegmenteerd in 
de beelden. Beeldvorming in prostaat- en schildwachtklier-weefsels bevestigde 
de trend: fhSPECT geeft een lagere resolutie met meer diepte-informatie, terwijl 
fhFluo een superieure resolutie levert voor oppervlakkige signalen. Daarmee liet 
dit hoofdstuk zien, gebruik makend van radioactieve en fluorescente (hybride) 
tracers, dat fhFluo complementaire waarde heeft ten opzichte van fhSPECT en 
een unieke beeldvorming- en navigatie-modaliteit levert.
 Hoofdstuk 8 focust specifiek op het verbeteren van de detectie van ra-
dioactieve tracers tijdens robot-geassisteerde laparoscopische chirurgie. Voor 
dit doel is er een bekabelde, kleine en uiterst flexibele DROP-IN gamma probe 
ontwikkeld welke in de intra-abdominale ruimte opgepakt wordt en welke tij-
dens scannen optimaal gebruik maakt van de gewrichten in de bestaande (ro-
botische) laparoscopische tangen. In vergelijking met de conventionele lapa-
roscopische gamma probe (die beweging met 4 vrijheidsgraden biedt), bleek 
de manoeuvreerbaarheid van de DROP-IN gamma probe in combinatie met de 
robotische tangen veel groter (beweging met 6 vrijheidsgraden). Fantoom-ex-
perimenten onderstreepten het belang van deze manoeuvreerbaarheid door te 
laten zien dat het onderscheiden van een laagradioactieve laesie (bijv. schild-
wachtklier) ten opzichte van een hoogradioactieve achtergrond (bijv. prostaat) 
alleen mogelijk was als de detector ≥90o weggedraaid kon worden van deze hoge 
achtergrond. Het ontwerp van verschillende prototype DROP-IN behuizingen 
werd verder beoordeeld in fantoom-studies, ex vivo klinische weefsel-studies 
(d.w.z. prostaat- en schildwachtklieren) en in vivo varkens studies. Na gron-
dige evaluatie van het oppak-ontwerp, gaf de chirurg de voorkeur aan een grip 
over 45o distaal gepositioneerd op de probe. Introductie en optimalisatie van 
de eerste DROP-IN gamma probe prototypes gaf aan dat radiogeleide chirurgie 
op deze manier beter geïntegreerd wordt met (robot-geassisteerde) laparosco-
pische chirurgie. Recent heeft de eerste klinische studie inderdaad de potentie 
van deze vorm van radiogeleide chirurgie laten zien tijdens robotische schild-
wachtklier procedures in prostaatkanker [2].
 In hoofdstuk 9 van dit proefschrift, het toekomstperspectief, werden de 
geïntroduceerde (hybride) detectie- en navigatie-modaliteiten geplaatst in een 
overzicht van de algemene wetenschappelijke ontwikkelingen voor virtual- en 
augmented-reality computerondersteunde procedures binnen de urologie. Veel 
verschillende benaderingen werden aangehaald voor zowel het urinewegstelsel 
(inclusief nefrolithotomie en nefrectomie) als het voortplantingssysteem (inclusief 
primaire tumor laesies en lymfatische uitzaaiingen). Binnen deze verschillende
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toepassingen werd de gedetailleerde patiëntenkaart gegenereerd met behulp 
van pre- of intra-operatieve beeldvorming, waaronder (cone-beam) CT-, MRI-
, ultrasound- en SPECT-modaliteiten. Registratie van deze chirurgische ‘road-
map’ en het intra-operatieve veld gebeurde over het algemeen met elektromag-
netische-, mechanische-, beeldanalyse- of dichtbij infrarood optische-tracking 
technieken. Dit wekte de indruk dat een combinatie van deze technieken su-
perieure resultaten geeft. Helaas is gebleken dat zachte-weefsel-deformaties 
nog steeds één van de grootste obstakels is in dit veld van zachte-weefsel chir-
urgie, waardoor validatie met intra-operatieve detectie-modaliteiten nodig bli-
jft. Dit heeft echter wel geresulteerd in de introductie van nieuwe intra-operati-
eve detectie-modaliteiten, zoals de DROP-IN US, transurethraal US, (DROP-IN) 
gamma probes en fluorescentie camera’s. Hoewel de meeste technieken alleen 
geëvalueerd zijn in kleine patiënten-groepen en er nog veel ruimte is voor verfi-
jning, bieden de gepresenteerde navigatie-technieken wel een mogelijke eerste 
stap in de richting van een veelbelovende toekomst voor computerondersteun-
de chirurgie binnen de urologie, waarbij chirurgische precisie en medisch resul-
taten verbeterd worden.
 De verschillende detectie en navigatie modaliteiten, zoals ontworpen en 
onderzocht in dit proefschrift, maakten allemaal gebruik van de complementaire 
eigenschappen van radioactieve en fluorescente tracers om de chirurg optimaal 
te begeleiden in het verwijderen van kanker-gerelateerd weefsel. Hopelijk kun-
nen deze beeldgeleide technieken bijdragen om het chirurgische veld vooruit te 
brengen richting preciezere, minder ingrijpende en meer effectieve procedures. 
Hoewel de eerste klinische evaluaties gericht waren op de schildwachtklierpro-
cedure binnen de urologie (d.w.z. prostaat- en peniskanker), zijn al de gepresen-
teerde technieken van dien aard dat ze met relatief weinig moeite ook overgezet 
kunnen worden naar vele andere (hybride) tracer-gebaseerde chirurgische 
procedures. Voorbeelden hiervan binnen de huidige chirurgie zijn de hybride 
schildwachtklierprocedures in hoofd-halskanker [3,4], baarmoederhalskanker 
[5] en borstkanker [6] en de radiogeleide lokalisatie van verborgen laesies [7]. 
Daarnaast openen de recente ontwikkelingen op het gebied van tumor-receptor 
gerichte hybride tracers de weg naar nog veel meer toepassingen in de (nabije) 
toekomst, inclusief de lokalisatie van primaire tumor en uitzaaiingen in nierkank-
er (bijv. met de tracer 111In-girentuximab-IRDye800CW tracer) [8], neuro-endo-
crine tumoren (bijv. met de tracer Cy5-111In-DTPA-Tyr3-octreotate) [9] en pros-
taatkanker (bijv. met de tracer PSMA I&F) [10]. Daarnaast laten modaliteiten 
zoals de geïntroduceerde DROP-IN technologie nu al hun waarde zien binnen de 
tumor-receptor gerichte chirurgie, in het bijzonder met PSMA-gerichte resectie 
van lymfeklier-uitzaaiingen bij prostaat kanker [11].
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